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ABSTRACT 
 
Nowadays, new spinal cord injury (SCI) cases are frequently due to non traumatic causes, 
especially vascular disorders. A prerequisite to developing mechanism-based 
neuroprotective strategies for acute SCI is a full understanding of the early 
pathophysiological changes to prevent later disability and paralysis. The immediate 
damage spreads from the initial site through excitotoxicity and metabolic dysfunction 
(ischemia, free radicals and neuroinflammation) to surrounding tissue (secondary 
damage). Using an in vitro neonatal rat spinal cord model, an experimental protocol 
(pathological medium, PM) has been developed to mimic the profound metabolic 
perturbation (hypoxia, aglycemia, oxidative stress, acidosis, toxic free radicals) occurring 
in vivo after ischemic SCI, a condition surprisingly worsened by extracellular Mg2+ (1 mM). 
The current study sought to identify the cells affected by PM (with Mg2+), and the 
associated molecular death pathways in the spinal lumbar region which contains the 
locomotor networks. The results indicated that 1 h PM+Mg2+ application induced delayed 
pyknosis chiefly in the spinal white matter via overactivation of poly (ADP-ribose) 
polymerase 1 (PARP1), suggesting cell death mediated by the process of parthanatos and 
also via caspase 3-dependent apoptosis. Grey matter damage was less intense and 
concentrated in dorsal horn neurons and motoneurons which became nuclear-
immunoreactive for the mitochondrial apoptosis-inducing factor. Moreover, TRPM2 
channel expression was enhanced 24 h later in dorsal horn and motoneurons, while 
TRPM7 channel expression concomitantly decreased. Conversely, TRPM7 expression 
grew earlier (3 h) in white matter cells, while TRPM2 remained undetectable. Our results 
show that extracellular Mg2+ amplified the white matter cell death via parthanatos and 
apoptosis, and motoneuronal degeneration via PARP1-dependent pathways with distinct 
changes in their TRPM expression. In fact, the PARP-1 inhibitor PJ34, when applied 30 
min after the moderate excitotoxic insult, could protect spinal networks controlling 
locomotion in more than 50 % of preparations. Interestingly, the drug per se strongly 
increased spontaneous network discharges without cell damage. Glutamate ionotropic 
receptor blockers suppressed this phenomenon reversibly. Our results suggest that 
pharmacological inhibition of PARP-1 could prevent damage to the locomotor networks if 
this procedure had been implemented early after the initial lesion and when the lesion was 
limited. PJ34 had also a positive effect on PM+Mg2+ treated spinal cords, especially in the 
white matter after 24 h, both alone or administered together with caspase-3 inhibitor. The 
neonatal rat in vitro SCI model was also useful to study the activation of endogenous 
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spinal stem cells. We identified the ATF3 transcription factor as a novel dynamic marker 
for ependymal stem/progenitor cells (nestin, vimentin and SOX2 positive) located around 
the central canal of the neonatal or adult rat spinal cord. While quiescent ependymal cells 
showed cytoplasmic ATF3 expression, over 6-24 h in vitro these cells mobilized and 
acquired intense nuclear ATF3 staining. The migration of ATF3-nuclear positive cells 
preceded the strong proliferation of ependymal cells occurring after 24 h in vitro. 
Pharmacological inhibition of MAPK-p38 and JNK/c-Jun, upstream effectors of ATF3 
activation, prevented the mobilization of ATF3 nuclear-positive cells. Excitotoxicity or 
ischemia-like conditions did not enhance migration of ependymal cells at 24 h. ATF3 is, 
therefore, suggested as a new biomarker of activated migrating stem cells in the rat spinal 
cord in vitro that represents an advantageous tool to study basic properties of endogenous 
stem cells. 
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INTRODUCTION 
 
1. SPINAL CORD INJURY 
1.1 Definition, statistics and symtomps 
Spinal cord injury (SCI) is due to damage to the spinal cord that causes dysfunction, with 
loss of sensory and motor function distal to the point of injury (Hulsebosch, 2002). SCI, 
either traumatic or non-traumatic, often produces long-terme effects with lifelong 
consequences, associated with severe disabilities which are of great concern to the 
person affected, but also to their family and society as whole (van den Berg et al., 2010). 
SCI is particularly troubling because it predominantly occurs in young, otherwise healthy 
individuals, with injury occurring with the greatest frequency in those between 15 and 25 
years of age. SCI occurs worldwide with an estimated annual incidence of 15–40 cases 
per million per year and every 5 cases, 4 affect males (Rowland et al., 2008). Total direct 
costs of caring for individuals with spinal-cord injury exceed $7 billion per year in the USA 
(McDonald and Sadowsky, 2002). SCI may induces one or more of the following 
symptoms: paralysis, loss of sensation such us the possibility to feel cold, heat and touch, 
hyper reflexia or spasms, loss of bowel and bladder control,  loss of sexual function and 
pain. The spinal cord is divided in cervical, thoracic, lumbar and sacral segments. 
Depending on what group of muscles, organs and sensation are affected, paralysis can be 
referred to as tetraplegia (or quadriplegia), when the level of injury is above the first 
thoracic vertebra, or paraplegia, when the level of injury occurs below the first thoracic 
spinal nerve (Figoni, 1984; Harkey et al., 2003). Of the estimated 12,000 new cases of 
quadriplegia and paraplegia that occur in the United States each year, 5000 die (Sekhon 
and Fehlings, 2001). Despite significant improvements in the early medical and surgical 
management and progress in neuroscience research, at the present day the 
pathophysiology of the SCI remains largely unknow and there are no effective treatments 
to improve neurological outcomes following SCI (Rowland et al., 2008). 
 
2.EPIDEMIOLOGY OF SCI. 
2.1 Complete and incomplete SCI 
No matter of its origin, and in relation to the forces involved in the injury (Harkey et al., 
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2003), from a clinical point of view a SCI can be complete, with no motor or sensory 
functions below the level of injury, or incomplete, when motor or sensory functions below 
the level of injury remains. The clinical scale established by American Spinal Injury 
Association (ASIA) divides patients in five categories, from A to E, depending on the 
severity of neurological loss: 
A = Complete. No sensory or motor function is preserved in the sacral segments S4-5. 
This will result in complete paraplegia or tetraplegia. 
B = Sensory Incomplete. Sensory but not motor function is preserved below the 
neurological level and includes the sacral segments S4-5 and no motor function is 
preserved more than three levels below the motor level on either side of the body. 
C = Motor Incomplete. Motor function is preserved below the neurological level, and more 
than half of key muscle functions below the neurological level of injury have a muscle 
grade less than 3. 
D = Motor Incomplete. Motor function is preserved below the neurological level, and at 
least half of key muscle functions below the neurological level of injury have a muscle 
grade more than 3. 
E = Normal. Sensory and motor functions are normal, in all segments.  
(http://www.asia-spinalinjury.org/elearning/ISNCSCI_ASIA_ISCOS_low.pdf). 
 
2.2 Traumatic SCI 
According to National Spinal Cord Injury Statistical Center (NSCISC) report, published in 
2012, in the United States the three leading causes of spinal cord injury from 2010 to 2012 
were traumatic (figure 1). Vehicular accidents, including cars and motorcycles, ranked as 
the leading cause of SCI (36.5%), even if there was a steady decrease in this percentage 
of SCI causes from 46.9 percent (1990-1994) to 36.5 percent (2010-2012). Falls ranked 
second (28.5%) followed by acts of violence, primarily gunshot wounds (14.3%). A 
decrease in the percentage of SCI due to sports-related activities from 14.4 to 9.2% 
occurred during the last twenty years. During the last decade there has been a significant 
increase in SCI as consequence of falls, probably due to aging of the population 
(https://www.nscisc.uab.edu/reports.aspx). A progressive increase of traumatic spinal cord 
diseases among older adults has been observed, from 79.4 per million older adults in 2007 
to 87.7 by the end of 2009, but remained steady among younger adults (Selvarajah et al., 
2013). 
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accidents
36.5%
Falls
28.5%
Violence
14.3%
Sports
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Other / 
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11.4%
 
Fig. 1. Causes of traumatic SCI from 2010 to 2012 
(https://www.nscisc.uab.edu/reports.aspx). 
 
2.3 Non-traumatic SCI 
A trend has been observed toward increased incidence in non-traumatic causes of SCI, 
which today account for about 30-50% of spinal cord disorders (Nair et al., 2005) and 
constitute a major risk factor for medical complications during rehabilitation such us 
thrombosis, spasticity or wound infections (McKinley et al., 2002). Non-traumatic SCI 
originates from vertebral stenosis, tumors, vascular ischemia, inflammatory conditions or 
cardiovascular disorders that comprise a cluster of post- surgical paralysis after abdominal 
aorta surgery (van den Berg et al., 2010; Nair et al., 2005). Although non-traumatic lesions 
are usually incomplete, the clinical symptoms are severe, and include paralysis and 
sensory dysfunction (van den Berg et al., 2010; Nair et al., 2005; Bianchetti et al., 2013), 
while traumatic SCI is four times more common in men than in women, gender is not a 
significant factor in non-traumatic diseases, even if women with SCI tend to suffer more 
from pain and depression (Nair et al., 2005). In contrast with traumatic SCI, there is a 
steady increase in incidence rate of non-traumatic SCI with advancing age. This may be 
due to the fact that etiologies in non-traumatic injuries are particularly associated with age-
related conditions, such as tumor compressions, degeneration or vascular problems (van 
den Berg et al., 2010). 
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3. PHASES OF SCI 
A detailed understanding of the pathophysiological processes occourring after acute SCI is 
a fundamental issue, as a prerequisite to develop mechanism-based neuroprotective 
strategies. Several elements of the injury response, including inflammatory response and 
reactive astrogliosis, have been found to act pathologically (Rowland et al., 2008). The 
interval from spinal cord injury to death ranges from 20 minutes to 9 months (Tator and 
Koyanagi, 1997). SCI responses that occur after injury have been divided into three 
phases: the immediate (or primary), secondary and chronic injury processes (Hulsebosch, 
2002; Tator, 1995). 
 
3.1 Primary injury phase (1-2 h) 
The primary phase of a traumatic SCI involves the initial mechanical insult, causes fracture 
and/or dislocation of the spinal column which directly imparts force to the spinal cord, 
disrupting axons plus damage to blood vessels and cell membranes (Hulsebosch, 2002; 
Rowland et al., 2008), and last up to 2 h (Norenberg et al., 2004). Within minutes following 
injury, the first sign is edema of the cord, due to exudation of fluid from capillaries, usually 
accompanied by parenchymal hemorrhages of the white and grey matter (Kakulas, 2004; 
Quencer et al., 1986). The resulting ischemia may extend both caudal by and rostral by to 
the injury site (Tator and Koyanagi, 1997). During this initial process, necrosis of the 
central grey matter is usual, due to the direct damage of the cell membranes and ischemia 
(Hulsebosch, 2002; Kakulas, 2004). At the same time, the injured nerve cells respond with 
an upregulation of proinflammatory cytokines TNFα and IL-β resulting in activated 
microglia (Papa et al., 2013; Pineau and Lacroix, 2007) and with an injury-induced barrage 
of action potentials together with electrolytic shifts, involving the monovalent and divalent 
cations Na+ (intracellular concentrations increase), K+ (extracellular concentrations 
increase), and Ca2+ (intracellular concentrations increase to toxic levels), that contribute to 
failure in normal neural function and spinal shock (Hulsebosch, 2002). The consequent 
depolarization induces a massive release of neurotrasmitters, including glutamate, whose 
extracellular concentration can rise to excitotoxic levels and open glutamate receptor-
operated ion channels, e.g. NMDA and AMPA (Wrathall et al., 1996). The pathology of SCI 
is due to secondary phenomena and not due directly to the primary traumatic event (Lipton 
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and Rosenberg, 1994); there may be a window of opportunity during the immediate phase 
for downregulating the harmful cascade of secondary events (Norenberg et al., 2004). 
 
3.2 Secondary injury phase (2h to 2 weeks) 
A typical feature of SCI is the delayed onset of a secondary lesion, with cell death affecting 
the initially spared neighboring tissue through complex mechanisms. It is the phase likely 
to be most amenable to neuroprotective interventions for practical reason, because it is 
typically the earliest point at which patients arrive at an appropriate center to receive 
treatment (Rowland et al., 2008). Secondary injury can be subdivided into early acute and 
subacute stages (Hulsebosch, 2002; Rowland et al., 2008). Two to 48 h following injury 
are the early acute phase, where the ischemic cellular death, increasing edema and 
inflammation continue after the immediate phase. The vascular dysfunction resulting in 
ischemia, ionic disregulation, free radical production and glutamate-mediated excitotoxicity 
is fully developed, inducing neuronal and glial cell death (Kakulas, 2004; Lipton and 
Rosenberg, 1994; Tator and Koyanagi, 1997). The inflammatory process involves cell 
populations including astrocytes, microglia, T cells, neutrophils and monocytes (David and 
Kroner, 2011; Donnelly and Popovich, 2008; Papa et al., 2013). Less severe injuries show 
a variety of axonal and myelin changes (Tator, 1995). The subacute phase continues for a 
maximum of two weeks after injury. It is characterized by a strong phagocytic response 
that could be beneficial in removing cell debris (Donnelly and Popovich, 2008). Delayed 
astrocytic response starts in this phase: the periphery of the lesion becomes hypertrophic 
and proliferative with a strong increase in glial fibrillary acid protein expression. The 
number of reactive astrocytes locally increases to produce scar-associated compounds 
which form the glial scar with negative anatomo-pathological consequences for spinal 
network connections. They have also beneficial effects, promoting the restoration of ionic 
homeostasis (Herrmann et al., 2008; Pineau and Lacroix, 2007). Primary and secondary 
injury after the spinal cord insult occur following different time points, shown in figure 2. 
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Fig. 2. Time course of primary and secondary injury after the spinal cord insult. Very early 
after the initial injury, excitotoxic mechanisms can damage neurones and glia. In addition, 
the initial damage triggers a number of events that can further contribute to the demise of 
the tissue, including depolarizations and the more-delayed mechanisms of inflammation, 
ischemia and programmed cell death (modified from Dirnagl et al., 1999). 
 
3.3 Intermediate phase (2 weeks to 6 months) 
During the intermediate phase, lasting up to 6 months, maturation of the scar produced by 
astrocytes continues, flanked by regenerative axonal sprouting which is, however, 
insufficient for recover from severe SCI (Hill et al., 2001). 
 
3.4 Chronic phase (>6 month ) 
The later phase continues lifelong. In this phase there is a stabilization of the lesion with 
Wallerian degeneration, astroglial and mesenchymal scar formation, development of cysts 
and syrinx (a syrinx is a cavity superficially similar to the cyst but with a denser gliotic wall) 
accompanied by delayed neurological dysfunction (Norenberg et al., 2004). The “Wallerian 
degeneration” is a process which may take years to complete, inducing the anterograde 
disintegration of axons and their demyelin sheaths that have been transected following 
injury. It is characterized by distorted and fragmented myelin sheaths with axoplasm. 
Eventually the astroglial scar replaces the destroyed myelinated axon, while on the one 
hand, products of reactive astrocytes derived from areas of Wallerian degeneration have 
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been reported to dampen neurite outgrowth (Bovolenta et al., 1992; Ehlers, 2004; 
Norenberg et al., 2004). The spectrum of chronic spinal cord injuries encompasses 
myelomalacia, a pathological term referring to the softening of the spinal cord, 
representing the final stage. 
 
4. MOLECULAR MECHANISMS UNDERLYING CELL DEATH AFTER SCI 
Death of CNS neurons during acute injury occurs as a result of a complex combination of 
excitotoxicity, necrosis, apoptosis, edema and inflammatory reactions (Aarts and 
Tymianski, 2005a; figure 3). One process contributing to the propagation of delayed cell 
death after an acute SCI is ischemia, which is strongly correlated with excitotoxicity and 
oxidative stress.  
 
 
Fig. 3. Mechanisms underlying secondary spinal cord injury are complex and strength 
correlated (Hall and Springer, 2004). 
5-LO = 5-lipoxygenase; TXA2 = thromboxane A2; LTs = leukotrienes; 
ONOO- = peroxynitrite anion; PMN = polymorphonuclear leukocyte. 
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4.1 Excitotoxicity 
The loss of ionic homeostasis which follows SCI in few minutes and the excitotoxic 
process are strongly correlated. Excitotoxicity is a process of cell death caused by 
overactivation of excitatory aminoacid receptors often resulting in neuronal cell death (Park 
et al., 2004; Szydlowska and Tymianski, 2010), caused by the action of excitotoxins like 
neurotransmitters (Olney, 1969). Glutamate is the principal excitatory neurotransmitter in 
the central nervous system (CNS), released by vesicles from the presynaptic terminals into 
the synaptic cleft. Excitotoxic process is primarily propagated through the glutamate 
postsynaptic receptor family, especially ionotropic receptors (NMDA, AMPA and kainate 
receptors; Aarts and Tymianski, 2003; Grant et al., 1997; Kumar et al., 1991) and/or Ca2+ 
permeable receptors (TRPM2 and TRPM7; Aarts et al., 2003; Kaneko et al., 2006; 
Perraud et al., 2001). Activation of ionotropic receptors leads to enhanced permeability to 
Na+, K+ and/or Ca2+. The overload of Ca2+ or perturbations of intracellular Ca2+ 
compartmentalization, as shown schematically in figure 4, can activate or enhance 
pathways leading to cell death (Szydlowska and Tymianski, 2010). Persistent activation of 
NMDA receptors causes a high influx of Ca2+ into the postsynaptic neuron due to activation 
of self-destructive cascades involving many calcium-dependent enzymes. The initial 
reports regarding a cytotoxic role of calcium ions were published over 30 years ago. 
Tymianski et al. (1993) suggested the “source specificity” of Ca2+ loading, that is Ca2+ 
entering via NMDA channels is more toxic than that entering via other sources (Mattson, 
2000; Tymianski et al., 1993). Potentially toxic cytoplasmic calcium concentrations can 
also occur due to its release from internal stores, either through physical damage to 
mitochondria and the endoplasmic reticulum, or to malfunction of receptors and channels 
present on their membranes. Such increases of cytoplasmic calcium concentrations can 
trigger a range of downstream neurotoxic cascades, including uncoupling of mitochondrial 
electron transfer from ATP synthesis, and activation and overstimulation of enzymes such 
as calpains and other proteases, protein kinases, nitric oxide synthase (NOS), calcineurin 
and endonucleases (Mattson, 2000; Szydlowska and Tymianski, 2010). Mitochondria 
sequester glutamate-induced Ca2+ loads producing a metabolic acidosis; metabolic stress 
may contribute to glutamate-induced neuronal death (Thayer and Wang, 1995). Despite 
the toxic role of calcium, drugs designed to block its entry into neurons have all failed to 
have any beneficial effects in clinical trials, because of deleterious side effects such as 
agitation, confusion, reduced level of consciousness, hallucinations, hypertension and, in 
the worst cases, mortality increased (Davis et al., 2000; Kalia et al., 2008; Lees et al., 
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2000; Szydlowska and Tymianski, 2010). Further, motoneuron properties expose them to 
the damaging effects evoked by glutamate overactivity. In fact, AMPA receptors on 
motoneurons often lack the GluR2 subunit, rendering them more permeable to Ca2+ influx 
(Van Damme et al., 2002).In addition, Ca2+ binding proteins (parvalbumin and calbindin) 
are absent in upper and lower motor neurons, thus limiting the calcium buffering capacity 
(Ince et al., 1993). While the term “excitotoxicity” is usually applied to neurons, where 
glutamate has excitatory effects, it is also widely used about glial cell. Although these cells 
normally do not exhibit true excitability due to absence of action potentials, glutamate 
mediated excitotoxicity is a significant contributor to secondary injury mechanisms in white 
matter tissue as well (Park et al., 2004). The source of white matter glutamate includes 
astrocytes (Araque et al., 2000), oligodendrocytes and the reverse glutamate transporter 
which is a significant contributor to glutamate release (Li and Stys, 2001). Excitotoxicity is 
proposed to be involved in a variety of neurological diseases like spinal cord injury, stroke, 
traumatic brain injury (Singleton and Povlishock, 2004) and neurodegenerative diseases of 
the central nervous system (CNS) such as multiple sclerosis, Alzheimer's disease, 
amyotrophic lateral sclerosis (ALS), Parkinson's disease, and Huntington's disease.  
 
 12 
Fig. 4. Mechanisms whereby glutamate increases cytoplasmic Ca2+ concentrations, and 
modulation by endoplasmic reticulum (ER) and mitochondria. Binding of glutamate to 
AMPA receptors and kainate receptors (KAR) opens the receptor channels resulting in Na+ 
influx and consequent membrane depolarization and opening of voltage-dependent Ca2+ 
channels (VDCC). Some forms of AMPA receptor are also very permeable to Ca2+. 
Binding of glutamate to NMDA receptors under depolarizing conditions opens the NMDA 
receptor channel resulting in large amounts of Ca2+ influx. Activation of metabotropic 
glutamate receptors (MetR) induces IP3 production and activation of IP3 receptor 
channels in the ER membrane resulting in release of Ca2+ from the ER into the cytoplasm. 
The increases in cytoplasmic Ca2+ levels in response to glutamate receptor activation can 
induce Ca2+ uptake into the mitochondria which, if excessive, can induce production of 
reactive oxygen species (ROS) and inhibits ATP production. By activating proteases and 
inducing oxidative stress, Ca2+ is a key mediator of excitotoxic cell death  (Mattson, 2003). 
 
4.2 Ischemia, oxidative stress and lipid peroxidation 
Vascular changes are a direct consequence occurring immediately after injury. Due to the 
decrease in tissue perfusion and oxygenation, the injured spinal cord becomes ischemic. 
Ischemia is characterized by a process named “oxygen and glucose deprivation” (OGD), 
which cause an immediate reduction of energy available to support neuronal and glial cells 
(Tator, 1972). Alteration in ionic gradients results in neuronal depolarization and excessive 
accumulation of intracellular Ca2+, acid pH and reactive oxygen species (ROS) production 
including ONOO- (Lewén et al., 2000). In SCI a strong relationship between excitotoxicity 
and ROS has been described, whereby free radical scavengers attenuated extracellular 
glutamate release up to 4 h after injury (Yamamoto et al., 1998). ROS peaks 12 h after 
SCI and remains elevated for 1 week, returning to the basal levels 4-5 weeks after injury 
(Rowland et al., 2008). Oxidative stress is an important contributor to secondary damage 
following SCI with radical mediated lipid peroxidation contributing to axonal disruption and 
death of both neurons and glia. Radical species such as hydrogen peroxide can be 
converted, through the Fenton reaction upon interaction with Fe2+ and Cu2+,
 to hydroxyl 
radical, a highly reactive free radical and potent inducer of membrane lipid peroxidation 
(Mattson, 2003).  This induction leads to fatty acid conformation alterations with the 
consequent severe loss of membrane integrity and edema formation, cell lysis and 
dysfunction of organelles, all contributing to Ca2+ dysregulation (Hall, 1993). A key 
mediator of oxidative stress induced by injury is the reactive nitric oxide (NO), a highly 
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diffusible free radical that has been implicated in glutamate-mediated neuronal cell death 
by formation of toxic peroxynitrite (Beckman et al., 1990; Dawson et al., 1994, 1991). After 
SCI, nitric oxide synthases (NOS) expression is increased in neutrophilis and vascular 
smooth muscles with a peak 24-48 h after weight-drop injury in immature rats (Clark et al., 
1996; Hamada et al., 1996). Peroxynitrite has been directly associated with the induction 
of neuronal apoptosis in rat SCI (Xiong et al., 2007). 
 
4.3 TRP channels and role of Mg2+ after injury 
One mechanism of neurotoxicity, that operate independently or in parallel with 
excitotoxicity, involves Transient Receptor Potential (TRP) channels. The TRP ion 
channels are a large class of non-specific cation channels united by a common 6-
transmembrane spanning core motif that forms the ion channel pore. All TRP family 
members are expressed abundantly in the mammalian brain (Aarts and Tymianski, 
2005a). TRP family is composed of six related families of proteins, including the melastatin 
(TRPM) subfamily, that contains eight distinct family members, from TRPM1 to TRPM8 
(McNulty and Fonfria, 2005), most of which are permeable to Ca2+. TRPM channels are 
expressed by neurons and by other cells, including microglia, astrocytes and vascular 
smooth muscle cells (Rempe et al., 2009). Of these, TRPM2 and TRPM7 have been 
associated with cell death due to anoxia (Aarts et al., 2003; Szydlowska and Tymianski, 
2010), reactive oxygen species (Ishii et al., 2007; Kaneko et al., 2006) and stroke (Aarts 
and Tymianski, 2005a; Sun et al., 2009). Both TRPM7 and TRPM2 channels are 
permeable to calcium. TRPM2 (formerly designated TRPC7 and LTRPC2; figure 5) is a 
non-selective cation channel permeable to Na+, K+ and Ca2+ and activated by adenosine 
diphosphoribose (ADPR) (Perraud et al., 2001). It is a long TRP channel containing an 
ADP-ribosylase domain; the homology between a small soluble protein (known as 
NUDT9), and the TRPM2 C-terminus (over a region now designated the NUDT9-H) played 
an important role in the identification of ADP-ribose as a TRPM2 gating ligand 
(Scharenberg, 2005). TRPM2 can be activated by H2O2 and agents that produce reactive 
oxygen/nitrogen species and it is also modulated positively by arachidonic acid, TNF-α and 
intracellular Ca2+ (Aarts and Tymianski, 2005a). TRPM2 channels have been proposed to 
mediate oxidative stress dependent cell death (McNulty and Fonfria, 2005). 
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Fig. 5. Schematic appearance of a transient receptor potential 
(melastatin) 2 (TRPM2) monomer (Scharenberg, 2005). 
 
The TRPM7 channel (figure 6), when heterologously expressed (Ryazanova et al., 2010), 
is activated by low extracellular divalent cations (Wei et al., 2007), ROS and pH changes 
(Wei et al., 2007), all of which occur in ischemia (Szydlowska and Tymianski, 2010). 
TRPM7 has been implicated in regulating Mg2+ homeostasis and in the permeation of 
trace metals into the cell (Aarts and Tymianski, 2005a; McNulty and Fonfria, 2005). The 
TRPM7 current is reportedly constitutively active and is suppressed by increasing 
concentration of Mg2+, leading to the suggestion that the stimulatory effect of ATP occurs 
as a consequence of a drop in free Mg2+ in the cell (McNulty and Fonfria, 2005; Schmitz et 
al., 2003). TRPM7 possess an α-kinase domain at the C-terminus and activation of 
TRPM7 has been proposed to require ATP, a functional kinase domain and 
autophosphorylation of the channel. The kinase domain of TRPM7 reportedly functions in 
the regulation of channel function but its presence is not critical for channel gating (Aarts 
and Tymianski, 2005a; Chen et al., 2012; Cook et al., 2009; Schmitz et al., 2003).  
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Fig. 6. Schematic appearance of a TRPM7 monomer. The region designated 
“unknown”, which lies between the end of the sixth TM span/coiled coil region and the 
kinase domain, differs markedly between TRPM6 and TRPM7, and has no homology to 
any known proteins (Scharenberg, 2005). 
 
In acute neuronal death, NMDA receptor activation during neuronal injury results in Ca2+ 
entry that stimulates production of nitric oxide (NO) and release of superoxide (O2-) from 
mitochondria. NO and O2- then combine to form the highly reactive species peroxynitrite 
(ONOO-). These free radicals, in turn, activate TRPM7 and/or heteromeric TRPM7/ 
TRPM2 channels resulting in further Ca2+ influx and production of oxygen and nitrogen 
free radicals. In addition, release of ADP ribose from injured mitochondria could activate 
TRPM2 subunits via the C-terminal ADP-ribosylase domain, as represented in figure 7. 
Ischemia and activation of NMDA receptors can also cause localized decreases in Ca2+ 
levels outside the cell, activating an extracellular Ca2+ sensing cation conductance 
attributed to TRPM7 (Aarts and Tymianski, 2005a).   
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Fig. 7. The activation mechanisms of TRPM channels during ischemia. Neurons express 
TRPM2 and TRPM7 channels. Reduced extracellular Ca2+ and Mg2+, which occurs during 
ischemia, activate TRPM7 channels, which conduct Ca2+ and other cations. TRPM2 
channels are activated by ADPribose (ADPR), which is also induced during ischemia 
(Rempe et al., 2009). 
 
Magnesium, the fourth most common cation in the body, has been the recent focus of 
much clinical and scholarly interest. This ion is established as a central electrolyte in a 
large number of reactions that either consume or produce ATP, including glycolysis, 
oxidative phosphorilation and cellular respiration, and plays a pivotal role in protein 
synthesis, cell cycle and neuronal function; it maintains the stability and integrity of the cell 
membrane and modulates other ion transport pumps and channels such as Na+/K+-
ATPase. It is also referred as a physiologica calcium blocker (Aarts and Tymianski, 2005b; 
Cook et al., 2009; Margaryan et al., 2009; Schmitz et al., 2003; Sumoza-Toledo and 
Penner, 2011). Brain lesions are transiently associated with decreased extracellular Mg2+ 
concentration (van den Berg et al., 2010), even if this observation has not been 
systematically confirmed in humans (Lin et al., 2004). Mg2+ solution infusion was tested as 
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a neuroprotector, but it was found to worsen the outcome in patients with traumatic brain 
lesions (Maas and Murray, 2007; Valadka et al., 1998). This result was also observed in 
stroke patients (Temkin et al., 2007). In accordance with this view there are reports of the 
lack of effectiveness of exogenous Mg2+ on experimental SCI or neonatal brain injury (Muir 
et al., 2004; Perlman, 2006). 
 
5. CELL DEATH PATHWAYS FOLLOWING SCI 
In view of the substantial progress in the biochemical and genetic exploration of cell death, 
the Nomenclature Committee on Cell Death (NCCD) has proposed, in 2012, a set of 
recommendations for the definition of distinct cell death pathways, classified into 13 
different types (table 1) (Galluzzi et al., 2012). After SCI cell death occurs through different 
pathways (Beattie et al., 2002; Zipfel et al., 2000). Shearing of membranes causes 
immediate necrotic death. Beyond this, intact and partially damaged cells are vulnerable to 
death for biochemical attack by free radicals and excitatory aminoacids released by dying 
neurons and other cells (Hall, 1996): understanding the mechanisms by which they 
mediate cell death after an acute SCI is mandatory, in order to provide new therapeutic 
targets. Cell death can occur through programmed cell death (PCD) pathways, like 
apoptosis, or by unprogrammed mechanisms, like necrosis. PCD mechanisms are 
involved in death of specific cells during development (Lockshin and William, 1965), they 
are fundamental during life for processes like the regulation of the immune system, but 
they can occur also in particular conditions, such as SCI. 
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Table 1. Classification of regulated cell death modes,  
proposed by NCCD (Galluzzi et al., 2012).  
 
Cell death pathways quite common after the primary insult of a SCI are discussed here. 
5.1 Necrosis 
For a long time, necrosis has been considered as a merely accidental cell death 
mechanism and was defined by the absence of morphological traits of apoptosis or 
autophagy (Galluzzi et al., 2012). It is now clear that necrosis can occur in a regulated 
manner (Cho et al., 2009; Degterev et al., 2005; He et al., 2009; Hitomi et al., 2008; Zhang 
et al., 2009), and it has a prominent role in multiple physiological and pathological settings, 
including ischemic injury and viral infection (Vandenabeele et al., 2010). Several triggers 
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can induce regulated necrosis, including alkylating DNA damage and excitotoxins (Galluzzi 
et al., 2012). The initiation of programmed necrosis by death receptors, such as tumour 
necrosis factor receptor 1, requires the kinase activity of receptor-interacting protein 1 
(RIP1; also known as RIPK1) and RIP3 (also known as RIPK3), and its execution involves 
the active disintegration of mitochondrial, lysosomal and plasma membranes 
(Vandenabeele et al., 2010; figure 8). Necrosis is characterized by cell swelling, energy 
loss, intense mitochondrial damage, disruption of internal homeostasis and the 
internucleosomal DNA fragmentation, which leads to the membrane lysis with the release 
of intracellular constituents. The immediate consequence of these events is the 
inflammatory response (Cohen, 1993; Lu et al., 2000). The immediate physical injury of 
SCI causes necrosis at the injury level, with the premature death of cells or living tissue 
(Crowe et al., 1997; Katoh et al., 1996; Liu et al., 1997). 
 
 
Fig. 8. Necrosis. Upon tumor necrosis factor a (TNFα) binding, the 
cytoplasmic tails of TNF receptor 1 (TNFR1, a prototypic death receptor) trimers 
recruit TNFR-associated death domain (TRADD), receptor-interacting protein 
kinase 1 (RIP1), cellular inhibitor of apoptosis 1 (cIAP1), cIAP2, TNFR-associated 
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factor 2 (TRAF2) and TRAF5. Within the so-called complex I, RIP1 is 
polyubiquitinated by cIAPs, thereby providing a docking site for the recruitment of 
transforming growth factor b (TGFb)-activated kinase 1 (TAK1), TAK1-binding 
protein 2 (TAB2) and TAB3 (which together deliver a pro-survival signal by 
activating the transcription factor NF-kB).  Cylindromatosis (CYLD)- 
deubiquitinated RIP1 engage in physical and functional interactions with its homolog 
RIP3, ultimately activating the execution of necrotic cell death. Necrosis 
can also be induced by alkylating DNA damage (possibly by the overactivation of 
poly(ADP-ribose) polymerase 1, PARP1) (Galluzzi et al., 2012). 
 
5.2 Apoptosis 
Apoptosis is the best characterized PCD. Every cell is able to perform apoptosis, by 
ultimately controlled destruction of DNA (Nagata, 1997). Apoptosis presents well 
estabilished morphological signs, including cells round up, forming blebs, zeosis 
(appearance of boiling due to rapid bleb formation), chromatine condensation, nuclear 
fragmentation and budding of apoptotic bodies. Fundamental for the occurring of this 
apoptotic morphological changes is the activation of caspases (Yuan et al., 2003). 
Caspases are cysteine-aspartyl-specific proteases that cleave, with high specificity, a 
small subset of aspartic acid residues, and are present in the cell as inactive pro-enzymes 
(or zymogens) activated by proteolytic cleavage. Two types of caspases exist: initiators 
and effectors, depending on their point of action in the apoptotic pathway (Fuentes-Prior 
and Salvesen, 2004). Initiator caspases (caspase-8,-9 and -10) are the first to be 
activated. They exist as monomers and bind to other proteins through the “caspase 
activation and recruitment domain” (CARD) in caspase-9 and the “death effector domain” 
(DED) in caspase-8 and -10. This protein-protein interaction leads to the dimerization of 
the initiator caspases, activating them (Bredesen et al., 2006). The effector caspases 
(caspase-3 and -7) exists in the cell as inactive dimers and they are activated by clivage 
by the initiator caspases. The caspase subtrates cover varied molecular pathways 
including activation of proteolytic cascades, inactivation of DNA repair, DNA cleavage, 
mitochondrial permeabilization and initiation of phagocytic process to clear up dying cells, 
apoptotic bodies and debris (Bredesen et al., 2006; Pop and Salvesen, 2009). Apoptotic 
pathways can be classified as extrinsic or intrinsic (figure 9). One of these pathways (or 
both) may operate in determining death of glial cells in the spinal cord subjected to PM 
application (dysmetabolic insult) (Kuzhandaivel et al., 2011). 
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5.2.1. Extrinsic pathway 
The extrinsic pathway is initiated by the binding of death factors to death receptors, 
resulting in receptor multimerization, recruitment of adaptor molecules and formation of a 
caspase-activating complex (Muzio et al., 1996; Salvesen and Dixit, 1997). The best 
studied extrinsic pathway is that of death receptor Fas, which is a member of tumor 
necrosis family (Itoh et al., 1991). Fas ligand (FasL) binds to death receptor Fas, resulting 
in receptor multimerization and consequent recruitment of the adaptor FADD (Chinnaiyan 
et al., 1995). FADD than interacts with caspase-8 through the caspase-8 domain DED. 
Interaction with FADD induces dimerization of caspase-8 to assume an active 
conformation (Fuentes-Prior and Salvesen, 2004). Activated caspase-8 than cleaves and 
activates effector caspases such as caspase-3 and -7 (Bredesen, 2000).  
5.2.2. Intrinsic pathway 
The components of cell-intrinsic machinery have become organized around mitochondria, 
which act as a hub for the apoptotic machinery. Almost all survival and death signaling 
pathways in post mitotic neurons are funneled through the mitochondria, where they are 
integrated largely by the Bcl-2 proteins (Becker and Bonni, 2004). The Bcl-2 family of 
proteins is a critical regulator of cell death, subdivided into the anti-apoptotic “multidomain” 
proteins containing BH 1-4 (Bcl-2, Bcl-xL etc.), the pro-apoptotic main BH 1-3 (Bax, Bak 
etc.), and the “BH 3 only” pro-apoptotic proteins. A major checkpoint in the common 
portion of this pathway is the ratio of pro-apoptotic (BAX) to anti-apoptotic (BCL-2) 
members. The multidomain members of the Bcl-2 family are associated with the outer 
mitochondrial membrane. Following an apoptotic stimulus, Bax or Bak becomes activated 
leading to its oligomerization with the outer mitichondrial membrane (Gross et al., 1999). 
Oligomerized Bax and Bak induces mitochondrial dysfunction and includes a change in the 
mitochondrial membrane potential, production of reactive oxygen species (ROS), 
formation of pores in the mitochondrial membrane with loss of mitochondrial constituents, 
including the intermembrane space protein cytochrome c (Gross et al., 1999; Vander 
Heiden and Thompson, 1999). The release of cytochrome c to the cytosol activates the 
adaptor apoptotic protease activating factor-1 (Apaf-1) and allows the formation of the 
apoptosome, a caspase-activating complex (Liu et al., 1996). The apoptosome is a large 
quaternary protein structure formed by cytochrome c, dATP nucleotides, Apaf-1. Once 
formed, the apoptosome can then recruit and activate the inactive pro caspase-9. As for 
FADD and caspase-8, the multimerization of pro caspase-9, is thought to contribute to its 
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activation (Becker and Bonni, 2004). Following caspase-9 activation, downstream effector 
caspases are again activated. There is also cross-talk between intrinsic and extrinsic 
pathways, resulting from cleavage of Bid by caspase-8 with subsequent traslocation of 
cleaved Bid to the mitochondria and the resultant release of cytochrome c (Bredesen, 
2000; Li et al., 1998). 
 
Fig. 9. Schematic representation of apoptosis cell-death pathways. The intrinsic 
pathway is initiated within the cell usually in response to cellular signals resulting from 
DNA damage, hypoxia, or other types of severe cell stress. These signals stimulate 
proapoptotic proteins (e.g., Bax) in the mitochondrial membrane leading to mitochondrial 
membrane permeabilization, that allows translocation of cytochrome c from the 
mitochondrial intermembrane space to the cytosol. Cytochrome c binds the adaptor APAF-
1, forming a large multiprotein structure known as apoptosome. The initiator caspase 9 is 
recruited into the apoptosome and activates the downstream effector caspases 3. The 
extrinsic pathway begins outside the cell through the activation of specific proapoptotic 
receptors on the cell surface by specific molecules known as proapoptotic ligands. Such a 
ligand binding induces receptor clustering and recruitment of the adaptor protein Fas-
associated death domain and the initiator caspases 8 as procaspases, facilitating their 
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autocatalytic processing and release into the cytoplasm where they activate the effector 
caspases 3, thereby converging on the intrinsic pathway (Kuzhandaivel et al., 2011). 
5.2.3. Other apoptotic pathways 
Evidence suggests that additional pathways of apoptosis may also exist. Caspases, in 
fact, are not exclusively cytosolic enzymes, but they can target or translocate to multiple 
cellular sites, including the nucleus, mitochondria, endoplasmic reticulum and Golgi 
apparatus (Jürgensmeier et al., 1998; Mancini et al., 2000). For example, endoplasmic 
reticulum specific apoptosis has been shown to be mediated by caspase-12 (Nakagawa et 
al., 2000). 
5.2.4. Apoptosis after SCI 
Many studies have been done with different SCI models to identify apoptosis (Crowe et al., 
1997; Katoh et al., 1996; Liu et al., 1996; Shuman et al., 1997) stemming from the 
evidence of apoptosis after ischemia and traumatic brain injury (Rink et al., 1995). 
Twentyfour hours after moderate weight drop contusion injury, damaged cord tissue shows 
evidences of apoptosis, especially in the white matter tracts at the injury epicenter (Beattie 
et al., 2000). Cells positive for the TUNEL assay, which is a common method for detecting 
DNA fragmentation that results from apoptotic signaling cascades, have been seen after 
cord compression with an increased Bcl-2 expression (anti-apoptotic protein), indicating 
that protection from apoptosis was being induced by injury (Liu et al., 1996). Also neurons 
are involved in apoptotic cell death following SCI (Liu et al., 1997; Yong et al., 1998). 
Neuronal apoptosis occurs from 4 to 24 hours after injury (Liu et al., 1997). Apoptosis is 
also reported in human traumatic SCI and is accompanied by the activation of caspase-3 
(Emery et al., 1998) and extensive studies with different SCI models also confirmed the 
morphological data for apoptosis in neurons after injury (Abe et al., 1999; Yong et al., 
1998). Glial cells, especially oligodendrocytes, may dye by apoptosis many days or even 
weeks following injury (Emery et al., 1998; Knoblach et al., 2005; Springer et al., 1999; 
Takagi et al., 2003) and death of oligodendrocytes by apoptosis contributes to the 
demyelination of intact axons (Beattie et al., 2000; Shuman et al., 1997). Loss of axons 
removes trophic support needed by the oligodendrocytes (Barres et al., 1993; Raff et al., 
1993), or the degeneration products of the axons are somehow toxic to the 
oligodendrocytes. The lesion centre early after injury is interested also by astrocytic 
apoptosis (Davis et al., 2007; Yoshino et al., 2004) and microglial apoptosis (Colak et al., 
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2005; Koda et al., 2002; Shuman et al., 1997). Apoptosis can be involved in the secondary 
injury, starting at the immediate phase along with necrosis, and continuing to other phases 
with making damage to white matter, oligodendrocytes and microglia. This later phase 
confined principally to the white matter that involves both oligodendrocytes and microglia. 
Further, it seems likely that the oligodendrocyte death might be associated with axonal 
death induced by the injury (Beattie et al., 2000, 2002). 
 
5.3 Parthanatos 
Parthanatos shares molecular and morphological features with apoptosis and necrosis, but 
it is the result of a distinct molecular mechanism (David et al., 2009). It is an intrinsic PCD 
pathway in which Poly-ADP-ribose (PAR) plays a pivotal role (David et al., 2009). PAR is 
synthesized by Poly-ADP-ribose polymerase-1 (PARP-1), a nuclear enzyme which 
responds to DNA damage. PARP superfamily includes 17 putative isoforms based on 
protein sequence homology to PARP catalytic domain, PARP-1 accounts for more than 
90% cellular PARP activity (Dawson and Dawson, 2004; Schreiber et al., 2006).  There 
are three major functional domains in PARP-1 (Kameshita et al., 1984; Schreiber et al., 
2006), namely:  
1. an N-terminal DNA-binding domain (42 kDa), containing two zinc-finger motifs and 
a nuclear localization sequence (NLS), which recognizes both double- and single- 
stranded DNA breaks, 
2. a central automodification domain (16 kDa) which is thought to be the target of self-
poly-ADP-ribosylation,  
3. a C-terminal catalytic domain (55 kDa) containing both the NAD binding site and the 
catalytic domain which synthesizes PAR. 
PARP-1 basal enzymatic activity is low, but nicks and breaks of the DNA strand potently 
activate PARP-1, thereby facilitating DNA repair (Lautier et al., 1993; Smulson et al., 
2000). PARP-1, in fact, can bind to a huge variety of DNA structures, including single and 
double strand breaks, crossovers, cruciforms and supercolis, as well as some specific 
double-stranded sequences (Kim et al., 2005) and its activity is stimulated dramatically in 
the presence of variety of allosteric activators, including damaged DNA, some undamaged 
DNA structures, nucleosomes and a variety of protein-binding partners (D’Amours et al., 
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1999; Kun et al., 2002; Oei and Shi, 2001). Once activated, PARP-1 enzymatic activity 
has a varied targets, including PARP-1 itself, core histones, the linker histone H1, and a 
variety of transcription-related factors that interact with PARP-1 (D’Amours et al., 1999; 
Huletsky et al., 1989; Kraus and Lis, 2003; Ogata et al., 1981) and are involved in DNA 
damage, detection and repair, cell death, modification of chromatin structure, 
transcriptional regulation, insulator function and mitosis (Ariumi et al., 1999; Pavri et al., 
2005; Poirier et al., 1982; Yu et al., 2004). PARP-1 also catalyzes the polymerization of 
ADP-ribose units from donor NAD+ on target proteins (Hayaishi and Ueda, 1977). The 
ADP-ribose units are linked to each other via glycosidic ribose-ribose bonds, so the 
resulting PAR polymers may be linear or branched (D’Amours et al., 1999), usually 
heterogeneous in terms of length and extent of branching with roughly one branch every 
per 20-50 ADP-ribose residues. However, it has been reported that PAR polymers of 
increasing complexity and molecular weight are more toxic (Andrabi et al., 2006). PAR 
once bound to its target protein may alter protein activity by functioning as a site-specific 
covalent modification, a protein binding matrix or a steric block (Kim et al., 2005). Poly-
ADP-ribose glycohydrolase (PARG) is the major enzyme responsible for the catabolism of 
PAR chains. PARG hydrolyze the glycosidic linkages between the ADP-ribose units of 
PAR (Jagtap and Szabó, 2005; Kim et al., 2005). 
In physiological conditions, in cases of low level of DNA damage, PARP-1 takes part in 
genomic repair acting as a survivor factor (Masson et al., 1998; Ruscetti et al., 1998). 
Despite this, in presence of massive DNA damage and/or stress, PARP-1 acts to promote 
cell death. PARP-1 activation can be due to oxidative stress by overproduction of nitric 
oxide (NO), which reacts with superoxide anion to produce the oxidant peroxynitrite and 
causes DNA damage that activates PARP-1 (Dawson et al., 1991; Xia et al., 1996). It has 
been observed that PARP-1 induces cell death through parthanatos in pathological 
condition like stroke, trauma, and ischemia/reperfusion injury in various organs (Lorenzo 
and Susin, 2007; Mandir et al., 2000; Szabó and Dawson, 1998). According with Berger 
(1985), massive DNA damage causes PARP-1 overactivation, which rapidly  depletes 
NAD pools with an impairment of NAD-dependent metabolic pathways, including 
glycolysis and mitochondrial respiration. The consequent depletion of ATP production and 
energy shortage is aggravated by the fact that NAD shortage activates nicotinamide 
phosphoribosyl transferase and nicotinamide mononucleotide adenylyl transferase that 
consume ATP to re-synthesize NAD. This altered metabolism contributes to the 
generation of a lethal cycle (Berger et al., 2004; Chiarugi, 2005). PARP-1 mediates cell 
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death also through translocation of apoptosis inducing factor (AIF) (Andrabi et al., 2008; 
David et al., 2009; Lorenzo and Susin, 2007; Wang et al., 2009). After overactivation of 
PARP-1, PAR is translocated from the nucleus to the cytosol, where it causes AIF release 
from mitochondria (Andrabi et al., 2006; Koh et al., 2005; Wang et al., 2011). The released 
AIF is then translocated to the nucleus, where it interacts with DNA and/or RNA to induce 
chromatine condensation or large scale DNA fragmentation (Susin et al., 1999; Ye et al., 
2002). How PAR translocates from the nucleus to the cytosol and how it induces the 
release of AIF is, at present, unknown. In mitochondria there are two pools of AIF; about 
80% of AIF is localized to the inner membrane and inner membrane space that does not 
bind PAR. However, 20-30% of mitochondrial AIF is localized to the cytosolic side of the 
outer mitochondrial membrane where it is available to bind PAR and be released during 
parthanatos (Wang et al., 2011). A schematic representation of parthanatos is shown in 
figure 10. 
 
Fig. 10. Schematic representation of parthanatos cell-death pathways mediated by 
PARP-1 hyperactivation. Following an injury, intracellular increase in free Ca2+ activates 
downstream cascades leading to peroxynitrite formation. This readily induces DNA 
damage, thereby activating PARP-1 that initiates the synthesis of PAR chains. PAR 
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interacts with the mitochondrial membrane to change its membrane potential, thus 
allowing AIF translocation to the nucleus, a process leading cell death. An additional lethal 
mechanism may originate from excessive PARP-1 activation to deplete the NAD pool and 
cause severe ATP starvation and cell energy failure with the outcome of cell death 
(Kuzhandaivel et al., 2011). 
 
5.3.1. Parthanatos after SCI 
Many studies with different SCI models identified PARP-1-dependent cell death after SCI, 
the presence of which was initially associated with the overproduction of nitric oxide and 
reactive oxygen species (Genovese and Cuzzocrea, 2008; Genovese et al., 2005; Scott et 
al., 2004; Wu et al., 2007). Oxidative stress as cause of parthanatos has been proposed 
also after ischemic and traumatic brain injury (David et al., 2009; Eliasson et al., 1997) 
even if the injury  occurs in the perinatal brain (Hagberg et al., 2004). PARP-1 mediated 
neuronal cell death is confirmed by the therapeutic efficacy of gene inactivation or 
pharmacological inhibition of PARP-1 in experimental models of stroke, cerebral ischemia, 
neurotrauma, Parkinson's desease and excitotoxicity  (Mandir et al., 1999, 2000; Szabó 
and Dawson, 1998; Whalen et al., 1999). In fact, PARP inhibitors protect neurons from 
NMDA and NO mediated toxicity (Zhang et al., 1994). PARP-1 KO mice are strongly 
resistant to NMDA exitotoxicity and stroke (Mandir et al., 2000). Studies performed in our 
laboratory have recently demonstrated the presence of parthanatos in neuronal cells and 
also in the white matter in excitotoxic or non-traumatic models of SCI (Bianchetti et al., 
2013; Kuzhandaivel et al., 2010a, 2011; Nasrabady et al., 2011a, 2012). 
 
6. SPINAL CORD MODELS IN VITRO 
In addition to in vivo animal models of SCI (Onifer et al., 2007), there are growing attempts 
to develop new in vitro models that can supply useful data, to understand basical 
mechanisms of SCI pathophysiology. In vitro models can be cell cultures, organotypic 
cultures or isolated spinal cord preparations. The main advantage for in vitro models is the 
fact that they simplify the complexity of in vivo SCI pathophysiology, and they can point to 
the identification of specific injury processes without interference by blood pressure 
changes and/or general anesthesia. Primary cultures from spinal cord tissue have been 
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applied to reproduce in vitro excitotoxicity (Van Den Bosch et al., 2000; Taylor et al., 2007) 
and ischemia (Kaushal and Schlichter, 2008). Despite this, these models present many 
disadvantages like influences caused by the culturing media and the difficulty in controlling 
the cell microenvironment, fundamental for axon growth and regeneration (Abu-Rub et al., 
2010; Silani et al., 2000).  Many reports are based on organotypic spinal cultures 
(Guzmán-Lenis et al., 2009), in vitro spinal slices (Zhang et al., 2010) and even the 
incision model very similar to the one reported here (Que et al., 2011). The main 
advantage of the organotypic system is that they maintain the basic cytoarchitecture of the 
tissue with the dorsal–ventral orientation of spinal segments. They also allow long-term 
studies (weeks) in which plastic changes in network properties can be explored in relation 
to changes in the local environment (Sibilla and Ballerini, 2009). These cultures, however, 
cannot generate locomotor-like patterns, and cannot readily relate molecular changes to 
complex network function. Acute slices of the spinal cord can be used for functional 
studies, even though they have limited viability in vitro, may pose barriers to drug diffusion 
and it is also impossible to ascertain if there had been any specific damage to locomotor 
networks.  
6.1. Neonatal rat isolated spinal cord preparation developed in our lab 
Our group has recently developed a novel model of in vitro SCI, in order to investigate the 
rapid evolution of early secondary damage (Taccola et al., 2008). It is an in vitro model, 
based on neonatal rat isolated spinal cord, in which we can mimic both non traumatic and 
incomplete SCI (Kuzhandaivel et al., 2010a, 2010b; Taccola et al., 2008, 2010). Our aim 
was to generate an experimental condition that might simulate the acute clinical setting 
occurring in vivo. In order to replicate the biochemical conditions believed to occur at the 
site of the lesion, we keep the isolated spinal cord inside a medium evoking excitotoxic 
damage (through the application of Kainic acid) or the ischemic-like damage (through the 
application of a pathological medium characterized by OGD, which contains reactive 
oxygen species, low osmolarity and acid pH conditions). After a 1-h application, the latter 
solution is washed out and standard Kreb’s solution superfused again for up to 24 h. Sham 
experiments are performed by keeping the preparations for analogous times in the same 
experimental setup without applying a toxic medium. This model presents intrinsic 
limitations such as absence of immune system responses, lack of vascular supply and rat 
neonatal age. Despite this, it has the great advantage of correlating the functional outcome 
of injury with >24 h monitoring of locomotor-like activity (termed fictive locomotion) to the 
number, type, and topography of damaged or dead cells. It allows to preserve the entire 
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tissue with its laminar and intersegmental organization. This point is fundamental, due to 
the fact that it has been demonstrated that the extent of loss of electrophysiological 
function depends on the extent of the damage (Nistri et al., 2010). It is simpler than in vivo 
models even if retains cellular connections, network and activities, and it doesn’t present 
the problem due to the general anesthesia. 
 
7. THERAPEUTICAL APPROCHES AT THE SCI 
7.1 Neuroprotection  
As well as surgical intervention and rehabilitation treatments, a variety of pharmacological 
agents have demonstrated neuroprotective or neuroregenerative properties in animal 
models of acute SCI. These drugs target specific secondary pathological events like 
edema, ischemia, inflammation, excitotoxicity, disturbances of ionic homeostasis, 
excessive cytokines release, caspases and calpain activation and/or apoptosis. Following 
the initial traumatic insult, it is rare that axons traversing the lesion epicenter are 
completely transected, so some myelinated and/or demyelinated axons function persist. 
Preclinical studies have demonstrated, for example, that K+/Na+ channel antagonists 
improve axonal conduction of damaged axons (Baptiste and Fehlings, 2008). Additionally, 
many promising pharmacological strategies were applied as neuroprotective agents. A 
summary of the most promising drugs are shown in figure 11.  
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Fig. 11. Promising pharmacological strategies to attenuate SCI  
(Baptiste and Fehlings, 2008). 
 
One of the most important points on which our group focused during last years has been 
inhibition of PARP-1 (Nasrabady et al., 2011a, 2011b, 2012). Involvement of PARP in 
damage following SCI is shown by the fact that PARP -/- phenotype in brain slices 
demonstrated protection to glutamate-NO-mediated ischemic insults (Eliasson et al., 1997) 
and mice lacking PARP-1 are highly resistant to NMDA excitotoxicity (Mandir et al., 1999). 
Inhibition of PARP by 3-aminobenzamide (3-AB) reduces injury after transient focal 
ischemia in rats and attenuates NMDA-induced glutamate efflux (Lo et al., 1998). The 
neonatal rat isolated spinal cord, treated with high dose of kainate to induce the 
excitotoxicity, demonstrates a significantly decrease in number of pyknotic cells after 
pharmacological inhibition of PARP-1 with (6-5(H)-phenanthiridinone; PHE) (Kuzhandaivel 
et al., 2010a). PHE could also prevent the translocation of AIF which is the last molecular 
effector of PARP-1 in inducing cell death. The use of inhibitors of PARP-1 like 3-
aminobenzamide (3-AB) or 5-aminoisoquinolinone (5-AIQ) in an experimental model of 
spinal chord trauma (in vivo) performed by Genovese's group (2005) decrease 
inflammation and tissue injury, PAR formation, neutrophil infiltration, apoptosis and the 
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motor disturbance. The neuroprotective effect of a novel potent inhibitor of PARP, namely 
N-(6-oxo-5,6-dihydrophenanthiridin-2-yl)-N-N-dimethylacetamide (PJ34), was tested by 
Abdelkarim et al. (2001) in the rat model of middle cerebral artery occlusion. PJ34 
administration significantly reduces infarct size: the effect of the drug is maintained even if 
given as late as 10 minutes prior to reperfusion time. PJ34 significantly protects at 4 hours, 
but not in a 24 hours permanent occlusion model. They suggested that PJ34 exerts 
massive neuroprotective agents, with a significant pharmacological approach for the 
treatment of acute stroke. PJ34 also induced positive effects in another rat model of 
stroke, like bilateral carotid occlusion-reperfusion, including suppressing the ischemia-
induced microglial activation and astrogliosis, decreased deficits in spatial memory and 
learning and increased neuronal density in hippocampal CA1 area. In general, it is 
proposed that treatment with PJ34 for several days after ischemia enhances long-term 
neuronal survival and neurogenesis by reducing tissue inflammation (Kauppinen et al., 
2009). 
 
7.2 Stem cells 
The discovery of neural stem cells (NCSs) in the adult brain (Reynolds and Weiss, 1992) 
raised new hopes for the development of neural repair, either by transplantation or by 
recruiting endogenous NSC (Foret et al., 2010). The manipulation of endogenous spinal 
stem cells after injury is preferred to stem cell transplantation, since it is non invasive and 
avoids the need for immune suppression (Meletis et al., 2008). Neural plasticity following 
brain injury illustrates the potential for regeneration in the central nervous system. 
Lesioning of the perforant path, which innervates the outer two-thirds of the molecular 
layer of the dentate gyrus, triggered a marked proliferation of newborn neurons. These 
result indicate that injury causes an increase in newborn neurons and lamina-specific 
synaptic reorganization indicative of enhanced plasticity (Perederiy et al., 2013). It has 
been demonstrated that the ependymal region of the adult spinal cord in mammals 
contains a pool of stem/precursor cells (SPCs), activated and recruited after a spinal 
damage (Hugnot and Franzen, 2011; Weiss et al., 1996). After SCI the neural stem cells 
proliferate (Yamamoto et al., 2001a) and produce scar-forming astrocytes and myelinating 
oligodendrocytes (Meletis et al., 2008). Spinal stem cells are difficult to identify due to their 
heterogeneity (figure 12) and lack of specific expressional markers, since the ones 
currently used significantly overlap with those of mature astrocytes (McDonough and 
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Martínez-Cerdeño, 2012). Moreover, there is no specific marker to discriminate between 
quiescent and activated ependymal spinal cells, or to monitor migratory ependymal cells. 
The signaling pathways and genes controlling the spinal SPCs destiny remain largely 
unknown, both in normal and pathological situations (Hugnot and Franzen, 2011). 
Evidences show that brain transcription factors that regulate formation and proliferation of 
neural SPCs depend on the Sox family of genes, in particular Sox2 (Liu et al., 2013). 
Moreover, Runx1 is a transcription factors that play essential roles during development 
and adult tissue homeostasis. It acts to promote proliferation in olfactory sensory neuron 
precursor cells (Zagami et al., 2009) and it is also expressed in post-mitotic neurons in the 
mouse CNS, especially motoneurons of the hindbrain and spinal cord (Stifani et al., 2008). 
Genomics and proteomics technologies have recently identified Wnt/beta-catenin, Notch, 
sonic hedgehog and growth factor networks as major signaling pathways involved in 
maintenance, self-renewal, proliferation and neurogenesis of the neural SPCs, 
demonstrating the cross-talk between key molecules of these pathways and their 
modulations by transcription factors, miRNA and histone modifications (Yun et al., 2010). 
Despite this, transcription factors controlling spinal cord stem cells remain incompletely 
understood as they have been studied with in vitro primary cultures, showing common 
expression of various homeodomain-type (Pax6, Pax7, Nkx2.2, and Prox1) and basic 
helix-loop-helix (bHLH)-type (Ngn2, Mash1, NeuroD1, and Olig2) regulatory factors in the 
adult and embryonic rat spinal neural progenitors (Yamamoto et al., 2001b). 
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Fig. 12. Schematic drawing of the adult mouse ependymal region. The ependymal region 
is composed of severalcell types, which are located either in direct contact with 
the lumen or in a subependymal position, evoking a pseudostratified epithelium 
 (Hugnot and Franzen, 2011). 
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AIMS OF THE STUDIES 
 
The immediate damage of acute SCI spreads from the initial injury site through 
excitotoxicity and metabolic dysfunction (ischemia, free radicals and neuroinflammation) to 
spared tissue (secondary damage). As the pathophysiological mechanisms of SCI remain 
largely unknown, the aims of our studies were:  
 identifying the molecular and cellular processes underlying this pathology. 
 
 enquire whether the increased severity of spinal damage evoked by PM+Mg2+ 
was due to recruitment of additional cell death pathways, their identity and the 
potential TRPM2 and/or TRPM7 involvement. 
 
As well as surgical intervention and rehabilitation treatment, a variety of pharmacological 
agents have demonstrated neuroprotective or neuroregenerative properties in animal 
models of acute SCI. Also the manipulation of endogenous spinal stem cells after injury 
raised new hopes for the development of reparative therapies, either by transplantation or 
by recruiting of endogenous NSC. Thence, we also studied: 
 
 the potential neuroprotective effect of PARP-1 inhibitors in SCI models. 
 
 the efficacy of ATF3 as a marker for the migration of ependymal stem cells of 
the spinal cord. 
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New spinal cord injury (SCI) cases are frequently due to non-traumatic causes, including vascular disorders. To develop
mechanism-based neuroprotective strategies for acute SCI requires full understanding of the early pathophysiological changes
to prevent disability and paralysis. The aim of our study was to identify the molecular and cellular mechanisms of cell death
triggered by a pathological medium (PM) mimicking ischemia in the rat spinal cord in vitro. We previously showed that
extracellular Mg2þ (1 mM) worsened PM-induced damage and inhibited locomotor function. The present study indicated that 1 h
of PMþMg2þ application induced delayed pyknosis chiefly in the spinal white matter via overactivation of poly (ADP-ribose)
polymerase 1 (PARP1), suggesting cell death mediated by the process of parthanatos that was largely suppressed by
pharmacological block of PARP-1. Gray matter damage was less intense and concentrated in dorsal horn neurons and
motoneurons that became immunoreactive for the mitochondrial apoptosis-inducing factor (the intracellular effector of
parthanatos) translocated into the nucleus to induce chromatin condensation and DNA fragmentation. Immunoreactivity to
TRPM ion channels believed to be involved in ischemic brain damage was also investigated. TRPM2 channel expression was
enhanced 24 h later in dorsal horn and motoneurons, whereas TRPM7 channel expression concomitantly decreased. Conversely,
TRPM7 expression was found earlier (3 h) in white matter cells, whereas TRPM2 remained undetectable. Simulating acute
ischemic-like damage in vitro in the presence of Mg2þ showed how, during the first 24 h, this divalent cation unveiled differential
vulnerability of white matter cells and motoneurons, with distinct changes in their TRPM expression.
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The clinical scenario of new spinal cord injury (SCI) cases is
changing because trauma is no more the leading cause.1
Non-traumatic SCI originates from vertebral stenosis, tumors,
or cardiovascular disorders that comprise a cluster of post-
surgical paralysis after abdominal aorta surgery.1 Although
non-traumatic lesions are usually incomplete, the clinical
symptoms are severe, and include paralysis and sensory
dysfunction. A typical feature of SCI is the delayed onset of a
secondary lesion, with cell death affecting the initially spared
neighboring tissue through complex mechanisms. This is an
important issue, as a prerequisite to the development of
mechanism-based neuroprotective strategies for acute SCI is
a detailed understanding of the early pathophysiological
changes. On the assumption that brain lesions are transiently
associated with decreased extracellular Mg2þ concentra-
tion,2 even if this observation has not been systematically
confirmed in humans,3 Mg2þ solution infusion was tested and
was found to worsen the outcome in patients with traumatic
brain lesions.4,5 This result was also observed in stroke
patients.6 In accordance with this view are reports on the lack
of effectiveness of exogenous Mg2þ on experimental SCI or
neonatal brain injury.7,8
To explore the cell death mechanisms, our laboratory has
developed an in vitro neonatal rat spinal cord model to mimic
the metabolic perturbation (hypoxia, aglycemia, oxidative
stress, acidosis, and toxic free radicals with low extracellular
Mg2þ ) occurring in vivo after ischemic SCI.9 This model is
based on the transient application of a toxic medium (termed
‘pathological medium’, PM) that recapitulates the chief
elements of metabolic dysfunction occurring in vivo and
depresses locomotor network function with cell death
predominantly in the white matter via an apoptotic pathway.
We have observed that more extensive pyknosis with block
of locomotor network activity is evoked when PM is
applied with a standard concentration (1mM) of extracellular
Mg2þ 10 when compared with preparations treated with
Mg-free PM.
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Although Mg2þ is essential for numerous enzymatic
reactions,11 novel targets of Mg2þ on the central nervous
system have emerged. In particular, Mg2þ gates the activity
of TRPM7, a bifunctional protein containing a protein kinase
fused to an ion channel12 and having a key role in neuronal
death caused by oxidative stress and excitotoxicity.13 Further,
TRPM2 (amember of the same channel family andmodulated
by Mg2þ ) is involved in the delayed death of brain neurons
after experimental ischemia.13–15 The aim of the present
report was to investigate whether the increased severity of
spinal damage evoked by PMþMg2þ was due to recruitment
of additional cell death pathways, as well as study their identity
and the potential involvement of TRPM2 and TRPM7.
Results
Cell death induced by PMþMg2þ . Our previous report10
indicated that a 1-h application of PM containing 1mM Mg2þ
induces, 24 h later, significant damage to the in vitro spinal
cord. This observation was confirmed by detecting extensive
pyknosis in the white matter region at 24 h (see arrow in the
example of Figure 1a). Figure 1b indicates the four ROIs
used for these experiments, whereas Figure 1c quantifies
these data. Significant pyknosis already emerged 3 h after
washing out the toxic medium (Figure 1c). It is noteworthy
that sham preparations (kept in standard Krebs for up to 24 h)
or mock preparations (bathed for 1 h in Mg-free Krebs
solution to which 1mM Mg2þ was added to test for any
artifact due to solution application and washout procedure)
showed no significant pyknosis (Figure 1c). Thus, unlike the
outcome with PM without Mg2þ (Figure 1c), the presence of
this divalent cation worsened an ischemia-like metabolic
perturbation, and cell damage developed over 24 h.
Characterization of the white matter damage evoked by
PMþMg2þ . Using biomarkers previously employed to
characterize spinal injury,16,17 we next investigated the
type of cell damage evoked by PMþMg2þ by studying
immunoreactivity to phospho-histone2A.X(Ser139) (H2AX a
marker of DNA double-strand breaks)18 and active-caspase
3 (a marker of apoptosis)19 in the white matter ROI where
extensive pyknosis was found (Figure 1c). Figure 2a shows
that the percentage of H2AX-positive cells in the white matter
region was higher in treated than in sham preparations at 3 or
24 h. Nevertheless, unlike the number of pyknotic nuclei
(Figure 1c), the number of H2AX-positive elements did not
increase from 3 to 24 h (Figure 2a), suggesting the presence
of early DNA double-strand lesions in keeping with former
studies.18,20 By comparing the 24-h data in Figures 1c and
2a, it seems likely that the PMþMg2þ damage affected the
vast majority of white matter elements, as about 75% of them
showed pyknosis and 25% had H2AX immunoreactivity.
Interestingly, in the same ROI, immunopositivity for active
caspase 3 (an important executor of apoptosis), although
limited too5% of the cells, was larger than that in the sham
condition (Figure 2b).
The poor expression of active caspase 3 was an
unexpected result, as PM (without Mg2þ ) is known to damage
the spinal white matter primarily via caspase-dependent
apoptosis.16 When the spinal damage is evoked by
excitotoxicity, the main process of cell death is a
non-apoptotic mechanism termed parthanatos caused
Figure 1 Pyknosis in the rat spinal cord in vitro following transient (1 h) application of pathological medium with or without Mg2þ . (a) Example of the spinal cord pyknosis
(see arrow) in the white matter 3 h after washout of PMþMg2þ . Scale bar: 10mm. (b) Schematic representation of the four spinal ROIs used for analysis. DH, dorsal horn;
CENT, central area; VH, ventral horn; WM, white matter. (c) Histograms show percentage of pyknotic cells in the four ROIs shown in (b). Mock data refer to preparations in
which washout of incubating medium was performed to test for any potential mechanical damage related to this procedure. Note: statistically significant increase in the white
matter pyknotic cell number in the samples treated with PM with or without Mg2þversus sham preparations at 3 or 24 h after washout. Data are the average taken from nine
sections from three rats. The Mann–Whitney test was used after performing an ANOVA Tukey test; *P¼ 0.022; **P¼ 0.004; ***Po0.001
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Figure 2 Characterization of white matter damage evoked by PMþMg2þ . (a) Left, examples of immunostaining for H2AX in the ventral quadrant of the spinal cord in
which the white matter shows minimal signal positivity in sham conditions. Scale bar: 30 mm; right, percentage of H2AX-positive cells in the ventrolateral white matter after
PMþMg2þ ; n¼ 9 sections, ***Po0.001. (b) Left, examples of immunostaining for active caspase 3 in the same ROIs as shown in (a); right, percentage of caspase 3-
positive cells in the ventrolateral white matter after PMþMg2þ ; n¼ 9 sections, *P¼ 0.034; ***Po0.001. (c) Histograms showing pyknotic nuclei after addition (on
PMþMg2þ washout) of caspase 3 inhibitor (1 mM), PJ34 (60 mM), or both. n¼ 9; ***Po0.001. For data shown in (a), (b) and (c), the Mann–Whitney test was used after
performing an ANOVA Tukey test. (d) Histograms show PAR tissue levels in various experimental conditions. For each test, data are from three spinal cords tested in
duplicate; one-way Anova Tukey test; ***Po0.001
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by excessive activation of PARP-1 (poly (ADP-ribose)
polymerase 1) to synthesize toxic concentrations of PAR
(poly-ADP-ribose) that disrupt cell energy stores.21 Therefore,
in the present report we investigated whether, in the white
matter ROI, PMþMg2þ could stimulate excessive production
of PAR, which is known to induce pyknosis.21,22 Thus, we
tested whether application of a selective inhibitor of either
PARP-1 activity or caspase-3 might protect white matter
elements from PMþMg2þ toxicity. To this end, we used
PJ34 (N-(5,6-dihydro-6-oxo-2-phenanthridinyl)-2-acetamide)
to block PARP-123 and the caspase peptide inhibitor (caspase
3 inhibitor II, Z-DEVD-fmk) to block apoptosis,24 which were
applied (for 24 h) either alone or in combination immediately
after washing out PMþMg2þ . Figure 2c summarizes these
data: whereas the caspase inhibitor alone did not significantly
reduce pyknosis (5% change; see Figure 2c), PJ34
significantly (Po0.001) decreased pyknosis by 425%, an
effect even stronger (435%) when the two pharmacological
blockers were applied together (Po0.001), indicating partial
convergence of these two cell death processes. Neither
inhibitor had any effect on sham preparations (Figure 2c).
Figure 2d indicates that PJ34 applied at a concentration of
60 mM was a strong inhibitor of the tissue generation of PAR
measured with an enzyme-linked immunosorbent assay
(ELISA). Halving the concentration of PJ was less effective.
Figure 3a illustrates an example of co-staining with
4,6-diamidino-2-phenylindole (DAPI) and the PAR antibody of
a pyknotic white matter cell 24 h after PMþMg2þ application.
Figure 3b shows that, among the total DAPI-stained elements,
the percentage of PAR-positive cells in white matter ROI
(hatched bars) had already increased significantly (Po0.001)
3h after PMþMg2þ , and it remained elevated (Po0.001) 24h
later. Figure 3b (filled bars) also quantifies co-occurrence of
PAR immunopositivity together with pyknosis for the total
number of pyknotic cells; it is clear that PMþMg2þ induced a
significant (Po0.001) increase in the association between
PAR and pyknosis at 3 and 24h. In fact, few cells were PAR
positive without pyknotic nucleus at either time (open bars).
This finding suggested that PMþMg2þ had transformed the
white matter damage from the apoptosis previously detected
with PM alone10 to a process with parthanatos characteristics.
We thus wondered whether an analogous process might have
developed in the gray matter.
Characterization of gray matter damage evoked by PMþ
Mg2þ . Despite the comparatively modest extent of the
lesion to the gray matter induced by PMþMg2þ (see
Figure 1c), this protocol is known to inhibit locomotor
network function.10 To further analyze neuronal damage, the
present study quantified the percentage of NeuN-positive
neurons in dorsal, central, and ventral ROIs at 3 and 24 h
after PMþMg2þ . Figure 4 demonstrates that significant
neuronal loss was absent at 3 h, and became apparent at
24 h as far as the dorsal and ventral ROIs were concerned.
Thus, in accordance with pyknosis data (Figure 1c), PMþ
Mg2þ had an early effect on white matter elements, and a
later one on gray matter cells, which, in the ventral horn,
constitute a small minority of the spinal cell population.25
As, among gray matter regions, the late damage by PMþ
Mg2þ appeared to mostly affect the ventral ROI that contains
motoneurons, namely, the essential output elements of
the locomotor network, we next investigated dysfunctional
changes in motoneurons, identified as large (425 mmsomatic
diameter) cells located in the ventral horn and immunopositive
for choline acetyltransferase (ChAT, the cytoplasmic ACh
synthetic enzyme), and for SMI32, a marker for motoneuron
cytoskeleton.26,27 Figure 5a shows that the number of ChAT-
positive motoneurons did not change following PMþMg2þ at
3 or 24 h, whereas the average intensity of the SMI32 signal
was significantly (Po0.001) decreased at 3 and 24 h
(Figure 5b). This observation suggests that, despite the
Figure 3 PAR immunoreactivity in the white matter after PMþMg2þ .
(a) Example of co-staining with DAPI (left) and PAR immunoreactivity (middle) of
a pyknotic white matter cell 24 h after PMþMg2þ application; right panel shows
overlapped images; scale bar: 10 mm. (b) Histograms show percentage of
PAR-positive cells (hatched bars) over total DAPI-stained elements, co-occurrence
of PAR immunopositivity and pyknosis (filled bars) and total number of pyknotic cells
(open bars). n¼ 9; the Mann–Whitney test was used after performing an ANOVA
Tukey test; ***Po0.001
Figure 4 Characterization of neuronal damage evoked by PMþMg2þ .
Histograms show percentage of neurons (NeuN-positive cells) observed in three
ROIs in control or after PMþMg2þ washout (3 or 24 h). The Mann–Whitney test
was used after performing an ANOVA Tukey test, n¼ 9; **P¼ 0.003; ***Po0.001
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unaltered number of motoneurons, these cells showed signs
of cytoskeleton damage.
Neuronal distress can strongly activate PARP-1 to generate
toxic levels of PAR (‘parthanatos’).28,29 In accordance with this
notion, a significant increase in PAR immunoreactivity was
detected in motoneurons early after PMþMg2þ , as exempli-
fied in Figure 5c and quantified in Figure 5d. It is noteworthy that
the PAR signal intensity did not increase further at 24h.
The toxic action of PAR is typically executed via transloca-
tion of the transcription factor apoptosis-inducing factor (AIF)
from the mitochondria to the nucleus22,29,30 and it thus
represents a delayed cell death signal. We examined the
expression and translocation of AIF in motoneurons as
indicated in Figures 6a and b. In sham conditions, the
confocal line scan of the motoneuron cell body (see line
across cell soma in Figure 6a, left) demonstrated that its DAPI
staining was confined to the cell nucleus (blue line; Figure 6a,
right), whereas AIF (red line in Figure 6a, right) was poorly
expressed throughout the cell. In contrast, 24 h after PMþ
Mg2þ (Figure 6b), whereas DAPI staining was still restricted
to the nucleus, AIF immunoreactivity was diffused and
extended to the cell nucleus as well. Detection of AIF in the
motoneuron nucleus was accompanied by loss of expression
of the nuclear transcription factor NeuN as shown in Figure 6c
(see open arrow). Finally, Figure 6d indicates that, 24 h after
PMþMg2þ , about 30% of motoneurons showed AIF nuclear
translocation. All together, these observations suggest
that, despite the persistence of ChAT immunoreactivity, a
significant fraction of motoneurons displayed multiple signs
of distress 24 h after PMþMg2þ , consistent with the onset of
a parthanatos-like process.
Expression of TRPM7 or TRPM2 after PMþMg2þ
application. TRPM7 and TRPM2 are members of a large
family of ion channels31 believed to play an important role in
the neurodegeneration evoked by ischemia in vivo or by
ischemia-like conditions in vitro.13,14,32–35 In the present
study, we found undetectable TRPM7 immunopositivity in the
white matter from freshly frozen preparations (Figure 7a,
open circle), or under 3 and 24 h sham conditions (Figure 7a,
Figure 5 Characterization of motoneuron damage evoked by PMþMg2þ . (a) Histograms show motoneuron numbers counted with ChAT immunostaining. Inset shows
an example of ChAT-stained ventral horn cells in sham-24 or PMþMg-24 conditions. Bar¼ 30mm. (b) Histograms show motoneuron SMI32 signal intensity that was already
decreased 3 h after PMþMg2þ washout; a t-test was performed after an ANOVA Tukey test; ***Po0.001. Inset shows an example of SMI32-stained ventral horn cells in
sham-24 h or PMþMg-24 h conditions. Bar¼ 30mm. (c) Examples of PAR immunoreactivity detected in motoneurons 3 h after PMþMg2þ ; scale bar: 30mm.
(d) Histograms show motoneuron PAR signal intensity enhanced after PMþMg2þ ; a Mann–Whitney test was performed after an ANOVA Tukey test, ***Po0.001. For all
experiments, data are from nine spinal sections from three rats
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open squares), or immediately after washing out PMþMg2þ
(Figure 7a, filled triangle). Vice versa, a strong signal became
apparent 3 h after PMþMg2þ washout and remained
stable 24 h later (Figure 7a, filled triangles). White matter
TRPM7 immunoreactivity was most frequently detected in
pyknotic cells (see arrows in Figure 7b) as quantified in
Figure 7c (filled bars). In the white matter ROI, there was no
significant TRPM2 immunoreactivity under treated or sham
conditions (not shown). Thus, it appeared that about half of
the white matter elements that died (pyknosis) after PMþ
Mg2þ treatment also expressed strong positivity to TRPM7.
In contrast to these data from the white matter ROI, in the
three gray matter ROIs we found baseline positivity to TRPM7
(Figures 8a and b) and TRPM2 (Figure 8c). After washing out
PMþMg2þ , the TRPM7signal was found significantly lower
24 h later (Figures 8a and b) in the dorsal horn ROI (Po0.001)
and in the motoneuron ROI (P¼ 0.002). Conversely, for the
same ROIs, TRPM2 immunopositivity appeared to move in
the opposite direction with a delayed increase 24 h after
washing out PMþMg2þ (Figure 8c).
Discussion
The focus of the present study was the role of extracellular
Mg2þ in the genesis of cell death after transient application of
a solution mimicking ischemia conditions. The present data
Figure 6 AIF signal in motoneurons after PMþMg2þ . (a) An example of AIF cytoplasmic distribution in sham motoneurons (left), with confocal line scan analysis plotted
on the right for the cell indicated by an open bar on the left. Note strong nuclear distribution of DAPI (blue) versus AIF. (b) Analogous presentation of data referred to sample
24 h after PMþMg2þ . Note DAPI signal colocalized with AIF in the nucleus. (c) Examples of DAPI (blue) co-staining with AIF (red; left columns) or NeuN (green; right
columns) under sham conditions (top row) or after PMþMg2þ (bottom row). Under sham conditions, the AIF signal was cytoplasmic and the NeuN signal was nuclear. After
PMþMg2þ , the AIF signal is expressed by the motoneuron nucleus that has lost NeuN immunoreactivity. Scale bar: 30mm. (d) Histograms show percentage of motoneurons
expressing nuclear AIF after PMþMg2þ . For all experiments, data are from nine spinal sections from three rats (see white arrow)
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indicate that the presence of this divalent cation contributed to
enhancing and widening the delayed damage to the white and
gray matters of the rat spinal cord by facilitating a distinct cell
death pathway.
A model of non-traumatic injury. The growing number of
non-traumatic causes of SCI1 led us to examine the
processes responsible for early cell death after the in vitro
insult. Our previous investigations indicated that applying a
toxic solution containing free oxygen radicals with no oxygen
or glucose supply especially damaged the white matter
elements, with moderate impairment of locomotor-like
patterns that were still present at regular frequency but with
clearly lower amplitude.9,10 Nevertheless, when the same
toxic solution contained the standard extracellular Mg2þ
concentration, the histological damage was intensified and
locomotor patterns were inhibited.10 The present report
sought to characterize the processes responsible for this
damage enhancement.
PMþMg2þ evoked lesion of white matter elements. This
solution was confirmed to produce stronger damage than the
original PM (without added Mg2þ ), as pyknosis was seen in
about 80% of the ROI white matter elements and was
accompanied by early phosphohistone positivity to indicate
relatively rapid DNA damage.18 The canonical marker of
apoptosis, namely, activated caspase 3,19 was evident in a
small minority of white matter cells only. Perhaps the damage
had evolved so quickly that cell death had become
apparent before any extensive apoptosis could be produced.
In keeping with this view was our observation that a
pharmacological inhibitor of apoptosis24 did not arrest
pyknosis, although it reduced pyknosis when coapplied with
PJ34, the inhibitor of PARP-1,23 which is essential for DNA
damage repair and whose hyperactivation generates the
toxic product PAR.23,28,29 PAR was already strongly
increased 3 h after the end of PMþMg2þ application,
suggesting a narrow time window before irreversible cell
damage could occur (demonstrated by colocalization of PAR
and pyknosis). When PJ34 is administered early during the
lesion protocol, a degree of functional neuroprotection is
observed36 in accordance with the present data. In general,
the present results suggest that the presence of Mg2þ during
the ischemic-like protocol aggravated the damage to the
white matter cells by promoting the activation of at least one
major cell death pathway, namely, parthanatos.
Gray matter damage by PMþMg2þ . Alongside low-scale
pyknosis, most NeuN-positive neurons exhibited a gradient
of neuronal loss: the strongest in the ventral horn, a modest
one in the dorsal horn, and apparently none in the central
region. Motoneurons, however, did not disappear, as their
typical marker ChAT was preserved even 24 h later. These
cells were, nevertheless, showing signs of distress because
their SMI32 positivity was decreased, suggesting distur-
bance of their cytoskeleton. Conversely, a traumatic lesion
in vivo is associated, a few days later, with loss of ChAT,
followed by upregulation of SMI32 expression by surviving
motoneurons, taken as an index of cell repair.37 The
differential evolution of ChAT and SMI32 in the present
study compared with in vivo experiments is unlikely due to
motoneuronal maturation, as neonatal motoneurons already
show adult somatic size.38 Accordingly, in the in vitro rat
spinal cord model, the number of SMI32- and ChAT-positive
cells and their staining pattern remain constant in the first
week of life.25 Further, AIF-dependent cell death mediates
neuronal death after hypoxia–ischemia in the neonatal rat
brain39 as much as in the adult brain.22 Hence, dynamic
changes in these two biomarkers may indicate distinct
processes and time course underlying either degenerative
mechanisms or restoration.
Concomitant with the fall in SMI32 signal was the detection
of rising PAR immunoreactivity in the same cells. This was
likely a sign of impending death, as it was accompanied by
strong AIF translocation into the nucleus, a known effector of
cell death.29 Interestingly, AIF nuclear translocation was
closely associated with loss of NeuN positivity. NeuN is an
intrinsic component of the neuronal nuclear matrix,40 whose
fast degradation (already at 1 h after injury)41 precedes
cytoskeletal changes (identified, for instance, with SMI32
positivity) in injured motoneurons.37
These results imply that various motoneuron biomarkers
should be tested for assessing damage in pathological
conditions, as their significance in the diagnosis of cell death
is time-dependent. Thus, we surmise that the development of
Figure 7 White matter expression of TRPM7 after PMþMg2þ application.
(a) Plot of the number of TRPM7-positive white matter cells against time following
PMþMg2þ (filled triangles). TRPM7 immunopositivity was undetectable in the
white matter from freshly frozen preparations (open circle at time 0) or under sham
conditions (open squares at 3 and 24 h). (b) Examples of TRPM7-positive white
matter cells (see arrows) after PMþMg2þ . (c) Histograms show percentage of
TRPM7-positive/pyknotic white matter cells calculated with respect to the total
number of pyknotic elements (filled bars). Open bars show percentage of TRPM7-
positive cells without pyknosis over total number of non-pyknotic cells. We also
quantified co-occurrence of TRPM7 immunopositivity together with pyknosis for the
total number of pyknotic cells. All data are from nine spinal sections from three rats
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parthanatos in motoneurons occurred on a slower time base
than in the white matter. Nevertheless, these pathological
changes have a strong negative impact on locomotor network
function.10
TRPM2 and TRPM7 roles in the PMþMg2þ effects.
These two membrane channels have recently been investi-
gated for their contribution to ischemic cell death in the
brain.13,35 These channels are gated open by intracellular
PAR, reactive oxygen species and Mg2þ (as under normal
conditions such channels are minimally activated).13,14,42–44
For these reasons, we studied how these channels were
expressed during our experimental protocol. In view of
reports on the ubiquitous occurrence of TRPM7 expres-
sion,45 their immunohistochemical absence in the white
matter under sham conditions was not anticipated. This
phenomenon could not be attributed to loss of protein
expression by keeping the preparation in vitro because
analogous lack of signal was found when the tissue was
frozen immediately after dissection. It seems feasible that
immaturity of the neonatal spinal cord was a factor for poor
TRPM7 expression in controls. It was, however, clear that
already 3 h after PMþMg2þ exposure a large number of
white matter cells (with pyknotic nucleus) were positive to
Figure 8 Gray matter expression of TRPM7 or TRPM2 after PMþMg2þ application. (a) Examples of TRPM7 immunoreactivity in the ventral horn under sham conditions
or 24 h after PMþMg2þ . (b) Histograms show distribution of TRPM7 immunoreactivity in dorsal, central and motoneuron ROIs. Note the significant fall in average signal
intensity 24 h after PMþMg2þ for dorsal and motoneuron ROIs; **P¼ 0.002; ***Po0.001. (c) Examples of TRPM2 immunoreactivity in ventral horn under sham conditions
or 24 h after PMþMg2þ . (d) Histograms show distribution of TRPM2 immunoreactivity in dorsal, central and motoneuron ROIs. Note the significant increase in TRPM2 signal
in all three ROIs examined; one-way Anova Tukey test, **P¼ 0.004; ***Po0.001. All data are from nine spinal sections from three rats
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TRPM7. Our interpretation is that metabolic distress in the
presence of Mg2þ triggered rapid trafficking of TRPM7
proteins to the cell membrane, where their activation might
have contributed to the observed damage.
Unlike the white matter cells, in the gray matter, baseline
expression of TRPM7 fell in motoneurons and dorsal neurons
24h after PMþMg2þ when low-scale pyknosis was
manifested. TRPM2 expression (that could not be observed
in the whitematter) showed an opposite pattern with a late rise
in gray matter neurons, which was especially strong in the
central region. It is not feasible to relate the intensity of
immunoreactivity to channel activation; thus, the present
results about differential TRPM7 and TRPM2 signal
intensities cannot be extrapolated to a specific role of these
proteins in neuronal survival or death. Nonetheless, the
present observations indicate a significant dichotomy in
TRPM7 and TRPM2 channel expression, whose molecular
mechanism remains to be clarified. Future studies are
necessary to investigate the functional activity of TRPM2 or
TRPM7 channels under the present experimental protocols.
This goal is, however, complex because of the difficulty to
isolate, in an intact network system, the contribution of these
conductances in the absence of selective inhibitors, the
widespread dysfunction of motoneurons and the lack of
knockout rat models.
Even if both TRPM7 and TRPM2 channels have been
proposed to be mediators of neuronal death after ischemia,46
the time dependence of their differential activation is not
known under the present conditions. As TRPM2 channels are
inhibited by intracellular glutathione,47 TRPM2 overexpression
was perhaps related to metabolic dysfunction that developed
early for the superficial motoneurons. The effects of the toxic
solution on deep central neurons were likely delayed
with morphological preservation of such cells that had shown
the strongest TRPM2 expression. One hypothesis is that
the TRPM2 activation would eventually lead to central neuron
damage occurring at the time point beyond the 24-h in vitro
survival of the isolated control spinal cord, and thus
outside our experimental range. As TRPM2 channels are
characterized by small conductance,14 it would follow that a
small-scale influx of these cations might determine the
delayed trigger of parthanatos.
Role of extracellular Mg2þ . From the point of view of an
in vitro spinal model, it is apparent that the standard
concentration (1mM) of Mg2þ amplified white matter
damage and extended it to the gray matter. The reason
might reside in the differential expression of TRPM7 and
TRPM2, plus the degree of PAR hyperproduction at the early
stage of damage, because the concentrations of PAR and
intracellular Mg2þ are potent modulators of the activity of
these channels.13,46 Recent studies with in vitro brainstem
neurons have proposed that changes in intracellular Mg2þ
concentrations occurring during pathological states can
affect the conductance of neuronal Cx36 gap junctions48
and presumably shape the damage outcome. Although
chemical synaptic inputs and Cx36-dependent electrical
synapses contribute to synchronization of spinal motoneuron
function,49 the expressions of Cx36 and Cx32 mRNA and
proteins are sparse and unchanged after rat SCI.50 The
complexity of the processes underlying ischemia-induced
damage in the spinal cord even when studied with an in vitro
model implies diversity of molecular pathways with distinct
time dependence and cell specificity, factors that contribute
to the difficulty of implementing successful neuroprotection
in vivo.51–53 The present report suggests that the extra-
cellular level of Mg2þ largely affects cell death mechanisms
in the spinal cord and extends damage to motoneurons by
facilitating the onset of parthanatos.
Materials and Methods
Rat spinal cord preparation. The experiments were performed on
neonatal Wistar rats of postnatal age 0–1 days in accordance with the guidelines
of the National Institutes of Health and the Italian act D.Lgs. 27/1/92 no. 116
(implementing the European Community directives no. 86/609 and 93/88), and the
protocols were approved by the SISSA ethical committee for animal experimenta-
tion. We minimized the number of animals used in order to allow clear statistical
analysis. Spinal cords were carefully dissected out from pups under urethane
anesthesia (0.2ml i.p. of a 10% w/v solution) at room temperature, with continuous
superfusion with Kreb’s solution containing (in mM) the following: NaCl, 113; KCl,
4.5; MgCl27H2O, 1; CaCl2, 2; NaH2PO4, 1; NaHCO3, 25; glucose, 11; gassed with
95% O2/5% CO2, pH 7.4 at room temperature (22 1C), as described previously.
26
Protocol for spinal cord lesion. Our aim was to generate an
experimental condition that might mimic the acute clinical setting when the
metabolic insult is often temporary because of intensive care treatment to correct
the metabolic derangement. In accordance with our studies10,11 and to simulate
the biochemical conditions believed to occur at the site of the lesion, we used a
metabolic perturbation protocol consisting of the transient application of PM
(see below) with the addition of 1mM Mg2þ .10 This protocol is known to induce a
pathological condition that includes locomotor network inhibition and histological
damage.10 Thus, a solution containing 10mM H2O2, 500mM sodium nitroprusside
(SNP) and 1mM Mg2þ and lacking oxygen and glucose was applied for 1 h.
NaHCO3 was omitted and 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid
(HEPES) was added to reach the pH range of 6.75–6.80 (with 0.1 N NaOH) and
the osmolarity was lowered to 230–240mOsm. This solution recapitulates the
biochemical derangement believed to occur in the spinal cord after acute
non-traumatic injury.9
After a 1-h application of PMþMg2þ , the latter solution was washed out and
standard Kreb’s solution was superfused again for up to 24 h, after which
preparations were fixed as previously reported9 and processed for histology as
detailed below. Sham experiments were performed by keeping the preparations for
analogous times in the same experimental setup without applying a toxic medium.
Quantification of dead cells. Using a Zeiss Axioskop2 microscope
(Oberkochen, Germany) and Metavue software (Metamorph suite sold by
Molecular Devices, Sunnyvale, CA, USA), cell counting was performed after DAPI
staining or NeuN positivity (for neurons). Data were counted with ‘eCELLence’
(Glance Vision Tech., Trieste, Italy) software.9,10 For each histological cross-
section of the spinal cord, four different regions were investigated: dorsal gray
matter (Rexed laminae I–IV), central gray matter (Rexed laminae V–VII and X),
ventral gray matter (Rexed laminae VIII–IX) and ventrolateral white matter. In each
region, three to six fields of 280 280-mm (gray matter) or 100 280-mm (white
matter) area were analyzed. For each experimental group, three spinal cords were
analyzed and, for each spinal cord, 3–4 different sections from T13 to L3 (thoracic
spinal cord segment 13 to lumbar spinal cord segment 3) segments were
examined. Pyknosis was readily observed as a change in nuclear morphology
resulting from chromatin condensation.54
Immunofluorescence procedure. Immunostaining was performed as
previously described.9,26 Briefly, paraformaldehyde-fixed spinal cords were
cryoprotected with 30% sucrose and sectioned (30 mm) with a sliding microtome.
In accordance with our former studies, we analyzed spinal regions between T13
and L3 segments. For all antibodies (except anti-PAR), after incubation in
blocking solution (5% normal goat serum, 5% bovine serum albumin, 0.3%
Triton-X 100) for 1 h at room temperature, the primary antibody was incubated at
4 1C overnight. Before incubating tissue sections with the PAR antibody, an
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antigen-retrieval procedure was performed by treating (20min at 60 1C) samples
with Tromethamine (TRIS)—Ethylenediaminetetraacetic acid (EDTA)—TWEEN 80
(pH¼ 8.5). To preserve the structure of spinal cord slices that could be damaged
by the antigen retrieval procedure, the TRIS–EDTA–TWEEN was washed out with
cold phosphate-buffered solution (PBS) five times to stop the reaction before
mounting the slices for immunostaining. The primary antibodies were visualized
using secondary anti-mouse Alexa fluor 488 or 594 antibodies (1 : 500; see
Supplementary Table 1). Sections were finally stained with DAPI for 20min and
analyzed as detailed below.
All antibodies (except TRPM2 and TRPM7) have been previously used and
validated for immunostaining with our preparations (for ChAT, NeuN, SMI32, see
Taccola et al. 9 and Cifra et al.25; for AIF, cleaved caspase-3, H2AX and PAR, see
Kuzhandaivel et al.16,21). The TRPM2 antibody was validated by Hara et al.55 and
the TRPM7 antibody by Everaerts et al.56
Immunofluorescence data analysis. For each spinal section, images of
the dorsal and ventral horns, the area around the central canal and the
ventrolateral white matter were acquired with a LEICA 6000 microscope ( 40
lens) using identical capture settings throughout, and ensuring that signals were
clearly below saturation and yielding a good signal/noise ratio. For each spinal
region, the acquisition procedure was repeated four times at z axis intervals of
1mm. In order to analyze all these images, we used the 3D Volocity software
(Perkin Elmer, London, UK) applied to four regions of interest (ROIs). For the
dorsal, central and white matter regions, the ROI size was 200 100mm. For
motoneurons, we drew by hand a ventral horn region that comprised
large-diameter (425mm) neurons. For each gray matter ROI, using the ‘voxel
spy’ facility of the software, we calculated the background fluorescence and
included in the analysis only those signals that were higher than this threshold
value. Owing to the large degree of cell meshing in the neuropile, the ROI signal
intensity was evaluated on a gray scale and expressed in arbitrary units (AUs).
The data were averaged from three histological sections from each one of three
rats. In the case of white matter quantification, it was possible to observe individual
cells that were counted and averaged for three sections from each one of
three rats.
This approach was employed for quantifying data concerning immunopositivity to
PAR, ChAT, SMI32, TRPM2 and TRPM7. For caspase 3, phosphohistone and
NeuN data, we used previously published procedures with a Zeiss Axioskop2
microscope and Metavue software.16
Analysis of AIF translocation. Images of single motoneurons were
acquired with a LEICA confocal microscope, using 0.5-mm z sectioning as
reported by Oh et al.57 After reconstructing the cell image, we selected a single
central optical section that comprised the largest nuclear staining with DAPI.
Thereafter, we performed a line scan of such an image to verify the distribution of
AIF immunofluorescence signal in the nucleus and in the cytoplasmic
compartment. The number of reconstructed motoneurons showing AIF nuclear
translocation was quantified with ImageJ (http://rsb.info.nih.gov/ij).
Nuclear and mitochondrial protein extraction. The nuclear extraction
was prepared in accordance with published reports.21,58 Thus, isolated spinal
cords were washed with ice-cold 250-STMDPS buffer (50mM Tris-HCl, pH 7.4,
250mM sucrose, 5mM MgCl2, 1 mM dithiothreitol (DTT), 1 mM phenylmethylsul-
fonyl fluoride (PMSF), 25mg/ml spermine and 25 mg/ml spermidine) and then
submerged in the same. After 15 strokes in a Dounce homogenizer, the extract
was centrifuged at 800 g for 15min. The pellet (Pellet I) was used to prepare the
nuclear fraction. The supernatant was again centrifuged at 6000 g for 15min to
remove mitochondria (Pellet II). To prepare the nuclear fraction, Pellet I was
homogenized with a single stroke in a Dounce homogenizer in 2 M-STMDPS
buffer (50mM Tris-HCl, pH 7.4, 2 M sucrose, 5 mM MgCl2, 1 mM DTT, 1 mM
PMSF, 25mg/ml spermine, and 25mg/ml spermidine) and fractionated at 80 000 g
for 5 min. The resulting pellet was resuspended in nuclear extract buffer (20mM
HEPES, pH 7.9, 1.5 mM MgCl2, 0.5 M NaCl, 0.2 mM EDTA, and 20% glycerol) and
used as the nuclear fraction (Pellet I). Pellet II was resuspended in hypotonic lysis
buffer (10mM HEPES, pH 7.9, 1 mM DTT, plus the protease inhibitor cocktail;
Sigma, Milan, Italy) and incubated on ice for 30min. The suspension was
sonicated to lyse mitochondria. Protein concentrations were determined for the
nuclear fraction and the mitochondrial lysate using the standard bicinchoninic acid
assay following the manufacturer’s protocol (Sigma). For each individual
experiment, three spinal cords were used. The purity of the extracted nuclear
fraction was validated by looking for (with western immunoblotting) any
mitochondrial contamination indicated by the cytochrome C oxidase IV protein
(Abcam, Cambridge, UK) in accordance with the method of Beirowski et al.59
These samples were then used for ELISA.
ELISA quantification of PAR. To obtain evidence for PARP-1 activation
and pharmacological inhibition by N-(5, 6-Dihydro-6-oxo-2-phenanthridinyl)-2-
acetamide (PJ34), we quantified its product PAR in accordance with Nasrabady
et al.60 For this purpose, lysates of spinal cords treated with PMþMg
and/or PJ34, or in sham conditions, were collected 24 h later and their PAR
levels were measured using the PARP in vivo pharmacodynamic assay II
(http//www.trevigen.com/protocols) following the manufacturer’s protocol
(Trevigen, Bologna, Italy). This assay is based on ELISA immunoreactivity resulting
in chemiluminescence signals recorded with a Glomax multi-detection system
(Promega, Milan, Italy). Whenever tests were performed for the action of PJ34,
this substance was added to the cell lysis buffer to avoid inhibitor dilution as per
the manufacturer’s instructions. All samples were run in duplicate. After
background subtraction (blank samples), the net PAR levels were quantified
using a standard linear plot (r¼ 0.98) based on the immunoreactivity induced by
known concentrations (20–1000 pg/ml) of PAR. Data were expressed as pg/ml/
100mg of protein (estimated as indicated below).
Drugs. SNP and PJ34 were purchased from Sigma; H2O2 was obtained from
Carlo Erba Reagents (Milan, Italy); and active caspase 3 inhibitor II was obtained
from CalBiochem-Millipore (Billerica, MA, USA).
Data analysis. The data are shown as mean±S.D. Statistical analysis was
carried out with SigmaStat 3.1 (Systat Software, Chicago, IL, USA). Parametric
and nonparametric data were first distinguished with a normality test (Anova
Tukey) and analyzed with the Student t-test and the Mann–Whitney test,
respectively, in accordance with the software choice. The significance level was
always Po0.05, and n indicates the number of tissue sections.
Conflict of Interest
The authors declare no conflict of interest.
Acknowledgements. We thank our colleague Dr. A Kuzhandaivel for her
help with the ELISA assay, Dr. Micaela Grandolfo for support with quantitative
image analysis and Dr. Andrea Tomicich for software support. This work was
supported by a grant from the government of the Friuli Venezia Giulia Region
(SPINAL project).
1. van den Berg ME, Castellote JM, Mahillo-Fernandez I, de Pedro-Cuesta J. Incidence of
spinal cord injury worldwide: a systematic review. Neuroepidemiology 2010; 34:
184–192.
2. Lin MC, Huang YL, Liu HW, Yang DY, Lee CP, Yang LL et al. On-line microdialysis-
graphite furnace atomic absorption spectrometry in the determination of brain magnesium
levels in gerbils subjected to cerebral ischemia/reperfusion. J Am Coll Nutr 2004; 23:
561S–565SS.
3. Valadka AB, Goodman JC, Gopinath SP, Uzura M, Robertson CS. Comparison of brain
tissue oxygen tension to microdialysis-based measures of cerebral ischemia in fatally
head-injured humans. J Neurotrauma 1998; 15: 509–519.
4. Maas AI, Murray GD. Magnesium for neuroprotection after traumatic brain injury. Lancet
Neurol 2007; 6: 20–21.
5. Temkin NR, Anderson GD, Winn HR, Ellenbogen RG, Britz GW, Schuster J et al.
Magnesium sulfate for neuroprotection after traumatic brain injury: a randomised controlled
trial. Lancet Neurol 2007; 6: 29–38.
6. IMAGES.. Magnesium for acute stroke (Intravenous Magnesium Efficacy in Stroke Trial):
randomised controlled trial. Lancet 2004; 363: 439–445.
7. Perlman JM. Intervention strategies for neonatal hypoxic-ischemic cerebral injury.
Clin Ther 2006; 28: 1353–1365.
8. Saeki H, Matsumoto M, Kaneko S, Tsuruta S, Cui YJ, Ohtake K et al. Is intrathecal
magnesium sulfate safe and protective against ischemic spinal cord injury in rabbits?
Anesth Analg 2004; 99: 1805–1812.
9. Taccola G, Margaryan G, Mladinic M, Nistri A. Kainate and metabolic perturbation
mimicking spinal injury differentially contribute to early damage of locomotor networks in
the in vitro neonatal rat spinal cord. Neuroscience 2008; 155: 538–555.
Cell death in ischemia-like spinal cord damage
E Bianchetti et al
10
Cell Death and Disease
10. Margaryan G, Mladinic M, Mattioli C, Nistri A. Extracellular magnesium enhances the
damage to locomotor networks produced by metabolic perturbation mimicking spinal injury
in the neonatal rat spinal cord in vitro. Neuroscience 2009; 163: 669–682.
11. Ryazanova LV, Rondon LJ, Zierler S, Hu Z, Galli J, Yamaguchi TP et al. TRPM7 is
essential for Mg2þ homeostasis in mammals. Nat Commun 2010; 1: 109.
12. Schmitz C, Perraud AL, Johnson CO, Inabe K, Smith MK, Penner R et al. Regulation of
vertebrate cellular Mg2þ homeostasis by TRPM7. Cell 2003; 114: 191–200.
13. Aarts MM, Tymianski M. TRPMs and neuronal cell death. Pflugers Arch 2005; 451:
243–249.
14. Ku¨hn FJ, Heiner I, Lu¨ckhoff A. TRPM2: a calcium influx pathway regulated by
oxidative stress and the novel second messenger ADP-ribose. Pflugers Arch 2005; 451:
212–219.
15. Sumoza-Toledo A, Penner R. TRPM2: a multifunctional ion channel for calcium signalling.
J Physiol 2011; 589: 1515–1525.
16. Kuzhandaivel A, Margaryan G, Nistri A, Mladinic M. Extensive glial apoptosis develops
early after hypoxic-dysmetabolic insult to the neonatal rat spinal cord in vitro. Neuroscience
2010; 169: 325–338.
17. Kuzhandaivel A, Nistri A, Mazzone GL, Mladinic M. Molecular mechanisms underlying cell
death in spinal networks in relation to locomotor activity after acute injury in vitro. Front Cell
Neurosci 2011; 5: 9.
18. Plesca D, Mazumder S, Almasan A. DNA damage response and apoptosis. Methods
Enzymol 2008; 446: 107–122.
19. Cohen GM. Caspases: the executioners of apoptosis. Biochem J 1997; 326: 1–16.
20. Cook PJ, Ju BG, Telese F,Wang X, Glass CK, Rosenfeld MG. Tyrosine dephosphorylation of
H2AX modulates apoptosis and survival decisions. Nature 2009; 458: 591–596.
21. Kuzhandaivel A, Nistri A, Mladinic M. Kainate-mediated excitotoxicity induces neuronal
death in the rat spinal cord in vitro via a PARP-1 dependent cell death pathway
(Parthanatos). Cell Mol Neurobiol 2010; 30: 1001–1012.
22. Wang Y, Dawson VL, Dawson TM. Poly(ADP-ribose) signals to mitochondrial AIF: a key
event in parthanatos. Exp Neurol 2009; 218: 193–202.
23. Abdelkarim GE, Gertz K, Harms C, Katchanov J, Dirnagl U, Szabo´ C et al. Protective
effects of PJ34, a novel, potent inhibitor of poly(ADP-ribose) polymerase (PARP) in in vitro
and in vivo models of stroke. Int J Mol Med 2001; 7: 255–260.
24. Vandenabeele P, Vanden Berghe T, Festjens N. Caspase inhibitors promote alternative
cell death pathways. Sci STKE 2006; 2006: pe44.
25. Cifra A, Mazzone GL, Nani F, Nistri A, Mladinic M. Postnatal developmental profile of
neurons and glia in motor nuclei of the brainstem and spinal cord, and its comparison with
organotypic slice cultures. Dev Neurobiol 2012; 72: 1140–1160.
26. Mladinic M, Nistri A, Taccola G. Acute spinal cord injury in vitro: insight into basic
mechanisms. In Aldskogius H (ed) Animal Models in Spinal Cord Repair. Springer
Scienceþ Business Media, LLC. Humana Press: Heidelberg/New York, 2013, pp 39–63.
27. Carriedo SG, Yin HZ, Lamberta R, Weiss JH. In vitro kainate injury to large SMI-32þ
spinal neurons is Ca2þ dependent. Neuroreport 1995; 6: 945–948.
28. Andrabi SA, Kim NS, Yu SW, Wang H, Koh DW, Sasaki M et al. Poly(ADP-ribose) (PAR)
polymer is a death signal. Proc Natl Acad Sci USA 2006; 103: 18308–18313.
29. Yu SW, Andrabi SA, Wang H, Kim NS, Poirier GG, Dawson TM et al. Apoptosis-inducing
factor mediates poly(ADP-ribose) (PAR) polymer-induced cell death. Proc Natl Acad Sci
USA 2006; 103: 18314–18319.
30. Susin SA, Lorenzo HK, Zamzami N, Marzo I, Snow BE, Brothers GM et al.
Molecular characterization of mitochondrial apoptosis-inducing factor. Nature 1999; 397:
441–446.
31. Venkatachalam K, Montell C. TRP channels. Annu Rev Biochem 2007; 76: 387–417.
32. McNulty S, Fonfria E. The role of TRPM channels in cell death. Pflugers Arch 2005; 451:
235–242.
33. Miller BA. The role of TRP channels in oxidative stress-induced cell death. J Membr Biol
2006; 209: 31–41.
34. Nicotera P, Bano D. The enemy at the gates. Ca2þ entry through TRPM7 channels and
anoxic neuronal death. Cell 2003; 115: 768–770.
35. Sun HS, Jackson MF, Martin LJ, Jansen K, Teves L, Cui H et al. Suppression of
hippocampal TRPM7 protein prevents delayed neuronal death in brain ischemia.
Nat Neurosci 2009; 12: 1300–1307.
36. Nasrabady SE, Kuzhandaivel A, Mladinic M, Nistri A. Effects of 6(5H)-phenanthridinone, an
inhibitor of poly(ADP-ribose)polymerase-1 activity (PARP-1), on locomotor networks of the
rat isolated spinal cord. Cell Mol Neurobiol 2011; 31: 503–508.
37. Penas C, Casas C, Robert I, Fore´s J, Navarro X. Cytoskeletal and activity-related changes
in spinal motoneurons after root avulsion. J Neurotrauma 2009; 26: 763–779.
38. Carrascal L, Nieto-Gonzalez JL, Cameron WE, Torres B, Nunez-Abades PA. Changes
during the postnatal development in physiological and anatomical characteristics of rat
motoneurons studied in vitro. Brain Res Brain Res Rev 2005; 49: 377–387.
39. Zhu C, Qiu L, Wang X, Hallin U, Cande´ C, Kroemer G et al. Involvement of
apoptosis-inducing factor in neuronal death after hypoxia-ischemia in the neonatal rat
brain. J Neurochem 2003; 86: 306–317.
40. Dent MA, Segura-Anaya E, Alva-Medina J, Aranda-Anzaldo A. NeuN/Fox-3 is an intrinsic
component of the neuronal nuclear matrix. FEBS Lett 2010; 584: 2767–2771.
41. Giordano G, Sa´nchez-Pe´rez AM, Montoliu C, Berezney R, Malyavantham K,
Costa LG et al. Activation of NMDA receptors induces protein kinase
A-mediated phosphorylation and degradation of matrin 3. Blocking these effects prevents
NMDA-induced neuronal death. J Neurochem 2005; 94: 808–818.
42. Chen HC, Su LT, Gonza´lez-Paga´n O, Overton JD, Runnels LW. A key role for Mg2þ in
TRPM7’s control of ROS levels during cell stress. Biochem J 2012; 445: 441–448.
43. Cook NL, Van Den Heuvel C, Vink R. Are the transient receptor potential melastatin
(TRPM) channels important in magnesium homeostasis following traumatic brain injury?
Magnes Res 2009; 22: 225–234.
44. Scharenberg AM. TRPM2 and TRPM7: channel/enzyme fusions to generate novel
intracellular sensors. Pflugers Arch 2005; 451: 220–227.
45. Penner R, Fleig A. The Mg2þ and Mg2þ -nucleotide-regulated channel-kinase TRPM7.
Handb Exp Pharmacol 2007; 179: 313–328.
46. Xie YF, Macdonald JF, Jackson MF. TRPM2 calcium and neurodegenerative diseases.
Int J Physiol Pathophysiol Pharmacol 2010; 2: 95–103.
47. Belrose JC, Xie YF, Gierszewski LJ, MacDonald JF, Jackson MF. Loss of glutathione
homeostasis associated with neuronal senescence facilitates TRPM2 channel activation in
cultured hippocampal pyramidal neurons. Mol Brain 2012; 5: 11.
48. Palacios-Prado N, Hoge G, Marandykina A, Rimkute L, Chapuis S, Paulauskas N et al.
Intracellular magnesium-dependent modulation of gap junction channels formed by
neuronal connexin36. J Neurosci 2013; 33: 4741–4753.
49. Tresch MC, Kiehn O. Synchronization of motor neurons during locomotion in the neonatal
rat: predictors and mechanisms. J Neurosci 2002; 22: 9997–10008.
50. Lee IH, Lindqvist E, Kiehn O, Widenfalk J, Olson L. Glial and neuronal connexin expression
patterns in the rat spinal cord during development and following injury. J Comp Neurol
2005; 489: 1–10.
51. Faden AI, Stoica B. Neuroprotection: challenges and opportunities. Arch Neurol 2007; 64:
794–800.
52. Savitz SI, Fisher M. Future of neuroprotection for acute stroke: in the aftermath of the
SAINT trials. Ann Neurol 2007; 61: 396–402.
53. Thuret S, Moon LD, Gage FH. Therapeutic interventions after spinal cord injury. Nat Rev
Neurosci 2006; 7: 628–643.
54. Burgoyne LA. The mechanisms of pyknosis: hypercondensation and death. Exp Cell Res
1999; 248: 214–222.
55. Hara Y, Wakamori M, Ishii M, Maeno E, Nishida M, Yoshida T et al. LTRPC2 Ca2þ 
permeable channel activated by changes in redox status confers susceptibility to cell death.
Mol Cell 2002; 9: 163–173.
56. Everaerts W, Vriens J, Owsianik G, Appendino G, Voets T, De Ridder D et al.
Functional characterization of transient receptor potential channels in mouse urothelial
cells. Am J Physiol Renal Physiol 2010; 298: F692–F701.
57. Oh YK, Shin KS, Kang SJ. AIF translocates to the nucleus in the spinal motor neurons in a
mouse model of ALS. Neurosci Lett 2006; 406: 205–210.
58. Cox B, Emili A. Tissue subcellular fractionation and protein extraction for use in
mass-spectrometry-based proteomics. Nat Protoc 2006; 1: 1872–1878.
59. Beirowski B, Babetto E, Gilley J, Mazzola F, Conforti L, Janeckova L et al.
Non-nuclear Wld(S) determines its neuroprotective efficacy for axons and synapses
in vivo. J Neurosci 2009; 29: 653–668.
60. Nasrabady SE, Kuzhandaivel A, Nistri A. Studies of locomotor network neuroprotection
by the selective poly(ADP-ribose) polymerase-1 inhibitor PJ-34 against excitotoxic injury to
the rat spinal cord in vitro. Eur J Neurosci 2011; 33: 2216–2227.
Cell Death and Disease is an open-access journal
published by Nature Publishing Group. This work is
licensed under a Creative Commons Attribution-NonCommercial-
NoDerivs 3.0 Unported License. To view a copy of this license, visit
http://creativecommons.org/licenses/by-nc-nd/3.0/
Supplementary Information accompanies this paper on Cell Death and Disease website (http://www.nature.com/cddis)
Cell death in ischemia-like spinal cord damage
E Bianchetti et al
11
Cell Death and Disease
  47 
 
 
 
 
 
 
 
 
 
 
 
 
 
Methods, materials and results 
 
 
Section 2 
 
Unusual increase in lumbar network excitability of the rat spinal cord evoked  
by the PARP-1 inhibitor PJ-34 through inhibition of glutamate uptake. 
Nasrabady SE, Kuzhandaivel A, Akrami A, Bianchetti E,  
Milanese M, Bonanno G, Nistri A. 
Neuropharmacology (2012). 
 
Unusual increase in lumbar network excitability of the rat spinal cord evoked
by the PARP-1 inhibitor PJ-34 through inhibition of glutamate uptake
Sara Ebrahimi Nasrabady a, Anujaianthi Kuzhandaivel a,1, Athena Akrami a, Elena Bianchetti a,
Marco Milanese b, Giambattista Bonanno b,c, Andrea Nistri a,d,*
aNeuroscience department, International School for Advanced Studies (SISSA), Trieste, Italy
bUnit of Pharmacology and Toxicology, Department of Experimental Medicine, University of Genoa, Genoa, Italy
cCenter of Excellence for Biomedical Research (CEBR), Genoa, Italy
d SPINAL (Spinal Person Injury Neurorehabilitation Applied Laboratory), Istituto di Medicina Fisica e Riabilitazione, Udine, Italy
a r t i c l e i n f o
Article history:
Received 12 December 2011
Received in revised form
11 April 2012
Accepted 16 April 2012
Keywords:
Excitotoxicity
Motoneurons
Fictive locomotion
a b s t r a c t
Overactivity of poly(ADP-ribose) polymerase enzyme 1 (PARP-1) is suggested to be a major contributor to
neuronal damage following brain or spinal cord injury, and has led to study the PARP-1 inhibitor
2-(dimethylamino)-N-(5,6-dihydro-6-oxophenanthridin-2yl)acetamide (PJ-34) as a neuroprotective
agent. Unexpectedly, electrophysiological recording from the neonatal rat spinal cord in vitro showed
that, under control conditions, 1e60 mM PJ-34 per se strongly increased spontaneous network discharges
occurring synchronously on ventral roots, persisting for 24 h even after PJ-34 washout. The PARP-1
inhibitor PHE had no similar effect. The action by PJ-34 was reversibly suppressed by glutamate iono-
tropic receptor blockers and remained after applying strychnine and bicuculline. Fictive locomotion
evoked by neurochemicals or by dorsal root stimulation was present 24 h after PJ-34 application. In
accordance with this observation, lumbar neurons and glia were undamaged. Neurochemical experi-
ments showed that PJ-34 produced up to 33% inhibition of synaptosomal glutamate uptake with no effect
on GABA uptake. In keeping with this result, the glutamate uptake blocker TBOA (5 mM) induced long-
lasting synchronous discharges without suppressing the ability to produce ﬁctive locomotion after
24 h. The novel inhibition of glutamate uptake by PJ-34 suggested that this effect may compound tests for
its neuroprotective activity which cannot be merely attributed to PARP-1 block. Furthermore, the current
data indicate that the neonatal rat spinal cord could withstand a strong, long-lasting rise in network
excitability without compromising locomotor pattern generation or circuit structure in contrast with the
damage to brain circuits known to be readily produced by persistent seizures.
 2012 Elsevier Ltd. All rights reserved.
1. Introduction
Hyperactivation of poly(ADP-ribose) polymerase enzyme 1
(PARP-1) is an important process contributing to brain damage
arising from stroke (Andrabi et al., 2008) and acute spinal injury
in vivo (Scott et al., 1999; Genovese et al., 2005; Wu et al., 2009).
In vitro models of acute spinal cord injury have conﬁrmed the role
of this enzyme in the excitotoxic neuronal death (Kuzhandaivel
et al., 2010a; Mazzone and Nistri, 2011), and have led to attempts
of pharmacological neuroprotection with PARP-1 inhibitors.
Experimental studies have shown that the PARP-1 inhibitor
2-(dimethylamino)-N-(5,6-dihydro-6-oxophenanthridin-2yl)acet-
amide (PJ-34; Abdelkarim et al., 2001; Kauppinen et al., 2009) could
provide a degree of neuroprotection against brain and spinal cord
ischemia in which excitotoxicity is thought to play a major role
(Virág and Szabó, 2002; Casey et al., 2005; Besson, 2009; Kauppinen
et al., 2009;Moroni, 2008;Moroni andChiarugi, 2009). Nonetheless,
Abbreviations: 5-HT, 5-hydroxytryptamine; ANOVA, analysis of variance; CCF,
cross correlation factor; CNQX, 6-cyano-7-nitroquinoxaline-2,3-dione; CV, coefﬁ-
cient of period variation; DAPI, 40 ,6-diamidino-2-phenylindole; D-APV, D-()-2-
Amino-5-phosphonopentanoic acid; DR, dorsal root; EAAT2, excitatory amino acid
transporter 2; FFT, fast Fourier transform; GABA, gamma-amino butyric acid; l, left;
L, lumbar; mGluR, metabotropic glutamate receptor; n, number of preparations;
NeuN, neuronal nuclei; NMDA, N-methyl–aspartate; PARP-1, poly(ADP-ribose)
polymerase enzyme 1; PHE, 6-5(H)-phenathridinone; PJ-34, 2-(dimethylamino)-N-
(5,6-dihydro-6-oxophenanthridin-2yl)acetamide; r, right; ROI, region of interest;
s.e.m., the standard error of the mean; SD, standard deviation; SMI 32, monoclonal
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clonal antibody; TBOA, DL-threo-b-benzyloxyaspartate; VR, ventral root.
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delayed application of PJ-34 had limited ability to protect rat spinal
neurons in vitro as it could efﬁciently counteract relatively small
excitotoxic damage only (Mazzone andNistri, 2011; Nasrabadyet al.,
2011a). In the course of those experiments, it became, however,
apparent that PJ-34 per se could persistently facilitate spontaneous
synaptic transmission in the spinal cord (Nasrabady et al., 2011a).
This serendipitous observation led us to investigate themechanisms
underlying such an unexpected phenomenon. Thus, the present
report provides new evidence that PJ-34 enhanced glutamatergic
transmission and triggered long-lasting network bursting. Our
results indicated that the rat spinal cord in vitro couldwithstand, for
at least 24 h, 1/3rd reduction in glutamate transport processes
without apparent structural or functional damage.
2. Methods and materials
2.1. Spinal cord preparations
To perform electrophysiological experiments thoracolumbar spinal cords were
carefully dissected from neonatal Wistar rats (0e2 days old) in accordance with the
guidelines of the National Institutes of Health and the Italian act D.Lgs. 27/1/92
no. 116 (implementing the European Union directives no. 86/609 and 93/88). Under
urethane anesthesia (0.2 ml i.p. of a 10% w/v solution) spinal cords were dissected
out and superfused (7.5 ml min1) in a recording chamber with Krebs solution (in
mM): NaCl, 113; KCl, 4.5; MgCl27H2O, 1; CaCl2, 2; NaH2PO4, 1; NaHCO3, 25; glucose,
11; gassed with 95% O2 5% CO2; pH 7.4 at room temperature (for full details see Beato
and Nistri, 1999; Taccola and Nistri, 2006a; Margaryan et al., 2009). All efforts were
aimed at reducing the number of animals and minimizing their suffering.
2.2. Electrophysiological recordings
DC-coupled recordings were performed through lumbar (L) ventral roots (VRs)
with tight-ﬁtting miniature Ag/AgCl suction electrodes (Taccola and Nistri, 2006a).
Signals were recorded from left (l) and right (r) L2 VRs (producing mainly ﬂexor
motor signals to the hind-limb muscles), and from L5 VRs (which convey mainly
extensor motor commands to the same limb) (Kiehn and Kjaerulff, 1998; Kiehn,
2006; Taccola and Nistri, 2006b). Signals acquired at 20 kHz were processed with
pClamp (version 9.2; Molecular Devices, Sunnyvale, CA, USA) and MATLAB software
(version R2010b). Preparations were electrically stimulated with single or train (30
stimuli at 2 Hz) pulses (0.1 ms duration) applied to the ipsilateral homosegmental
dorsal root (DR). To evoke cumulative depolarizationwith superimposed alternating
oscillatory activity typical of ﬁctive locomotion, the stimulation strength was 2
threshold, whereby threshold was taken as the minimum intensity to elicit
a detectable response in the homolateral VR (Taccola et al., 2004; Nasrabady et al.,
2011b). On average, threshold was obtained with 1.61  0.58 V stimulus intensity
(n¼ 6). VR responses induced by weak stimuli close to threshold were considered to
be indicative of monosynaptic reﬂexes (Fulton and Walton, 1986). The peak ampli-
tude of the responses were calculated by averaging at least 5 events.
Fictive locomotion, deﬁned as rhythmic discharges alternating between homo-
segmental and left-right lumbar VRs, was induced by co-application of N-methyl-D-
aspartate (NMDA; 4 or 5 mM) and 5-hydroxytryptamine (5-HT; 10 mM) (Cazalets et al.,
1992; Kiehn and Kjaerulff, 1998; Butt et al., 2002). The period value for rhythmic
discharges was measured as the time between the onset of two cycles of oscillatory
activity (calculated after averaging at least 20 cycles), and its regularity indicated by
the coefﬁcient of period variation (CV). Disinhibited bursting (Bracci et al., 1996a,b,
1997) was induced by continuously bath-applied strychnine (1 mM) and bicuculline
(20mM). Full details concerning the deﬁnition of bursts and theirmeasurementswere
as reported before (Bracci et al., 1996a,b). In order to see the changes in network
excitability caused by glutamate uptake block, the non-transportable inhibitor DL-
threo-b-benzyloxyaspartate (TBOA; 5 mM; Shigeri et al., 2004) was applied for 1 h
in a separate batch of experiments. TBOA has an IC50 value of circa 7 mMto selectively
block the EAAT2 and 3 glial transporters, while at concentration of 100 mMproduces
a broad-spectrum inhibition of all glutamate uptake systems (Shigeri et al., 2004).
2.3. Study protocol
First, all preparations were tested for their ability to generate locomotor
network activity and reﬂexes. While untreated sham spinal cords were kept for 24 h
in Krebs solution (Taccola et al., 2008), parallel preparations were continuously
treated with PJ-34 (1 mM or 60 mM) for up to 24 h when, following washout with
Krebs solution, all electrophysiological tests were repeated. The higher concentra-
tion of PJ-34 was selected as the one producing full block of PARP-1 activity in the rat
spinal cord (Nasrabady et al., 2011a). A batch of experiments was also performed by
applying a different PARP-1 inhibitor, namely (6-5(H)-phenathridinone; PHE),
which we have previously investigated for its potential neuroprotection in the rat
spinal cord (Kuzhandaivel et al., 2010a).
2.4. Immunohistochemistry
Each preparation was histologically ﬁxed at the end of the electrophysiological
experiment as previously described in detail (Taccola et al., 2008). Thus,
paraformaldehye-ﬁxed spinal cords were cryoprotected with 30% sucrose and
sectioned (30 mm). The sections were washed in phosphate buffer solution (PBS) and
incubated in blocking solution (5% normal goat serum, 5% bovine serum albumin,
0.3% Triton-x 100) for 1 h at room temperature followed by primary antibody (NeuN,
1:50, Millipore, Milan, Italy; SMI 32, 1:200, Convance, Rome, Italy; or S100, 1:100
dilution, Dako, Milan, Italy) incubation at 4 C overnight. After rinsing with PBS, the
sections were incubated with goat antimouse or antirabbit IgG Alexa Fluor 488 or
594 secondary antibodies (1:500; Invitrogen, Milan, Italy) for 1 h at room temper-
ature followed by 20 min of DAPI incubation to label the nuclei. The sections were
mounted with Vectashield (Vector Laboratories, Milan, Italy) and analyzed using
a Zeiss Axioskop2 microscope and Metavue software.
2.5. Quantiﬁcation of dead cells
Quantiﬁcation of dead cells was done as described previously (Margaryan et al.,
2009; Kuzhandaivel et al., 2010b). Brieﬂy, pyknotic nuclei (identiﬁed with DAPI
staining) were counted in the regions of interest (ROIs) comprising ventral, central,
dorsal grey matter or ventrolateral white matter. For neuronal or protoplasmic
astrocyte counting we used NeuN or S100 immunopositivity, respectively, in ventral,
central, or dorsal grey ROIs (Taccola et al., 2008; Margaryan et al., 2009) using
“eCELLence” (Glance Vision Tech, Trieste, Italy) software. For each ROI, 3e7 ﬁelds of
280 280 mm (greymatter) or 100 280 mm (white matter) areawere analyzed. For
each experimental group, 4e11 spinal cords were analyzed and, for each spinal cord,
4e6 different sections from T12 to L3 segments were examined. For estimating
motoneuron numbers, SMI32 labelling was performed (Taccola et al., 2008) and
Rexed laminae VIII and IX were analyzed.
2.6. PAR ELISA assay
Endogenous PARP-1 activity was determined by measuring PAR levels with an
ELISAmethod as described previously (Nasrabady et al., 2011a). Brieﬂy, tissue lysates
were prepared from the spinal cords treated with different concentrations of PJ-34,
or from sham preparations. PAR levels were measured using the HT PARP in vivo
Pharmacodynamic Assay II kit (http://www.trevigen.com/protocols/pdf/4520-096-
K.pdf) following the manufacturer’s protocol (Trevigen, Bologna, Italy). PAR levels
were always quantiﬁed 4 h after application of PJ-34. The present assay is based on
the ELISA immunoreactivity resulting in chemiluminescence signals recorded with
Glo(R)max multi detection system (Promega, Milan, Italy). All samples were run in
triplicate. The net PAR levels were quantiﬁed from the known standard concentra-
tions (20e1000 pg/ml) of PAR. Data were expressed as pg/ml per 100 mg of protein.
2.7. Neurochemical measurements of amino acid uptake
Neonatal Wistar rats (0e2 days old) were sacriﬁced and the spinal cord rapidly
removed after exposure of the spinal column. Puriﬁed synaptosomes were prepared
essentially as previously described (Stigliani et al., 2006). Brieﬂy, the tissue was
homogenized in 10 volumes of Tris-buffered sucrose (0.32 M; pH 7.4) using
a glasseteﬂon tissue grinder. The homogenate was centrifuged (5 min, 1000 g) to
remove nuclei and debris and the supernatant was gently stratiﬁed on a discontin-
uous Percoll (GE Healthcare) gradient (2, 6, 10 and 20% v/v in Tris-buffered sucrose)
and centrifuged at 33,500 g for 5 min. The layer between 10 and 20% Percoll
(synaptosomal fraction) was collected and washed by centrifugation. All the
procedures were performed at 0e4 C.
Synaptosomes were resuspended in assay buffer (mM: NaCl, 140; KCl, 3; MgSO4
1.2; NaH2PO4,1.2; NaHCO3 5; CaCl21.2; HEPES10; glucose,10; pH7.4). Protein content
wasmeasured according to the Bradfordmethod (Bradford,1976)with bovine serum
albumin as standard. Aliquots (0.5 ml) of the synaptosomal suspension were incu-
bated for 5min at 37 C; uptakewas then started by the addition of [3H]D-aspartate or
[3H]GABA to a ﬁnal concentration of 3 mM and stopped 2 min later by the addition of
5 ml of assay buffer. Samples were immediately ﬁltered under vacuum through
celluloseﬁlters andwashed twicewith 5ml of assay buffer. PJ-34 (0.1e100 mM), TBOA
(0.1e100 mM) or N-(4,4-phenyl-3-butenyl)-nipecotic acid (SKF 89976A; 10 mM;
Yunger et al., 1984) was introduced at the beginning of incubation period. Non-
speciﬁc uptake was determined in presence of 300 mM unlabelled L-glutamate or
GABA. Filter radioactivity was evaluated by liquid scintillation counting.
2.8. Data analysis
Statistical analysis was carried out with SigmaStat (SigmaStat 3.1, Systat Soft-
ware, Chicago, IL, USA) and the data are shown as mean  SD unless otherwise
indicated. Parametric and non-parametric data were ﬁrst distinguished with
a normality test and analyzed with the Student’s t-test or ManneWhitney test,
respectively, in accordance with the software choice. Uptake data were analyzed by
one-way ANOVA followed by Dunnet’s or NewmaneKeuls test, as appropriate. For
the electrophysiological experiments, comparison was made between the data
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obtained on the ﬁrst day (before and after application of the drug) and on second
day of each experiment (comparing sham and the group treated with PJ-34). The
signiﬁcant level was always P < 0.05 and n indicates the number of preparations.
For analysis of complex spontaneous events elicited by PJ-34, we applied
a bootstrap method (Thomson and Chave, 1991; Kass et al., 2003) whereby temporal
windows (1 min size) were randomly chosen from the original records (20 kHz
sampling; 5 min long) of pairs of VRs. In each pair, cross correlation values were
calculated for two windows of simultaneously recorded traces using MATLAB soft-
ware. We then repeated this procedure 500 times in order to build a distribution of
mean cross correlation values for each condition. Thereafter, data from different
conditions were compared using t-test (or its non-parametric equivalent). To
analyze the frequency of events from different experimental setting, we used 1 min
windows, applied the same boot-strapping method indicated above, and calculated
the fast Fourier transform (FFT) values.
2.9. Drugs
[3H]D-aspartate (speciﬁc activity ¼ 89.5 Ci/mmol) and [3H]GABA (speciﬁc
activity ¼ 11.3 Ci/mmol) were obtained from Perkin Elmer (Milan, Italy). NMDA and
TBOAwere purchased from Tocris (Bristol, UK), while PJ-34, PHE, 5-HT, SKF 89976A,
and strychnine hydrochloride were from Sigma (Milan, Italy). Bicuculline methio-
dide was obtained from Fluka (Milan, Italy).
3. Results
3.1. Onset of spontaneous network activity following PJ-34
application
Fig.1 shows examples of early changes in electrically-evoked and
spontaneous network activity recorded from lumbar VRs after PJ-34
application (60 mM). The amplitude of short-latency synaptic
responses induced by low threshold stimuli and usually regarded as
indicative of monosynaptic transmission (Fulton and Walton, 1986;
Evans, 1989; Kerkut and Bagust, 1995) was increased already after
40 min application (Fig. 1A): on average, this increment was nearly
two fold (see Table 1). Furthermore, the average decay time also
became signiﬁcantly longer (from18345ms,n¼5, to 29883ms,
n ¼ 4; P ¼ 0.03). Fig. 1B shows that the peak of polysynaptic
responses generated by stronger DR stimuli (>2 threshold) was,
however, unchanged after PJ-34 application (see Table 1).
Conversely, cumulative depolarization with superimposed oscilla-
tions induced by DR stimulus trains (Marchetti et al., 2001) was
signiﬁcantly lower 40min from the start of PJ-34 application (Fig.1C
and Table 1), even if it was accompanied by a similar number of
oscillations (Table 1). In addition to these changes in electrically-
evoked synaptic responses, it was noteworthy that, in the presence
of PJ-34, the baseline trace had become noisier with spontaneous
events appearing at irregular interval (see Fig.1BeD). These complex
events appeared with a latency of approximately 15 min from the
start of PJ-34 application.
Fig. 2A shows, on the same preparation, examples of the gradual
intensiﬁcation of spontaneous events after application of PJ-34.
Although the mammalian spinal cord in vitro normally expresses
random spontaneous discharges (Fulton and Walton, 1986; Kerkut
and Bagust, 1995), the events observed after PJ-34 were clearly
more numerous and larger as shown in the distribution histograms
of Fig. 2B. Thus, 15 min later, large discharges emerged (Fig. 2A,
middle) and became very intense 24 h later (Fig. 2A, right). Fig. 2C
Fig. 1. Electrically-evoked responses recorded from in vitro spinal cord preparations early after PJ-34 (60 mM) application on the ﬁrst experimental day. (A) Example of average
monosynaptic response recorded from L5 homolateral VR in control (left) and after 40 min application of PJ-34. (B) Example of polysynaptic VR responses recorded from the same
preparation as in (A). (C) Examples of cumulative depolarization with superimposed oscillatory cycles elicited by train of DR stimuli in control solution and 40 min after the
application of PJ-34. (D) Example of spontaneous complex discharges appearing after application of PJ-34 (note faster timebase).
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Fig. 2. Persistent effect of PJ-34 on spinal networks. (A) Example of sporadic spontaneous discharges recorded in control solution (before application of PJ-34 60 mM, left) and their
gradual intensiﬁcation after 15 min (middle) and 24 h (right) application of PJ-34. (B) Amplitude probability distribution of depolarizing events in a window of 5 min. Filled bars
represent the distribution of the signiﬁcantly higher average amplitude discharges after PJ-34 application for 15 min (P < 0.0001; ManneWhitney) in comparison with control
(open bars); n ¼ 4. (C) Histograms demonstrate the signiﬁcant difference of CCF values between groups treated with PJ-34 for 15 min or 24 h to show discharge synchronicity across
segments and across preparations (*P < 0.001; n ¼ 4) (D) Plot indicates the mean FFT values of discharges from preparations treated for 15 min or 24 h with PJ-34; n ¼ 4. (E)
Histograms show increased average FFT values (mean  s.e.m.) one day after treatment with PJ-34: the frequency power at 15 min PJ-34 application was signiﬁcantly (*P < 0.0001)
smaller than at 24 h (n ¼ 4). (F) Example of spontaneous VR discharges recorded on the second day in vitro from a sham (top) or PJ-34 treated (bottom) spinal cord. (G) Plots of
mean FFT values show signiﬁcant (P < 0.002) increase after 24 h application of PJ-34.
Table 1
Early effects of PJ-34 on VR responses to single (or trains of) DR stimuli.
Monosynaptic reﬂex
peak amplitude (mV)
Polysynaptic reﬂex
peak amplitude (mV)
Cumulative depolarization
amplitude (mV)
Number of oscillations
induced by train of stimuli
Controla 0.129  0.04 (n ¼ 5) 2.59  1.06 (n ¼ 6) 0.873  0.228 (n ¼ 6) 5.5  1 (n ¼ 6)
40 min after application
of PJ-34 60 mM
0.277  0.09 (n ¼ 5) 2.51  0.87 (n ¼ 6) 0.412  0.168 (n ¼ 6) 4.5  0.5 (n ¼ 6)
P-value 0.013 0.889 0.003 0.098
a Control responses refer to those recorded from the same preparations prior to PJ-34 application. Signiﬁcant P-values are shown in bold.
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shows that, on average, events recorded early (ﬁlled column) from
various VR pairs of different preparations, had a high cross corre-
lation value, indicating their synchronicity across segments and
across preparations. Even if 24 h later the cross correlation value
was reduced (Fig. 2C, open column), it was still larger than 0.5,
suggesting retention of good coupling of electrical discharges
between VRs at homo and heterosegmental level.
Fig. 2D plots FFT data from 4 preparations to estimate the pre-
vailing event frequency over a range of 0.1e100 Hz. Thus, for the
same spinal cords, the whole frequency power spectrum at 15 min
PJ-34 application was signiﬁcantly (P < 0.0001) smaller than 24 h
later, indicating the delayed, gradual emergence of slow events
(mainly below 10 Hz). This result was accompanied by a signiﬁcant
increase in the average FFT value at 24 h (Fig. 2E) to support a global
increment in spontaneous event occurrence.
We also compared, after 24 h in vitro, spontaneous events from
sham preparations with those from PJ-34 treated preparations (see
example in Fig. 2F). The FFT plot of Fig. 2G demonstrates a signiﬁ-
cantly (P < 0.002) stronger frequency power after PJ-34. In
summary, these data suggest that PJ-34 evoked complex and long-
lasting synchronous discharges from lumbar VRs, compatible with
a substantial rise in network excitability. These delayed effects
were, however, absent when spinal cords were treated (for 24 h)
with another PARP-1 inhibitor (PHE; 60 mM) that did not induce any
detectable change in spontaneous network discharges after 24 h
(n ¼ 5).
3.2. Relation between PARP-1 inhibition by PJ-34 and network
activity
Fig. 3A shows the concentration (1e60 mM)-dependent changes
in PARP-1 activity estimated on the amount of measured PAR. In
accordance with our previous report (Nasrabady et al., 2011b), after
24 h in vitro, spinal cord samples had a basal PARP-1 activity cor-
responding to 55.9 7 pg PAR/100 mg protein that fell to 476.2 pg
PAR/100 mg protein in the presence of 1 mM PJ-34. With 30 mM PJ-
34, the PARP-1 activity decreased to 25 8.4 pg PAR/100 mg protein,
while with 60 mM PJ-34 it was 26  5.3 pg PAR/100 mg protein,
indicating that it had reached a plateau level of inhibition. These
values were signiﬁcantly smaller than those for sham preparations
in all three groups (P ¼ 0.05 for 1 mM PJ-34, P ¼ 0.001 for 30 and
60 mM PJ-34). Fig. 3B shows that even the lowest tested concen-
tration of PJ-34 (1 mM) signiﬁcantly (P < 0.001) increased the FFT
values of the spontaneous network discharges after 24 h in
comparison with sham preparations, although this effect was less
intense than the phenomenon detected after 60 mM PJ-34 (see
Fig. 2). As exempliﬁed in Fig. 3C, the onset of the electrophysio-
logical discharges evoked by 1 mM PJ-34 was delayed and fully
expressed 24 h later (Fig. 3C) in comparison with the large spon-
taneous events already detected after 15 min PJ-34 application (see
Fig. 2A, middle).
3.3. Effect of PJ-34 on ﬁctive locomotion and disinhibited bursting
We next enquired whether these changes in network excitability
evoked by PJ-34 could impact on the ability to generate ﬁctive
locomotion. Fig. 4A compares locomotor-like cycles (evoked by co-
applied NMDA and 5-HT) recorded, after 24 h, from a sham prepa-
ration with those from a PJ-34 treated spinal cord. In fact, ﬁctive
locomotion was apparently unperturbed by long-lasting PJ-34
application as indicated by similar cycle period or amplitude values
(Fig. 4A, left, right). There was, however, a small, signiﬁcant incre-
ment in the period CV value (Fig. 4A, middle), suggesting a slightly
irregular pattern.
Fig. 3. Concentration-dependent effects of PJ-34 on PAR and network activity. (A) Plot quantiﬁes PAR levels produced by PARP-1 activity of tissue lysates from sham or PJ-34
(1e60 mM) treated spinal cords. The values are signiﬁcantly smaller than sham in all three groups (*P ¼ 0.05 for 1 mM PJ-34, **P ¼ 0.001 for 30 and 60 mM PJ-34) (n ¼ 3 for
each group). (B) FFT plot indicates the higher values of discharges 24 h after application of PJ-34 1 mM (P < 0.001, n ¼ 4). (C) Example of sporadic spontaneous VR discharges
recorded in control (before 1 mM PJ-34 application, left), early after PJ-34 (middle) and 24 h later (right); traces are all from the same preparation.
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Fig. 4B shows, for the second day in vitro, examples of cumulative
depolarization generated by shamor PJ-34 treated preparationswith
similar number of superimposed oscillations. Table 2 quantiﬁes such
data and also indicates that there was no change in mono and
polysynaptic reﬂexes recorded after 24 h application of 1 or 60 mM
PJ-34. Likewise, disinhibited bursting elicited by blocking synaptic
inhibition with strychnine and bicuculline was unchanged by 24 h
application of PJ-34 since the period was 42 24 s (vs 45 14 sham
data; n¼ 10), and burst durationwas 15 9 s (vs. 15 7 sham data).
Hence, locomotor network activity tested with either neurochemi-
cals or DR stimuli as well as basic circuit rhythmicity were not dis-
rupted by long-lasting PJ-34 application.
3.4. Pharmacological block of PJ-34 evoked discharges
Since glutamate is the main excitatory transmitter of locomotor
networks (Cazalets et al., 1992) acting on NMDA and non-NMDA
receptors (Beato et al., 1997), we investigated whether block of ion-
otropic glutamate receptors by CNQX (10 mM) and D-APV (50 mM)
could eliminate spontaneous as well as PJ-34 induced events. Fig. 5A
(left) shows VR records from a preparation exhibiting strong ongoing
discharges in Krebs solution (24 h after application of PJ-34 and
washout). When CNQX and APV were applied for 15 min,
spontaneous events disappeared (Fig. 4, middle), and returned after
10 min of washout of these antagonists, a result consistent with the
dependence of spontaneous events on glutamatergic drive.
We also explored the potential contribution of GABA and glycine
receptors to the PJ-34 elicited spontaneous events. This was difﬁ-
cult because the disinhibited bursting arising fromblock of synaptic
inhibition is associated with strong depression of spontaneous
excitatory events during the interburst interval (Bracci et al.,
1996a), making it unfeasible to test glutamatergic events in isola-
tion. Thus, we took advantage of a previous protocol whereby
disinhibited bursts can be entrained on a 1:1 basis by low frequency
DR stimulation (0.05 Hz; Bracci et al., 1997) as exempliﬁed in
Fig. 5B. Hence, after 24 h application of PJ-34 and washout, spon-
taneous disinhibited bursting was produced by strychnine and
bicuculline, followed by a long (6.5 min) DR stimulus train that
regularly entrained bursts. During the electrical stimulation, and
unlike the interburst depression typical of control experiments
(Bracci et al., 1997), spontaneous synchronous bursts emerged as
exempliﬁed, on a faster timebase, in Fig. 5 C. We next calculated
whether appearance of such spontaneous events could inﬂuence
the subsequent electrically-driven one: plotting the evoked burst
amplitude (Fig. 5D, top) vs. the time interval from the preceding
spontaneous burst showed a linear relation (r ¼ 0.716), showing
Fig. 4. Chemically or electrically induced ﬁctive locomotion in sham preparations or after 24 h application of PJ-34 60 mM. (A) Examples of ﬁctive locomotion (top traces) induced by
NMDA (4 mM) plus 5-HT (10 mM) on sham (left) or PJ-34 treated spinal cord (right). The bottom histograms show similar characteristics of ﬁctive locomotion (except for period CV
value, P ¼ 0.01, middle) of sham or PJ-34 treated spinal cords (n ¼ 9). (B) Examples of alternating oscillatory cycles induced by trains of DR stimuli on sham or PJ-34 treated spinal
cords. Number of oscillations and cumulative depolarization amplitude were similar in the two groups.
Table 2
Characteristics of VR responses of sham or PJ-34 treated spinal cord to single (or trains of) DR stimuli on the second day in vitro.
Monosynaptic reﬂex
peak amplitude (mV)
Polysynaptic reﬂex
peak amplitude (mV)
Cumulative depolarization
amplitude (mV)
Number of oscillations induced
by train of stimuli
Sham 0.25  0.07 (n ¼ 7) 0.73  0.39 (n ¼ 7) 0.54  0.27 (n ¼ 6) 5.17  0.88 (n ¼ 6)
After application of PJ-34 (60 mM) 0.31  0.08 (n ¼ 6) 0.82  0.36 (n ¼ 7) 0.35  0.1 (n ¼ 6) 5.97  1.67 (n ¼ 7)
P-value* 0.196 0.664 0.158 0.317
After application of PJ-34 (1 mM) 0.31  0.15 (n ¼ 4) 0.80  0.27 (n ¼ 4) 0.38  0.05 (n ¼ 4) 5.88  1.95 (n ¼ 4)
P-valuey 0.367 0.770 0.352 0.762
* and y indicate the P-value of the comparison between Sham and 60 mM PJ-34 or 1 mM PJ-34 application respectively.
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that large bursts were preceded by a long quiescent period.
Conversely, there was no apparent relation between evoked burst
duration and time interval from previous spontaneous burst
(Fig. 5D, bottom). Globally, these data were compatible with sus-
tained increase in glutamatergic network activity as the main
process responsible for continuous synchronous discharges, and
that, when network discharges were fully engaged as bursts, there
was a subsequent, transient downregulation of circuit excitability.
3.5. Histochemistry of PJ-34 treated spinal cords
In analogy with our previous studies (Taccola et al., 2008;
Nasrabady et al., 2011a), we analyzed four ROIs of spinal cord
sections from the same preparations used for our electrophysio-
logical tests. First, we assessed whether pyknosis (condensed
chromatin appearance) was more common 24 h after PJ-24 appli-
cation: Fig. 6A, B indicates that pyknosis was a comparatively rare
occurrence (<10%) in all ROIs from sham or treated preparations.
Using immunostaining for S100, the main biomarker for grey
matter astrocyte precursors in the neonatal rat spinal cord
(Kuzhandaivel et al., 2010b; Cifra et al., in press), we also found no
difference between sham and treated preparations (Fig. 6E, F).
Fig. 6C, D shows no loss of NeuN-stained neurons across spinal cord
sections after 24 h application of PJ-34, with good preservation of
motoneuron numbers (Fig. 6G, H) evaluated with SMI 32 immu-
noreactivity (Taccola et al., 2008; Mazzone et al., 2010).
3.6. Effect of the glutamate uptake inhibitor TBOA
The strong increase in network excitability with spontaneous
discharges evoked by PJ-34 without concomitant loss of neurons
raised the possibility that this drug was partially inhibiting the
uptake of glutamate without reaching toxic consequences for
network structure and function. To examine this issue, we applied
a low concentration of the selective uptake blocker TBOA at a dose
close to its IC50 value (circa 7 mM) for inhibiting the glutamate glial
transporters EAAT2 and 3 (Shigeri et al., 2004). Fig. 7A shows an
example of the gradual increase in spontaneous event occurrence
developing after the application of TBOA with strong electrical
discharges emerging synchronously on L2 and L5 VRs (average CCF
value after 40min¼ 0.72 0.17, and after 24 h¼ 0.710.25; n¼ 5).
By performing a FFT analysis of such events from 5 spinal cords and
comparing them with the average data from PJ-34 treated prepa-
rations (24 h later), the power spectrum appeared overall similar
(Fig. 7B) though a small signiﬁcant (P < 0.001) difference was
detected as the plot related to the TBOA treated preparations was
shifted downwards.
We next investigated the long-term consequences of 24 h
TBOA application (5 mM) on ﬁctive locomotion. This pattern was
present in 4 out of 5 preparations (see example in Fig. 7C) with
characteristics similar to the activity observed in parallel sham
preparations (period ¼ 4.16  0.59 s, CV ¼ 0.09  0.03,
amplitude ¼ 0.06  0.02 mV after TBOA vs 4.59  1.23 s,
0.10 0.04, 0.110.05mV in sham conditions). The basic network
rhythmicity expressed as disinhibited bursting was also present
after 24 h application of TBOA. Although the bursts appeared at
faster rate (bursts period ¼ 28.6  17.9 s vs 45.8  14.0 s in sham,
P ¼ 0.03), the other characteristics of network bursting such as CV
(0.61 0.22 vs 0.44  0.15 in sham), amplitude (0.75  0.32 mV vs
0.79  0.24 mV in sham), and burst duration (8.51  5.08 s vs
15.78  7.66 s in sham) remained similar. No deleterious action by
TBOA (24 h application) on neurons, glia and motoneurons was
found on histologically-processed spinal cords (Fig. 6B, D, F, H,
open bars).
Fig. 5. Ionotropic receptor blockers inﬂuence discharges evoked by PJ-34. (A) Examples of spontaneous VR events recorded 24 h after application of PJ-34 and washout which are
completely suppressed by co-application of CNQX (10 mM) and APV (50 mM) (middle). The spontaneous events return after 10 min washout with Krebs solution (right). (B) Dis-
inhibited bursting is elicited by application of strychnine and bicuculline one day after PJ-34 application and wash. Although bursts are entrained (1:1) by a DR train of twenty
stimuli (2 threshold, 0.05 Hz; see artefacts shown as downward deﬂections), spontaneous bursts emerge in the intervals between stimuli. (C) Faster timebase example of dis-
inhibited bursting with electrically-driven and spontaneous events taken from (B). (D) A spontaneous burst affects the subsequent electrically-driven one. Top plot indicates that
evoked burst amplitude is linearly related to the time interval between a spontaneous burst and the following electrically-evoked one (P < 0.001; n ¼ 5). Nonetheless, no linear
relation (bottom plot) between evoked burst duration and time interval from the previous spontaneous burst is apparent (P ¼ 0.39).
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3.7. Neurochemical measurement of glutamate uptake
The uptake of [3H]D-aspartate or [3H]GABA and its inhibition by
PJ-34 were evaluated in synaptosomes puriﬁed from the spinal cord
of 0e2 day old rats. The control uptake of [3H]D-aspartate and of [3H]
GABA in synaptosomes exposed to 3 mM of the radioactive tracers
amounted to 1355  136 pmol/mg protein/2 min (n ¼ 12) and
3225191 pmol/mg protein/2min (n¼ 5), respectively. Fig. 8 shows
the concentration-dependent decrease by PJ-34 (0.1e100 mM) of the
uptake of [3H]D-aspartate: the maximal effect amounted to 30%
inhibition with IC50 value, estimated from the ﬁtted curve, equal to
0.33 mM. [3H]D-aspartate uptake was inhibited also by TBOA
(0.1e100 mM) in a concentration-dependent manner (maximal
inhibition about 90%: IC50¼ 2.18 mM. Fig. 8). Synaptosomal [3H]GABA
uptake was unaffected by 100 mM PJ-34 (3225  191 nmol/mg
protein/2min in control vs 3089175 nmol/mg protein/2min in the
presence of PJ-34; n ¼ 5). Conversely, [3H]GABA uptake was
decreased from 3225  191 pmol/mg protein/2 min to
225  37 pmol/mg protein/2 min by 10 mM SKF 89976A, a canonical
GABA uptake inhibitor (Milanese et al., 2010; n ¼ 5; P < 0.001).
4. Discussion
The principal ﬁndings of the present report are that: 1. the PARP-
1 inhibitor PJ-34 was a partial blocker of glutamate uptake, 2. this
action was associated with a strong increase in network discharges
persisting even after washout, and 3. it had no neurotoxic conse-
quence, for at least 24 h, on neurons and glia in the neonatal rat
spinal cord. These data demonstrate that prolonged electrical
discharges per se did not damage complex network activities like
the locomotor program.
4.1. PJ-34 as an inhibitor of glutamate uptake:
functional consequences
Neurochemical data showed this agent to be a signiﬁcant blocker
of glutamate uptake with no action on GABA transport. It was
interesting to detect this effect at micromolar concentrations of
PJ-34, implying that this phenomenon might occur with pharma-
cological rather than toxic doses of this drug. The action of PJ-34was
translated into an early enhancement of glutamate-mediated
monosynaptic reﬂexes, indicating that glutamate uptake was an
important process to regulate excitatory transmission. This
response was observed together with the smaller amplitude of
cumulative depolarization probably due to steadily-depolarized
neurons, still capable of generating a standard series of alternating
oscillations. Polysynaptic reﬂexeswere unchanged perhaps because
of their heterogeneous presynaptic origin.
While the effect of PJ-34 on glutamate uptake and synaptic
reﬂexes was relatively rapid, there was a gradual intensiﬁcation of
spontaneous network discharges: one day later, despite sustained
washout of PJ-34, these strong discharges continued, suggesting
that spinal circuits had become hyper-excitable.
4.2. Characteristics of spontaneous discharges induced by PJ-34
VR recordings were ill-suited to identify the electrophysiological
nature of the PJ-34 evoked events which likely included the activity
of several classes of premotoneuron impinging upon motoneurons.
Experiments with pharmacological antagonists showed, however,
that these discharges were fully dependent on ionotropic glutamate
receptor activation, and that,whenGABAandglycine receptorswere
blocked, spontaneous bursts could emerge in the interval between
Fig. 6. PJ-34 or TBOA does not induce spinal cord histological damage one day later. (A) Representative images showing DAPI stained dorsal horn of sham or PJ-34 treated spinal
cord 24 h later. (B) Histograms plot the low occurrence (<10%) of pyknosis detected in different ROIs of sham, PJ-34 or TBOA treated spinal cords. Pyknosis is normalized with
respect to the total number of DAPI sensitive cells. (C) Representative images showing NeuN-stained ventral horn of sham or PJ-34 treated spinal cord. (D) Histogram plots the
number of NeuN positive neurons in ROIs from sham, PJ-34 and TBOA treated spinal cords. (E) Representative images showing S100 stained dorsal horn of sham or PJ-34 treated
spinal cord. (F) Histogram plots the number of S100 positive protoplasmic astrocytes in ROIs of sham, PJ-34 or TBOA treated spinal cords. (G) Representative images showing SMI 32
stained motoneurons in the ventral horn of sham or PJ-34 treated spinal cord. (H) Histogram plots the number of SMI 32 positive motoneurons in the ventral horn region of sham,
PJ-34 or TBOA treated spinal cords. For all the experiments the number of spinal cords was 4, 9, 5 for sham, PJ-34 and TBOA, respectively.
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electrically-stimulated bursts. The presence of synchronous events
across segments is compatible with the possibility of recurrent
excitation recruiting awidespread neuronal assembly into collective
discharge mode (Streit et al., 2001). In fact, our analysis indicated
that these dischargeswere in general rather slow in accordancewith
the view that theyoriginated fromanample neuronal population. As
previously shown for the rat spinal dorsal horn (Nie and Weng,
2009), impaired glutamate uptake probably induced spill-over of
extracellular glutamate outside the active synapses to extensively
raise neuronal excitability. The present data cannot distinguish the
relative contribution by uptake block and/or facilitated release of
this excitatory transmitter to the strong enhancement in sponta-
neous discharges. Inviewof thedifﬁculty to probe, in the spinal cord,
endogenous glutamate release originating from multiple spinal
sites, future experiments based on analysis of synaptic events with
patch clamp recording might help to clarify this issue.
The PJ-34 evoked state of spinal cord hyperexcitability did not
exert a deleterious action on locomotor-like patterns, nor was it
translated into spontaneous bouts of ﬁctive locomotion. Likewise,
former studies with the glutamate uptake blocker dihydrokainate
have shown that it could only facilitate ﬁctive locomotion induced by
bath-applied glutamate to the lamprey spinal cord in vitro (Brodin
and Grillner, 1985) or by mesencephalic stimulation of the cat
in vivo (Douglas et al., 1993), but rarely could it produce this pattern
directly.
Fig. 7. Effect of TBOA (5 mM) on VR discharges of the spinal network. (A) Traces are examples of early (15 min and 40 min, left and middle, respectively) application of TBOA
compared to long-lasting (24 h) application of this drug (right). (B) Comparison of FFT values between 24 h application of TBOA or PJ-34 shows that the TBOA plot is shifted
downwards (P < 0.001; ManneWhitney) with a power spectrum slightly different from PJ-34 (n ¼ 5). (C) Examples of ﬁctive locomotion induced by NMDA plus 5-HT on a sham and
one preparation treated with TBOA for 24 h (and washout). The values of locomotor-like activity in the group treated with TBOA were similar to the sham.
Fig. 8. Effect of PJ-34 (ﬁlled circles) or TBOA (open circles) on the uptake of [3H]
D-aspartate by synaptosomes from the spinal cord of 0e2 old rats. Data are expressed
as percent inhibition of [3H]D-aspartate uptake and represent the mean  s.e.m of 6
independent experiments run in triplicate. *P < 0.05, **P < 0.001, ***P < 0.0001 vs. the
respective controls (ANOVA plus NewmaneKeuls test).
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4.3. Relative contribution by glutamate uptake inhibition or PARP-1
depression to spontaneous network discharges
A relatively low concentration of PJ-34 (1 mM) produced a partial
inhibition of PARP-1 activity amounting to circa 13% reduction in
the production of PAR, the compound that (in high concentrations)
underlies excitotoxic death (Kuzhandaivel et al., 2011). This rather
modest decrease in PARP-1 functionwas probably unable to explain
the strong rise in network excitability: indeed, application of PHE,
a different PARP-1 inhibitor (Nasrabady et al., 2011b), did not
generate an analogous rise in network discharges. The lowest PJ-34
concentration (1 mM) could, however, induce a signiﬁcant depres-
sion of glutamate uptake (about 25%) which was not very different
from the depression (30%) detected with the highest PJ-34
concentrations, and could also evoke delayed onset of strong
network discharges. These data, therefore, suggest that partial
inhibition of PARP-1 activity was not per se a crucial factor to
increase network excitability, an effect more likely attributable to
the partial depression of glutamate uptake. Hence, it seems prob-
able that the induction of persistent network discharges was an
unexpected property of PJ-34 because of its additional action on the
glutamate transport system.
It is difﬁcult to relate the present in vitro ﬁndings to the in vivo
administration of PJ-34 since, to the best of our knowledge, the
actual plasma concentration of this drug and its ﬁnal redistribu-
tion to the brain tissue remain unclear. Since the dose of PJ-34
injected into experimental animal is 3-30 mg/kg (Abdelkarim
et al., 2001; Virág and Szabó, 2002; Kauppinen et al., 2009;
Crawford et al., 2010), assuming uniform drug distribution
throughout body compartments of an adult rat (and ignoring any
bound fraction that might lower the free drug concentration), one
might estimate a plasma concentration of approximately 37 mM
after 10 mg/kg, that is in the range of the concentrations tested
in vitro in the present report. Even if the actual concentration of
free PJ-34 at neuronal membrane level is likely to be lower, it
seems feasible that it would still be compatible with those tested
in the present study.
4.4. Downregulation of glutamate transport translated into
network plasticity
Following perturbation of neurotransmitter systems, activity-
dependent synaptic plasticity regulates brain network excit-
ability (Marder, 1998; Abbott and Nelson, 2000; Neves et al.,
2008). This process is known to develop in the spinal cord as
well (Parker and Grillner, 2000). We propose that application of
PJ-34 biased spinal network activity towards excitation over
inhibition as shown by increased random discharges dependent
on glutamatergic transmission. It is likely, however, that a degree
of homeostatic plasticity had occurred whereby the enhanced
level of extracellular glutamate must have led to a compensatory
downregulation of glutamatergic transmission as demonstrated
by the unchanged size of monosynaptic reﬂexes (and cumulative
depolarization) one day later. Hence, in spinal networks,
homeostatic plasticity (Galante et al., 2001; Rosato-Siri et al.,
2002) and efﬁcient synaptic inhibition (which enabled loco-
motor network function; Kiehn, 2006) possibly contributed to
prevent any runaway excitation caused by the partial block of
glutamate transport. When GABA and glycine receptors were
blocked by bicuculline and strychnine, disinhibited bursting
following PJ-34 exposure was similar to control. Nonetheless,
spontaneous bursts emerged in the interval between electrically-
driven bursts and exerted a rapid downregulation of subsequent
bursts indicating state-dependent, short term plasticity (Bracci
et al., 1997).
4.5. Persistent electrical discharges had no structural consequences
on spinal networks
Although excitotoxic damage elicited by impaired glutamate
uptake is thought to be a major process to lesion neurons (Kim
et al., 2011), and, in particular, motoneurons (Foran and Trotti,
2009), the present study shows that persistently raised network
discharges had not caused early loss of neurons or glia in the spinal
cord. To account for the structural and functional resilience of
spinal networks, it is proposed that build-up of extracellular
glutamate might have also activated compensatory processes that
have prevented neurotoxicity. In particular, it is likely that wider-
scale activation of metabotropic glutamate receptors might have
counteracted network hyperexcitability as proposed for brain
circuits (Huang et al., 2004; Hartmann et al., 2008; Potier et al.,
2010). All main subtypes of metabotropic glutamate receptor are
largely expressed by the rat spinal cord (reviewed by Nistri et al.,
2006) to regulate synaptic transmission and reﬂexes (Marchetti
et al., 2003). Indeed, a recent study of the rat dorsal horn has
shown that inhibition of glutamate transporters enhances group I
mGluR-dependent oscillatory activity (Galik et al., 2008). Further-
more, in the rat hippocampus, raised glutamatergic signalling is
reported to induce release of endocannabinoids from postsynaptic
cells to depress, in a retrograde fashion, further neurotransmitter
release (Hofmann et al., 2008; Nahir et al., 2010). Future studies are
necessary to explore if a similar process occurs also in the spinal
cord as it would represent a powerful system to dampen network
excitability. Thus, the most parsimonious explanation is that, as far
as locomotor networks were concerned, moderate block of gluta-
mate transport did not trigger neurodegeneration because
compensatory mechanisms were likely to contrast the potential
risk of excitotoxicity. In support of our suggestion is the report that
prolonged elevation of extracellular glutamate due to its transport
blockade in vivo is innocuous for spinal motoneurons, while direct
activation of glutamate receptors is highly neurotoxic (Tovar-Y-
Romo et al., 2009).
4.6. Implications for neurodegeneration in the spinal cord
Previous models of spinal excitotoxicity and allied neuro-
degeneration had relied on the application of various concentra-
tions of kainate (Mazzone et al., 2010), a glutamate analoguewidely
employed also for evoking experimental brain lesions with
behavioural effects like generalized convulsions (Vincent and
Mulle, 2009). Indeed, it is thought that repeated seizures are the
cause for chronic epilepsy (Ben-Ari, 2001) since about 1 h of
electrically-induced seizures is sufﬁcient to obtain substantial
neurodegeneration in the rat hippocampus (Norwood et al., 2011).
The present results suggest that, in the rat spinal cord in vitro,
intense synchronous discharges were not per se able to produce
cell or functional damage. This observation differs from the
neurotoxicity data following application of kainate that depolarizes
neurons directly by binding to its receptors and it also triggers
release of endogenous glutamate from depolarized neurons
(Mazzone and Nistri, 2011) to perpetrate a vicious circuit of exci-
tation-neurotoxicity.
In conclusion, strongly and persistently enhanced glutamatergic
activity at spinal network level did not trigger neurodegeneration
and allowed preservation of locomotor-like function. Thus, these
results are consistent with the notion that delayed administration
of PJ-34 could protect spinal neurons from excitotoxicity as long as
the insult was relatively small (Mazzone and Nistri, 2011;
Nasrabady et al., 2011a). It seems probable that, for spinal networks,
summating the excitation evoked by PJ-34 to a strong excitotoxic
stimulus becomes a tall order to cope with.
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Highlights:  
 ATF3 is expressed in rat ependymal stem/progenitor cells from neonatal to adult age. 
 In quiescent ependymal cells ATF3 immunostaining overlaps with nestin and vimentin. 
 Migrating spinal stem cells show nuclear ATF3 immunostaining. 
 Migrating cells make chain formation termed funicular migratory stream. 
 MAPK-p38 and JNK/c-Jun inhibitors prevent the migration of ATF3 positive cells 
 
Keywords: Activating transcription factor 3, quiescent stem cells, spinal cord injury, in vitro rat 
spinal cord, excitotoxicity, oxygen-glucose deprivation 
 
Abbreviations: ATF3, activating transcription factor; AU, arbitrary units; bHLH, basic helix-
loop-helix; bZIP, Basic Leucine Zipper; CC, central canal; CREB, cAMP responsive element-
binding; CSF, cerebrospinal fluid; DAPI, 4,6-diamidino-2-phenylindole; DCX, doublecourtin; 
DIV, days in vitro; EdU, 5-ethynyl-20-deoxyuridine;  FMS, funicular migratory stream; GFAP, 
glial fibrillary acidic protein; MAPK, mitogen-activated protein kinases; PM, pathological 
medium; RMS, rostral migratory stream; SPCs, stem and progenitor cells; TBP, TATA binding 
protein. 
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ABSTRACT  
The present study identified the ATF3 as a novel dynamic marker for ependymal stem/progenitor 
cells (nestin, vimentin and SOX2 positive) around the central canal of the neonatal or adult rat 
spinal cord. While quiescent ependymal cells showed cytoplasmic ATF3 expression, during 6-24 
h in vitro these cells mobilized and acquired intense nuclear ATF3 staining. Their migratory 
pattern followed a centrifugal pathway toward the dorsal and ventral funiculi, reminiscent of the 
rostral migratory stream of the brain subventricular stem cells. Thus, the chain cell formation 
was, by analogy, termed funicular migratory stream (FMS). The FMS process preceded the 
strong proliferation of ependymal cells occurring only after 24 h in vitro. Pharmacological 
inhibition of MAPK-p38 and JNK/c-Jun (upstream effectors of ATF3 activation) prevented the 
FMS mobilization of ATF3 nuclear-positive cells. Excitotoxicity or ischemia-like conditions, 
reported to evoke neuronal and glial injury, did not further enhance migration of ependymal cells 
at 24 h, suggesting that, at this early stage of damage, the FMS phenomenon had peaked and that 
more extensive repair processes are delayed beyond this time point. ATF3 is, therefore, useful to 
identify activation and migration of endogenous stem cells of the rat spinal cord in vitro. 
 
1. INTRODUCTION 
The ependymal region of the adult spinal cord in mammals harbours a pool of stem and 
progenitor cells (SPCs) readily activated and recruited by spinal damage (Weiss at al.,1996; 
Hugnot and Franzen, 2011). Even though their adult neurogenesis has not been observed 
(Hugnot and Franzen, 2011; Sabourin et al., 2009), the neural stem cells present in the adult 
spinal cord are recruited and proliferate after spinal cord injury (Yamamoto et al., 2001b), 
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producing scar-forming astrocytes and myelinating oligodendrocytes (Meletis et al., 2008). The 
manipulation of endogenous spinal stem cells after injury could represents one valid alternative 
to stem cell transplantation, since it is noninvasive and avoids the need for immune suppression 
(Meletis et al., 2008). 
Spinal stem cells are difficult to identify due to their heterogeneity and lack of specific 
expressional markers, since the ones currently used significantly overlap with those of mature 
astrocytes (McDonough and Martinez-Cardeno, 2012). Furthermore, there is no specific marker 
to discriminate between quiescent and activated ependymal spinal cells, or to monitor migratory 
ependymal cells. Moreover, the signaling pathways and genes controlling the spinal SPC fate in 
normal and pathological conditions, remain largely unknown (Hugnot and Franzen, 2011).  
Brain transcription factors that regulate formation and proliferation of neural SPCs depend on the 
Sox family of genes, in particular Sox2 (Liu et al., 2013). Genomics and proteomics technologies 
have recently identified Wnt/beta-catenin, Notch, sonic hedgehog and growth factor networks as 
major signaling pathways involved in maintainance, self-renewal, proliferation and neurogenesis 
of the neural SPCs, and have demonstrated cross-talk between key molecules of these pathways 
and their modulations by transcription factors, miRNA and histone modifications (Yun et al., 
2010).  
At variance with the wealth of brain data, transcription factors controlling spinal cord stem cells 
remain incompletely understood as they have been studied with in vitro primary cultures, 
showing common expression of various homeodomain-type (Pax6, Pax7, Nkx2.2, and Prox1) 
and basic helix-loop-helix (bHLH)-type (Ngn2, Mash1, NeuroD1, and Olig2) regulatory factors 
in adult and embryonic rat spinal neural progenitors (Yamamoto et al., 2001b). In the course of 
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our studies with biomarkers of neuronal damage (Khuzhandaivel et al., 2011) we serendipitously 
discovered intense immunostaining of ependymal cells for the activating transcription factor 3 
(ATF3): this observation led us to explore its expression in control or damage-induced protocols. 
ATF3 belongs to the mammalian ATF/cAMP responsive element-binding (CREB) protein 
family of the Basic Leucine Zipper (bZIP) transcription factors (Hashimoto et al., 2002) that 
generate a wide range of either repressors or activators of transcription (Thompson et al., 2009). 
ATF3 is thought to be an immediate early gene, a stress inducible gene and an adaptive response 
gene, which, when activated by various stimuli, can control cell cycle and cell death machinery 
(Hunt et al., 2012). 
ATF3 expression is normally very low in central neurons and glia, but it is markedly upregulated 
in response to injury and closely linked to survival and regeneration of peripheral axons (Hunt et 
al., 2012). Both cytoplasmic and nuclear ATF3 immunostaining has been reported with 
variations related to cell type, species, and injury state when it becomes prevalently nuclear 
(Hunt et al., 2012). ATF3 is supposed to have a role in neurite growth and regeneration (Moore 
et al., 2011) and it has been identified as regulator of neuronal survival against excitotoxic and 
ischemic brain damage (Zhang et al., 2011). ATF3 knockout exacerbates inflammation and brain 
injury after transient focal cerebral ischemia (Wang et al., 2012). 
ATF3 has no known role in neuronal development of the intact nervous system, neither its 
expression has been reported in SPCs. The present study is the first report of ATF3 as a reliable 
marker of activated neuroprogenitor cells in the rat spinal cord. 
 
2. MATERIAL AND METHODS 
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2.1. Animals 
The experiments were performed on neonatal or adult Wistar rats in accordance with the 
guidelines of the National Institutes of Health and the Italian act D.Lgs. 27/1/92 no. 116 
(implementing the European Community directives no. 86/609 and 93/88), and with approval by 
the SISSA ethical committee for animal experimentation. All efforts were aimed at reducing the 
number of animals used and at minimizing their suffering. Spinal cords were dissected out from 
neonatal animals under urethane anesthesia (0.2 ml i.p. of a 10% w/v solution) with continuous 
superfusion with Kreb’s solution containing (in mM): NaCl, 113; KCl, 4.5; MgCl27H2O, 1; 
CaCl2, 2; NaH2PO4, 1; NaHCO3, 25; glucose, 11; gassed with 95% O2/5% CO2, pH 7.4 at room 
temperature, as described previously (Mladinic et al., 2013). The adult spinal cord was dissected 
out from adult pregnant females, anaesthetized with the 10.5% chloral hydrate, 0.4 ml/100 g i.m. 
and subsequently killed by an intracardiac injection (2 ml) of chloral hydrate.  
2.2. Experimental protocols 
The dissected spinal cords were immediately fixed or maintained for the preset times in Kreb’s 
solution (up to 24 h) and then fixed. The p38 inhibitor SB203580 or the JNK/c-Jun inhibitor 
SP600125 (both form Calbiochem/ Millipore, Milan, Italy) was added to the Kreb’s solution for 
12 or 24 h. To induce moderate or severe excitotoxic spinal cord injury, either 50 μM or 1 mM 
kainate was added to the Kreb’s solution for 1 h and then washed out in Kreb’s solution for 
further 24 h (this procedure has previously been described in detail (Mladinic et al., 2013; 
Taccola et al., 2008)). The ischemia-like metabolic perturbation was induced as previously 
described (Mladinic et al., 2013; Taccola et al., 2008; Bianchetti et al., 2013) by incubating the 
tissue for 1 h in pathological medium (PM), namely Kreb’s solution containing 10 mM H2O2, 
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500 mM sodium nitroprusside, lacking oxygen and glucose, with 6.75–6.80 pH and 230–240 
mOsm osmolarity. When the spinal cord was maintained in vitro for >24 h, the tissue was kept in 
oxygenated (95% O2/5% CO2) BME Eagle's basal medium (Sigma-Aldrich, St. Louis, MM, 
USA) supplemented with 0.2% fetal calf serum, 30 ng/ml 7S nerve growth factor, 10 μg/ml 
insulin and 0.1 mg/ml gentamycin (Mladinic, 2007). 
2.3. Fluorescence immunostaining procedure 
The free-floating immuno-fluorescence protocol was as previously described (Mladinic et al., 
2013; Taccola et al., 2008). The primary antibodies (Supplemental Table 1) were visualized 
using appropriate secondary fluorescent Alexa Fluor 488 or 594 antibodies (1:500 dilution, 
Invitrogen, Carlsbad, CA, USA). Sections were stained in 1 g/ml solution of 4,6-diamidino-2-
phenylindole (DAPI) for 20 min to visualize cell nuclei and mounted on Superfrost Plus 
(Menzel-Glaser, Braunschweig, Germany) slides. The immunostaining signal was analysed by 
Zeiss Axioskop2 microscope (Oberkochen, Germany) or TCS SP2 LEICA confocal microscope 
(Wetzlar, Germany), using 1 μm z sectioning. The ATF-3 (C-19, sc-188) antibody (Santa Cruz 
Biotech, CA, USA) has previously been used as a reliable marker for immunostaining (Tsujino et 
al., 2000; Tsuzuki et al., 2001; Zhang et al., 2012). Its specificity for rat ependymal spinal cells 
was tested by incubating the antibody with the specific blocking peptide (Santa Cruz Biotech, sc-
188P; dilution 1:5) for 2h at room temperature, prior to the immunostaining procedure 
(Supplemental Figure 1). Quantification of immunofluorescence signals (gray level intensity 
expressed in arbitrary units, AU) was performed with Meta-Vue imaging software (Molecular 
Devices, Sunnyvale, CA, USA) using the densitometry function to calculate mean signal 
intensities for areas of interest reactive to ATF3 or SOX2 (1000 μm2 covering the ependymal 
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zone as shown in Fig. 4A; white rectangles). The values are mean±SD (at least three different 
fields in each one of three different sections from two different spinal cords). 
2.4. Quantification of ATF3, Ki67 or EdU positive cell nuclei 
To analyze mobilization of stained cells, ATF3, Ki67 or 5-ethynyl-20-deoxyuridine (EdU) 
nuclearly labeled cells were counted in a central spinal region (termed funicular migratory 
stream, FMS; 150 μm wide) that, as shown in Figure 3C, included a sagittal area from the apex 
of the dorsal funiculus to the apex of the ventral funiculus. The proliferation assay Click‑iT® 
EdU (Invitrogen) was used in accordance with the manufacturers’ instructions as recently 
detailed (Mazzone et al., 2013). Thus, the spinal cords were incubated for 12 h in Kreb’s solution 
containing EdU (10 μM), fixed, cryopreserved and microtome-sectioned. Incorporated EdU was 
detected with the fluorescent azide coupling reaction. Sections were then washed twice with 3% 
BSA in PBS and immunostained with ATF3 or Ki67 antibody.  
2.5. Western blotting 
Cytoplasmic and nuclear fractions were separated by a standard procedure (Kuzhandaivel et al., 
2010). Quantification of protein content was performed using a bicinchoninic acid test. Gel 
electrophoresis was performed on 12% acrylamide SDS gels. As a size standard, Page Ruler 
Prestained Protein Ladder (Fisher Scientific SAS, Illkirch Cedex, France) from 10 KDa to 170 
KDa was used. As positive control, we used RAW 264.7 Cell Lysate (sc- 2211, Santa Cruz 
Biotech). The membrane was incubated with anti-ATF3 (ATF-3, C-19, sc-188, Santa Cruz 
Biotech) diluted 1:100 in blocking solution. For the negative control, the primary antibody was 
pre-incubated with the specific blocking peptide (Santa Cruz Biotech, sc-188P; dilution 1:5). 
Blots were incubated overnight at 4°C. The signal was visualized using fluorescence-labeled 
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secondary antibodies anti-rabbit, produced in goat, with the 1: 2000 dilution (Dako Italia, Milan, 
Italy). The results were acquired using Alliance LD2-77WL (Uvitec, Cambridge, UK) and 
analyzed with Uviband software (Uvitec). ATF3 levels for the cytoplasmic fractions were 
normalized for β-actin using a β-Actin−Peroxidase antibody (A3854, Sigma-Aldrich), while the 
nuclear fractions were normalized for TATA binding protein (AB62126, Abcam, Cambridge, 
UK). 
2.6. Data analysis 
All data are expressed as mean±SD, except for the Western blotting where the data are 
mean±S.E. Statistical analysis was carried out with SigmaStat 3.1 (Systat Software, Chicago, IL, 
USA). The statistical analysis of the ATF3 immunostaining intensity measurements in spinal 
cords of various aged rats were performed using One Way Analysis of Variance test, and then, 
for the pairwise multiple comparison procedures, the Tukey Test was used. The number of 
measurements in each group was >20 (at least two measurements in each of ten different spinal 
cord sections from three different animals). For the statistical comparison of the ATF3 and 
SOX2 immunostaining intensity measurements, the t-test was used. The number of 
measurements in each group was 10 (at least three measurements in each of three different spinal 
cord sections from two different animals). For the statistical analysis of the number of cells with 
the ATF3, Ki67 or EdU positive nuclei, the t-test was also used. The number of sections on 
which the counting was performed ranged from 6 to 20 for each experimental protocol. For the 
statistical analysis of the Western blotting ATF3 signal, data were first assessed as parametric 
with a normality test (Anova Tukey) and then analyzed with the paired and two tailed 
distribution Student t-test. The signals obtained from two different blots were analyzed, and in 
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each experiment, different protein samples, coming from the three different animals, were 
collected. Thus, the total number of animals for each experimental group was six. 
 
3. RESULTS 
3.1. Postnatal ATF3 expression in spinal ependymal cells overlaps with nestin, 
vimentin and SOX2 
Strong ATF3 immunostaining was detected in the cytoplasm of ependymal cells around the 
spinal central canal of rats aged from postnatal day (P) 1 up to adulthood (Figure 1A,B,D). The 
ATF3 filamentous staining in the ependymal zone is clearly observed at higher magnification in 
Figure 1B. The intensity of the ATF3 immunostaining in the area of interest of ependymal zone 
(see methods) was measured in tissues from animals of different age, and was found to increase 
postnatally, and remain elevated in adulthood (Figure 1C). ATF3 staining overlapped with 
vimentin (Figure 1Ad-f,) and nestin (Figure 1Dc,d), markers previously shown to be expressed in 
stem cells of the spinal ependymal region (Hugnot and Franzen, 2011). As previously reported 
by (Mokry et al., 2008), in adult rats nestin staining was observed not only in the ependymal 
region, but also in blood vessels (Fig. 1Dc,d), while the ATF3 staining remained restricted to the 
ependymal zone (Figure 1Db).  Ependymal cells from embryonic and P0 tissue did not show 
ATF3 staining. 
Both neonatal and adult ependymal cells were co-stained for ATF3 and the transcription factor 
SOX2 (Figure 2A,B). Figure 2D shows, at higher magnification, a central section from a stack of 
z-plane confocal images of adult spinal ependymal cells that confirmed the cytoplasmic ATF3 
and nuclear SOX2 stainings of densely packed cells.  
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Outside the ependymal zone, no significant ATF3 staining was observed in the grey matter as 
shown by the spinal cord cross section in Figure 2C. It is noteworthy, however, that, in the lateral 
and ventral regions of the white matter, cytoplasmic ATF3 staining was detected in sparse cells 
at early postnatal age (P1-P4) (Figure 2C). In these white matter cells (showing ramified 
morphology similar to the NG2/BrdU positive cells (Horner et al., 2000), the cytoplasmic ATF3 
staining again coincided with nuclear SOX2 staining (Figure 2C).  
ATF3 staining in the  ependymal region did not overlap with any of the following cell-specific 
markers: NeuN (neurons), DCX (neuronal precursors and immature neurons), GFAP 
(astrocytes), NG2 (astrocyte precursor cells), O4 (oligodendrocytes and their precursors), CD68 
(activated microglia) (Supplemental Figure 2). It should be noted that the same ATF3 antibody 
did not show any immunopositive cells in the ependymal spinal cord region of the mouse (results 
not shown). It has been previously reported that ATF3 immunostaining (cytoplasmic and 
nuclear) is species-specific (rat or mouse) (Hunt et al., 2012).  
3.2. In vitro mobilization of ependymal spinal cord cells and nuclear ATF3 
expression 
Previous studies have indicated that the spinal cord preparation survives in vitro for at least 24 h 
with functional network activity clearly observed as locomotor-like patterns recorded from 
multisegmental motor pools (Kuzhandaivel et al., 2011). Figure 3 shows that such in vitro 
protocol stimulated mobilization of ependymal cells from the central canal zone toward the 
dorsal and ventral funiculi (Figure 3B-D), creating, at 24 h, a characteristic pattern reminiscent 
of the rostral migratory stream (RMS) of the brain subventricular stem cells (Coskun and Luskin, 
2002; Murase and Horwitz, 2004). By analogy, the spinal cord ependymal migration was termed 
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FMS (see methods), and was clearly restricted to this 150 m wide area (Fig. 3C, red lines). The 
time course of nuclear ATF3 staining is shown in Figure 3E, and plotted in Figure 3F. Thus, a 
detectable ATF3 nuclear signal appeared 4h after dissection and reached a plateau between 14 
and 24 h. Likewise, the occurrence of ATF3 positive cells in the FMS area (indicated by the blue 
rectangle in Figure 3C) had a similar time course (Figure 3G). The ATF3-nuclear positive 
migratory cells were nestin (Supplemental Figure 3A), vimentin (Supplemental Figure 3B) and 
SOX2 (Supplemental Figure 3C) positive. Figure 4A demonstrates the differential distribution of 
ependymal cell ATF3 staining that was strong around the central canal of fresh tissue (top row in 
A; region of interest quantified in Figure 4 B), whereas it significantly (P<0.001) decreased 
(Figure 4 A, bottom row, and Figure 4 B) at 24 h in vitro. Figure 4 C,D compares the ATF3 
expression in two areas of interest (indicated by hatched squares in Figure 4A, bottom left) and 
demonstrates that mobilized cells (Figure 4 D) showed nuclear ATF3. On the other hand, nuclear 
SOX2 staining was consistently found in cells surrounding the central canal in fresh tissue 
(Figure 4 A, top row) or after 24 h in vitro (Figure 4 A, bottom row) and remained expressed 
even in the migrated cells (Figure 4 B, D). These results suggest that, while SOX2 was a general 
stem cell marker, ATF3 preferentially stained nuclei of those ependymal cells undergoing 
mobilization. 
ATF3 is widely used as a marker for axotomized motoneurons (Tsujino et al., 2000), or injured 
dorsal root ganglion neurons (Tsuzuki et al., 2001). The present study examined ATF3 
expression in motoneurons at various times in vitro. ATF3 was detected in the motoneuron 
cytoplasm already 2 h after dissection, reached a peak at 4 h, after which it decreased with no 
nuclear staining (Supplemental Figure 4A). Supplemental Figure 4B shows, in the same spinal 
section, strong ATF3 signal in the FMS area (right edge) in contrast with lack of signal from 
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motoneurons (left edge) at 24 h in vitro. At this time point motoneurons were well preserved as 
shown by their SMI32 staining (Supplemental Figure 4C) and remain functionally viable 
(Kuzhandaivel et al., 2011). These results validate ample survival of motoneurons at 24 h in 
control conditions with no nuclear ATF3 staining characteristic for the injured motoneurons. 
3.3. Proliferative markers of the ependymal region in vitro 
The time-dependent redistribution of ATF3 stained cells might have suggested not only 
mobilization, but also cell proliferation developing during a few hours in vitro. To examine this 
possibility, we first investigated in the FMS region of interest (see Figure 3 C) if cells, which had 
incorporated EdU as a DNA marker of cell proliferation (Mazzone et al., 2013) also showed 
ATF3 positivity at 6 or 24 h in vitro. At 6 h, we detected 50±10 EdU positive cells (Figure 5 B) 
and a lower number of ATF3 nuclear-positive cells (20±7; n=6). Figure 5 A shows the mismatch 
between ATF3 and EdU nuclear positive cells in the FMS at 24 h. In fact, while the number of 
EdU positive cells in the FMS area had not changed (52±5; n=6) vs the value at 6 h (Figure 5 B), 
the number of ATF3 nuclearly-positive cells increased more than four times (83±18, n=20). In 
support of this observation we also studied the number of cells with their nucleus positive for the 
proliferative marker Ki67 (Mazzone et al., 2013) or ATF3. Figure 5 C shows a similar number of 
Ki67 or ATF3 positive nuclei at 24 h in the FMS region, while a significant rise was detected at 
48 h only. Even if double immunostaining with Ki67 and ATF3 was not possible for lack of 
compatible antibodies, these data are consistent with ependymal cell proliferation occurring 
mainly after the first 24 h. Thus, our results suggest that ATF3 nuclearly-stained cells migrated 
away from the central canal with a time profile distinct from local cell proliferation. 
3.4. Signaling pathways underlying ATF3 activation 
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ATF3 activation has been previously shown to be dependent on c-Jun phosphorylation (Lindwall 
et al., 2004) or the mitogen-activated protein kinases (MAPK)/p38 pathway (Lu et al., 2007). In 
keeping with this notion, the MAPK-p38 inhibitor SB203580 or the JNK/c-Jun inhibitor 
SP600125 prevented the rise in the number of ATF3 nuclear-positive cells in the FMS region at 
12 h in vitro (Figure 6A,B). In fact, application of SB203580 (1μM) or SP600125 (50-100μM) 
treatment (12 h) led to absence of nuclear ATF3 signal that was replaced by filament-like 
staining (Figure 6A).  
We next investigated ATF3 protein levels in the nuclear and cytoplasmic extracts from freshly 
frozen spinal tissue, or maintained for 24 h in Kreb’s solution (with or without SB203580 or 
SP600125). To this end, we used the same anti-ATF3 antibody used for immunostaining 
previously validated to detect ATF3 protein by Western blotting in cancer tissue (Buganim et al., 
2011). The 22 kDa band, corresponding to the full-length ATF3 (Hashimoto et al., 2002; 
Buganim et al., 2011; Chen et al., 1994), was of the highest intensity in nuclear lysates (loading 
control was TBP) from spinal tissue maintained in vitro for 24 h (sham; Figure 6C, top lane, and 
Figure 6D), very low from fresh tissue, and significantly (P>0.01) weaker 24 h after SB203580 
(1 µM) or SP600125 (100 µM) treatment (Figure 6 C,D). As a positive control, the lysate from 
RAW 264.7 cells (Abelson murine leukemia virus-induced tumor) was employed, as suggested 
by the ATF3 antibody manufacturer (see Figure 6C, right lanes), to produce a strong ATF3 band. 
Thus, the change in the intensity of the ATF3 specific nuclear expression mirrored the pattern of 
the ATF3 immunofluorescence signal observed in the nuclei of mobilized cells. Regardless of 
the protocol used, a band of 28 kDa (as reported by the ATF3 antibody manufacturer) was 
observed with unchanged intensity in cytoplasmic lysates (β-actin loading control; Figure 6C, 
lower lanes). 
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3.5. ATF3 activation after experimental SCI 
We recently reported that in vitro spinal cord lesions like excitotoxic injury (Mazzone et al., 
2013) or oxygen-glucose deprivation (Bianchetti et al., 2013) applied for a short time (1 h), 
induce a slowly developing process of cell death that peaks at 24 h. We, therefore, wondered if 
these paradigms could activate ependymal cell early mobilization. Figure 7A shows the presence 
of ATF3 positive cells in the FMS area 24 h after 50 μM kainate application (1 h). Likewise, 
Figure 7B depicts, in the same region, ATF3-positive cells 24 h following ischemic-like injury (1 
h application of a pathological medium lacking oxygen and glucose and containing reactive 
oxygen species (Bianchetti et al., 2013)). Such cells, with ATF3 positive nuclear staining, were 
also nestin and vimentin positive (Figure 7 A,B). Figure 7D shows that, with either protocol, the 
number of cells with the ATF3 positive nucleus in the FMS area was similar to control at 24 h in 
vitro. Only when the concentration of kainate was raised to 1mM to apply a very intense 
excitotoxic stimulus, the number of ATF3-nuclear positive cells significantly (P=0.005) fell by 
one third, suggesting substantial cell loss (Figure 7C,D).  
 
4. DISCUSSION 
The current study is the first report of the dynamic expression of the ATF3 by ependymal spinal 
stem cells, as this protein was localized to the cytoplasm when such cells were quiescent, but was 
found in their nucleus when cells became activated. This property enabled us to follow up 
activated ependymal cells that migrated from the central canal toward the ventral and dorsal 
white matter, forming the FMS that resembles the RMS of the brain SPCs. 
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The fact that ATF3 immunostaining coincided with well-known SPC markers, such as nestin, 
vimentin and SOX2, suggests that ATF3 labeling in the spinal cord was primarily expressed by 
intrinsic stem cells, typically found around the central canal (Hugnot and Franzen, 2011). ATF3 
was mainly expressed in the cytoplasm and processes of these cells from P1 onwards, grew 
during the first postnatal week and remained elevated later. Such ATF3 stained cells in fresh 
tissue had small diameter, large egg-shaped nucleus, and were closely packed together. Grey 
matter cells remained, however, devoid of ATF3 staining, adding specificity to the role of this 
protein for stem cell labeling.  
Previous reports of the role of ATF3 in the regulation of SPCs are scant. Recent studies (Gao et 
al., 2013; Gargiulo et al., 2013) have indicated involvement of ATF3 in the control of genes like 
SOX2 or BMI1, critical for pluripotency and reprogramming of the human embryonic stem cells 
or glioblastoma stem-like cells. The present observation of ATF3 and SOX2 co-staining is 
consistent with this possibility. Moreover, the CREB transcription factor family, of which the 
ATF3 is a member, has an established role in the SPC regulation and neurogenesis (Merz et al., 
2011; Mantamadiotis et al., 2012). Our results suggest, however, a new role of ATF3 not only in 
the maintenance of the spinal ependymal cells but also in their activation.  
When spinal cords were kept in vitro for 24 h, we observed a novel phenomenon, namely 
centrifugal mobilization of ependymal stem cells which formed a migratory chain analogous to 
the brain RMS (Lois et al., 1996; Wichterle et al., 1997; Tanvig et al., 2009) as they moved away 
from the central canal to the adjacent ventral and dorsal white matter. When this occurred, ATF3 
was clearly expressed in the cell nucleus. This phenomenon developed gradually after 4 h and 
was clearly observed at 24 h. Interestingly, ependymal cells which did not mobilize, retained 
their SOX2 nuclear staining, yet lost the ATF3 cytoplasmic one. Hence, ATF3 nuclear labeling 
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could be interpreted as a novel marker of migrating ependymal cells. The fact that in vitro 
conditions induce mobilization of stem cells has been earlier reported with organotypic brain 
slices (Tanvig et al., 2009): in such a case RMS toward the olfactory bulb is occurring after 
several days, while the present report shows a much faster process developing within hours. The 
unchanged occurrence of Ki67 or EdU positive cells in FMS at 24 h in vitro is consistent with a 
process of ependymal cell early mobilization rather than proliferation that occurred at later time. 
In support of this hypothesis is the recent observation that, in rat organotypic slices, significant 
proliferation of neuroprogenitors was detected only after a few days in culture (Mazzone et al., 
2013).  
The question then arises regarding the mechanism(s) responsible for activation and mobilization 
of ependymal cells in vitro, given that spinal networks are fully preserved and viable during this 
timeframe, including electrophysiological activity of locomotor networks (Taccola et al., 2008). 
In vivo the ependymal cells are in direct contact with the cerebrospinal fluid (CSF) and 
numerous blood vessels (Hugnot and Franzen, 2011). Thus, their delayed activation in vitro 
might be due to the disappearance of yet-unclear signals from the CSF or blood (Menezes et al., 
2002), which might normally keep the ependymal cells quiescent (Cheung et al., 2013). 
Additionally, the activating signal might come from a few cells injured during dissection, even if 
systematic analysis of in vitro tissue showed minimal pyknosis at 24 h in vitro (Taccola et al., 
2008). A recent review has highlighted how stem cell quiescence is a state maintained by 
signaling pathways ready to allow rapid activation (Cheung et al., 2013). Deciphering the 
molecular mechanisms regulating stem cell quiescence is, therefore, an important goal for future 
studies to increase our understanding of tissue regeneration mechanisms in pathological 
conditions (Cheung et al., 2013). Identification of the factors underlying even brain RMS 
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remains incomplete as various chemo-attractants, chemo-repellents, growth factors and cell 
adhesion molecules have been proposed to guide migrating cells (Tanvig et al., 2009; Menezes et 
al., 2002). The intracellular presence of other ATF/CREB family members with which ATF3 
forms heterodimers may ultimately decide the functional role of ATF3 (Thompson et al., 2009), 
as much as the influence of regulators like other transcription factors, miRNA or histone 
modifications (Yun et al., 2010). 
Previous studies have demonstrated that the signal transduction pathways mediating ATF3 
expression include c-Jun co-expressed with ATF3 in the nervous system after injury and stress 
(Hunt et al., 2012). The selective JNK/c-Jun inhibitor SP600125 fully blocks ATF3 induction in 
adult rat ganglion neurons and inhibits outgrowth of their axons (Lindwall et al., 2004). 
Furthermore, the MAPK/p38 pathway is also required for ATF3 expression in several non-
neuronal cell lines undergoing apoptosis, an effect suppressed by the specific MAPK/p38 
inhibitor SB203580 (Lu et al., 2007). In accordance with these results, our current data showed 
the involvement of both molecular pathways (JNK/c-Jun and MAPK/p38) in the control of the 
ATF3 nuclear expression in mobilized spinal ependymal cells. This observation was also 
supported by Western blotting analysis indicating ATF3 expression (of molecular weight in full 
accordance with reports by (Hashimoto et al., 2002; Chen et al., 1994) in nuclear fractions at 24 
h in vitro. The origin of the variation in the molecular weight between the nuclear and 
cytoplasmic ATF3 protein remains unclear and will need future work.  
Excitotoxic or ischemic-like protocols, that are reported to produce moderate damage to the 
spinal cord (Taccola et al., 2008; Bianchetti et al., 2013; Mazzone et al., 2010), did not enhance 
the number of activated and migrating ATF3 positive cells 24 h later. When the excitotoxic 
stimulus was very strong (1 mM kainate), the number of activated ependymal cells actually 
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decreased in line with widespread neurotoxicity (Taccola et al., 2008). Our previous 
investigations have indicated that, in the rat spinal cord, neuronal and glial death occurs mainly 
during the first 24 h (Taccola et al., 2008; Bianchetti et al., 2013; Mazzone et al., 2013). Any 
attempt to repair cell damage might perhaps require an intervention by stem cells occurring over 
several days after the primary injury. This process has been examined with long-term 
organotypic cultures in which stem cell activation two weeks after excitotoxic stimulation failed 
to produce significant neurogenesis (Mazzone et al., 2013). While ATF3 is reported as a marker 
for the axotomy-dependent motoneuronal injury in the rat (Zhang et al., 2012), we detected 
transient, rather early cytoplasmic (never nuclear) staining for ATF3 in motoneurons, a 
phenomenon that disappeared by 24 h in vitro. Our data, thus, confirm that maintaining the rat 
spinal cord in vitro did not per se lead to neuron damage as clearly indicated by fully preserved 
network responses (Taccola et al., 2008) and that ependymal cell mobilization was probably a 
reaction to changes in the extracellular milieu.   
We propose that the role of ATF3 might be different in the neuronal (postmitotic) and 
ependymal (mitotic) spinal cells. In neurons ATF3 is viewed as a late marker for injury (Tsujino 
et al., 2000; Tsuzuki et al., 2001; Francis et al., 2004), with a neuroprotective and pro-survival 
influence (Zhang et al., 2011; Wang et al., 2012). The role of ATF3 in proliferation and 
migration of ependymal cells could be similar to the ATF3 role in cancer cells in which ATF3 
promotes proliferation, motility and invasiveness of certain cancer cell lines (Thompson et al., 
2009; Wang et al., 2008).  
 
5. CONCLUSIONS 
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In lower vertebrates the spinal cord can regenerate after injury, a process in which ependymal 
cells play a major role (Hugnot and Franzen, 2011). The mammalian spinal cord, however, 
cannot regenerate after lesion: hence, intense efforts are in progress to develop new, noninvasive, 
endogenous-stem cells based strategies for the treatment of spinal injury (Barnabe-Heider et al., 
2008; Sahni and Kessler, 2010; Ruff and al., 2012). The discovery of ATF3 as a marker not only 
for quiescent but particularly for activated, migrating spinal SPCs should help future work to 
monitor their migration and fate (neurogenesis or gliogenesis) after injury and to test drugs to 
change the outcome. One might even imagine that it would be possible to up-regulate the ATF3 
gene in ependymal spinal cells after injury to find out the impact on the neuronal tissue repair. 
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FIGURE LEGENDS 
Figure 1. Age-related expression of ATF3 by spinal ependymal cell and its co-expression with 
nestin and vimentin immunostaining. (A): Top row shows cytoplasmic ATF3 immunostaining 
(red) of the ependymal region around the central canal (CC) of  P4 (a), P7 (b) and P21 (c) rat 
spinal cord cross-sections (30 μm thick). Bottom row shows ATF3 immunostaining (red) 
overlapping with vimentin staining (green) in P4 (d), P7 (e) and P21 (f) sections. Cell nuclei are 
counterstained with the nuclear dye DAPI (blue).  (B): Higher magnification of ATF3 
immunostaining (with DAPI nuclear counterstaining) of ependymal cells in P4 spinal cord. For 
image clarity fluorescent stainings (left and middle panels) were converted to grayscale and their 
negatives are shown to reveal the fibrillary, cytoplasmic ATF3 staining of ependymal cells. In 
right panel, ATF3 (red) and DAPI (blue) fluorescent stainings are merged. (C): Histograms show 
the intensity of ATF3 immunostaining (AU) in an area of interest covering the 1000 μm2  of the 
ependymal zone (from postnatal day 2, P2, until adult age) as shown with a white rectangle in 
Fig. 4A.) The values are mean±SD (at least three different fields in each one of three different 
sections from two different spinal cords). The data from P2 and adult spinal cords are 
significantly different from those obtained from those of P4-7 (P<0.001; One Way Analysis of 
Variance test). (D): Cross-section (30 μm thick) of adult female rat spinal cord showing the zone 
around the central canal (CC) stained with DAPI (a; fluorescent blue staining was converted to 
grayscale), ATF3 (green; b), nestin (red; c), and merged image (d). Scale bars = 50 μm. 
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Figure 2. ATF3 immunostaining of ependymal spinal cord cells overlaps with SOX2 in neonatal 
and adult rats. (A, B): Spinal cord cross-sections (30 μm thick) of neonatal (A, top row) or adult 
(B, bottom row) spinal cord immunostained with SOX2 and ATF3. The left panels show cell 
nuclei stained with DAPI (grayscale conversion). In the right panels the fluorescent signals with 
DAPI (blue), SOX2 (green) and ATF3 (red) are merged. (C): Half-section of the P1 spinal cross-
section reconstructed from 6 different images (10x). Note that ATF3/SOX2 staining is localized 
to the ependymal zone, with scattered positive cells in the white matter. (D): central section from 
a stack of z-plane confocal images showing (highly magnification) the ependymal zone of adult 
spinal cord stained with cytoplasmic ATF3 (red), nuclear SOX2 (green) and counterstained with 
DAPI (blue). Scale bar is 100 μm in A-C and 10 μm in D. 
 
Figure 3. Nuclear ATF3 immunostaining of activated, mobilized stem cells. (A-D): ATF3 
immunostaining (grayscale) in 30 μm thick sections from the central zone around the central 
spinal canal (CC) of P2 rat spinal cord. Note fresh tissue with fibrilar, cytoplasmic ATF3 
staining of ependymal cells (A) and nuclear ATF3 staining of cells after 24 h in vitro (B-D) 
demonstrating migration from the central canal toward dorsal and ventral spinal funiculi. (C): 
Half-section of the spinal cord shows the 150 μm wide zone (delimited by red lines) through 
which the spinal ependymal cells migrate to form the funicular migratory stream (FMS). (D): 
FMS zone (reconstructed from two images taken at 10 x). (E): Grayscale conversion of ATF3 
fluorescent immunostaining of P2 rat spinal cords maintained in vitro for 0-24 h, indicating the 
time course of ependymal cell migration. (F): Number of cells in FMS zone with the nuclear 
ATF3 staining show migration started between 4 and 6 h in vitro, and peaked after 24 h. (G): 
Time-dependent occurrence of ATF3 nucleary-positive cells in the FMS zone (blue rectangle) 
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150 μm away from the central canal. Scale bar is 50 μm in A, B and D, 200 μm in C and 100 μm 
in E. 
Figure 4. Differential ATF3 and SOX2 immunostaining in ependymal zone of spinal tissue 
maintained in vitro. (A):  Central region of the spinal cord (30 μm thick cross-sections) stained 
with ATF3 (red) and SOX2 (green) and counterstained with DAPI (grayscale); upper panels 
show freshly fixed tissue (FF), while lower panels show spinal cord tissue after 24 h in vitro. In 
right panels the ATF3 (red), SOX2 (green) and DAPI (blue) fluorescent stainings are merged. 
Note the fibrillary, cytoplasmic ATF3 staining in ependymal cells of fresh tissue, which largely 
disappears after 24 h in vitro. On the contrary, the nuclear SOX staining remains similarly 
intense in fresh tissue and after 24 h in vitro. (B): Histograms of signal intensity (AU) in the area 
of interest of the ependymal zone indicated by the white rectangles in (A). Note significant drop 
of ATF3 signal (P<0.001) after 24 h in vitro while the SOX2 signal did not change. Data are 
mean ± SD from 10 sections for each group. (C): Confocal images of DAPI (blue), SOX2 
(green) and ATF3 (red) staining of ependymal cells of the spinal cord maintained in vitro for 
24h. Bottom hatched box (A, left) indicates the ependymal region used for confocal microscopy. 
Note the absence of the ATF3 immunostaining signal in (C). (D): DAPI (blue), SOX2 (green) 
and ATF3 (red) staining of the region apical to the central canal, to which ATF3 nucleary-
positive cells migrate. Note nuclear ATF3 staining overlapping SOX2 nuclear staining. Scale bar 
= 50 μm in A and 10 μm in C and D.  
Figure 5. Proliferative cells in funicular migratory stream (FMS). (A): Nuclear co-
immunostaining of ATF3 (red) and EdU (green) in spinal section (30 μm thick) of  spinal cord 
maintained in vitro for 24 h. The labeled cells belong to the FMS (CC). Note that the green EdU 
signal does not overlap with ATF3 positive nucleus. Scale bar = 50 μm. (B): EdU positive nuclei 
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in FMS region of spinal cords maintained in vitro for 6 or 24 h (n=6-20 sections from 3 spinal 
cords). (C): ATF3 or Ki67 positive nuclei in the FMS region of spinal cords maintained one or 
two days in vitro (DIV), showing significant increase by the second day (P=0.039 for ATF3 and 
P=0.004 for Ki67; n=6-20 sections from 3 spinal cords). 
Figure 6. The p38 inhibitor SB203580 or the JNK/c-Jun inhibitor SP600125 blocks nuclear 
ATF3 staining in spinal cords after 24 h in vitro.  (A):  Control ATF3 immunostaining 
(grayscale) in the region near the central canal (CC) after 12 h in Kreb’s solution (left, sham; 
note the intense nuclear ATF3 staining), after treatment with the p38 inhibitor SB203580, or the 
JNK/c-Jun inhibitor SP600125 for the 12 h. Note filamental ATF3 staining (middle and right 
panels). Scale bar = 50 μm. (B): Number of cells with nuclear ATF3 staining in the FMS region 
(delineated with red lines in Figure 3C) are plotted to show inhibition of cell occurrence after 
SB203580 or SP600125 treatment (n=6-20 sections from 3 spinal cords for each condition). (C): 
Western blots show ATF3 in the nuclear (upper band) and cytoplasmic (lower band) protein 
fractions from the freshly frozen tissue (FF) or the tissue maintained in vitro for 24 h with or 
without (SHAM) SB203580 or SP600125 inhibitors. As a positive control, the lysate from RAW 
264.7 cells (Abelson murine leukemia virus-induced tumor) is used and the negative control are 
the results obtained after incubating the ATF3 antibody with the specific blocking peptide prior 
to immunostaining the Western blot. The loading control for the cytoplasmic fractions was β-
actin and for the nuclear fractions TATA binding protein (TBP). (D): Intensity of 22 kDa band 
ATF3 is of the highest value in nuclear lysates from spinal tissue maintained in vitro for 24 h, 
when compared to fresh tissue or the tissue treated with the inhibitors (P>0.01; data are duplicate 
experiments for 6 spinal cords for each condition). 
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Figure 7. ATF3 positive cells after excitotoxic or ischemia-like spinal injury. (A): ATF3 (red) 
and nestin (green) double staining of FMS region around the central canal of 30 μm thick 
sections of spinal cord 24 h after exposure to moderate (1 h long) excitotoxic injury with 50 μM 
kainate. (B): similar experiment as in A using ATF3 and vimentin co-staining, although the toxic 
stimulus was 1h application of pathological medium (PM) mimicking ischemia conditions. (C): 
very strong excitotoxic stimulus with 1 mM kainate leads to decrease ATF3 signal in the FMS 
region. (D): The number of the cells with nuclear ATF3 staining in the FMS region (delineated 
with red lines in Figure 3C) is significantly (P=0.005) smaller in 1 mM kainate treated spinal 
cords with 1 mM kainate (n=6-20 sections from at least 3 spinal cords for each group). 
 
Supplementary Figure 1. Negative control for the Activating transcription factor 3 (ATF3) 
immunostaining. Sections of P1 rat spinal cord kept for 24 h in Kreb’s solution were 
immunostained with ATF3 antibody (green; upper panels) or with ATF3 antibody pre-incubated 
with the specific blocking peptide (lower panels). Sections are counterstained with DAPI to 
shown cell nuclei (original DAPI blue fluorescence is converted to a grayscale for clarity; left 
panels). The DAPI (blue) and ATF3 signals (green) are merged in the right panels. Note the 
disappearance of the ATF3 signal after the incubation with the specific blocking peptide. Scale 
bar= 50 m. 
Supplementary Figure 2. ATF3 staining does not overlap with NeuN, DCX, GFAP, NG2, O4 
or CD68 staining. Double immunostaining of ATF3 (red) and different neuronal or glial markers 
shown in green pseudocolor [NeuN for neurons; doublecourtin ( DCX) for neuronal precursors 
and immature neurons; glial fibrillary acidic protein (GFAP) for astrocytes; NG2 for astrocyte 
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precursor cells; O4 for oligodendrocytes and their precursors; CD68 for activated microglia] are 
shown in the ependymal zone of P1 rat transverse spinal cord sections (30 m thick). Scale bars 
= 100 m. 
 
Supplementary Figure 3. The activated, migrating ATF3 cells are nestin, vimentin and SOX2 
positive. The central area of the 30 m thin sections cut from P2 spinal cords maintained for 24 h 
in Kreb’s solution and double immunostained for ATF3 (red) and nestin (A), vimentin (B) or 
SOX2 (C) (green) is shown. The sections were counterstained with DAPI (blue) to reveal cell 
nuclei. Scale bars = 100m in A and 50m in B and C. 
Supplementary Figure 4. Time course of ATF3 activation in spinal cord motoneurons 
maintained in vitro. Thirty m sections from P2 rat spinal cords maintained in vitro for 0-24 h 
were immunostained for ATF3. (A): Images are from the ventral horn area that contains 
motoneurons. The fluorescent ATF3 signal is converted to a grayscale signal, the negative of 
which is shown for clarity. Note absence of nuclear signal and presence of cytoplasmic ATF3 
with peak at 4h. (B): Spinal cord section comprising motoneurons (left side) and ependymal cells 
(right side) stained for ATF3. At 4 h (left panel) cytoplasmic ATF3 staining is observed in  
motoneurons and the ependymal region. At 24 h (right panel), ATF3 signal disappears from 
motoneurons, while the signal becomes nuclear in the ependymal cells that migrate from the 
central canal (CC) versus ventral funiculus in an ordinate chain formation. (C): Motoneurons are 
shown with SMI32 immunostaining (green) as large cells in the ventral horn of the spinal cord 
kept in vitro for 24 h. The section is counterstained with DAPI to visualize cell nuclei. Note good 
preservation of star-like motoneuronal cells. Scale bar = 100 μm. 
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Supplemental Table 1. Antibodies used for immunofluorescent staining 
Name Company Code Type Dilution 
ATF-3 (C-19) Santa Cruz 
Biotech  
sc-188 rabbit polyclonal 1:200 
CD68 Abcam ab31630 mouse 
monoclonal 
1:750 
DCX 
Doublecourtin 
Santa Cruz 
Biotech 
sc-8066 goat polyclonal 1:20 
GFAP Glial 
fibrillary acidic 
protein 
Sigma G3893 mouse 
monoclonal 
1:200 
Ki67 Abcam ab15580 rabbit polyclonal 1:100 
Nestin Millipore MAB353 mouse 
monoclonal 
1:100 
NeuN Millipore MAB377 mouse 
monoclonal 
1:50 
NG-2 Millipore AB5320 rabbit polyclonal 1:100 
Oligodendrocyte 
Marker O4 
R&D Systems MAB1326 mouse 
monoclonal 
1:200 
SOX2, Abcam ab79351 mouse 
monoclonal 
1:1000 
Vimentin Abcam ab8069 mouse 
monoclonal 
1:100 
SMI32 Millipore NE1023 mouse 
monoclonal 
1:200 
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DISCUSSION 
In relation to the aims of my project, I achieved the following points: 
The principle focus of the present study was understand the role of extracellular Mg2+ in 
the genesis of neurotoxicity after transient application of a medium mimicking ischemia-
anoxic conditions. The present data indicate that the presence of this divalent cation 
contributed to enhance the delayed damage to the white matter spreading it to the grey 
matter of the rat spinal cord via distinct cell death pathways. The addition of Mg2+ to the 
Kreb's solution did not lead to damage, indicating that this ion is not toxic by itself but it 
worsens an ischemic-like condition. We investigated the potential TRPM2 and TRPM7 
involvement in the damage mediated by Mg2+, and found a significant dichotomy in 
TRPM7 and TRPM2 channel expression. In order to find new neuroprotective or/and 
neuroregenerative strategies, we tested the potential neuroprotective effect of PARP-1 
inhibitors on SCI models and we probed the efficacy of ATF3 as a marker for the migration 
of ependymal stem cells of the spinal cord. 
A model of non-traumatic injury has been developed in our laboratory. Non-traumatic 
causes of SCI are recently incrising in number and importance (van den Berg et al., 2010; 
McKinley et al., 2002; Nair et al., 2005; Sekhon and Fehlings, 2001). This point led us to 
develop a specific rat model, in order to examine the processes responsible for cell death 
early after the insult. This is a difficult goal with in vivo preparations, due to the need of 
anesthesia, the difficulty to induce metabolic perturbations targeted to a specific region of 
the spinal cord and complexity of electrophysiological analysis. Therefore, we have 
recently employed an in vitro model that can express electrical oscillations typical of 
locomotion and can allow detailed analysis of the underlying pathophysiological 
mechanisms (Kuzhandaivel et al., 2011; Mladinic and Nistri, 2013). This in vitro model is 
largely versatile, permitting to study a particular process underlying injury, such us 
excitotoxicity or ischemia-like tests. After an excitotoxic damage induced by Kainate, an 
analog of glutamate (Taccola et al., 2008), we have observed that neurons are the most 
affected, rather than white matter in which the damage is limited, and the principle 
mechanism leading to neuronal death is parthanatos (Kuzhandaivel et al., 2010a). 
Different concentrations of KA, from 1 to 1000 µM, were tested; KA at the concentration of 
50 μM is already sufficient to induce an irreversible loss of fictive locomotion even if spinal 
reflexes persist (Mazzone et al., 2010). Conversely, white matter elements are the most 
affected by the methabolic perturbation evoked in our model by PM, a toxic solution 
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containing free oxygen radicals with no oxygen or glucose supply (Taccola et al., 2008). It 
has also been demonstrated by previous experiments done in our lab that the predominant 
mechanism by which white matter dies after PM insult is apoptosis (Kuzhandaivel et al., 
2010b). After PM, the grey matter region is more preserved compared to white matter, with 
moderate impairment of locomotor-like patterns that were still present at regular frequency, 
but with clearly lower amplitude (Margaryan et al., 2009; Taccola et al., 2008). 
Nonetheless, the addition to the PM solution of standard extracellular Mg2+ concentration 
of 1 mM is enought to worsen the white matter lesion and to extend the histological 
damage to neurons (Bianchetti et al., 2013; Margaryan et al., 2009), with the inhibition of 
the locomotor patterns (Margaryan et al., 2009). Data collected during my PhD sought to 
characterize the processes responsible for this damage enhancement. 
PM+Mg2+ extends damage of white matter elements. The original PM medium (without 
Mg2+) produces a strong damage in the white matter. The addition of Mg2+ worsened this 
damage, inducing pyknosis in about 80 % of white matter elements. This pyknosis was 
accompanied by early phosphohistone positivity, indicating an ongoing DNA damage 
(Plesca et al., 2008). Caspase 3, the tipical marker of apoptosis (Cohen, 1997), was 
evident in a small persentage of white matter cells only. In keeping with this view was our 
observation that a pharmacological inhibitor of apoptosis, named the caspase-3 inhibitor 
(Vandenabeele et al., 2006), arrested pyknosis in the 5% only of the total white matter 
cells. Almost half of the white matter elements showed positivity for PAR, indicating a 
switch of cell death mechanism from apoptosis after PM application to parthanatos after 
PM+Mg2+. In fact, the caspase-3 inhibitor reduced cell death when it was coapplied with 
PJ34, an inhibitor of PARP-1 (Abdelkarim et al., 2001). While PARP-1 is essential for DNA 
damage repair, its hyperactivation generates the toxic product PAR (Abdelkarim et al., 
2001; Andrabi et al., 2006; Berger, 1985; Yu et al., 2006). PAR increased strongly already 
3 h after the end of PM+Mg2+ application suggesting a narrow time window before 
irreversible cell damage could occur. Co-localization of PAR and pyknosis supported this 
hypothesis. Neuroprotection remained, however, incomplete probably for a variety of 
reasons like rate of access of exogenous drugs to intracellular targets, speed of lethal 
cascade reactions, and multiple effectors of cell damage. In general, the present results 
suggest that the presence of Mg2+ during the ischemic-anoxic like protocol aggravated the 
damage to the white matter cells by promoting the activation of at least one major cell 
death pathway, namely parthanatos (David et al., 2009). 
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PM+Mg2+ extended the damage to the grey matter. It was interesting that grey matter 
elements were much less sensitive to PM+Mg2+ damage than white matter ones. 
Morphological analysis indicated low-scale pyknosis and persistence of most NeuN 
positive neurons, even though the damage was relatively more intense in the ventral horn 
area. The number of motoneurons, however, did not decrease, as their typical marker 
ChAT was preserved even 24 h later. These cells were, nevertheless, showing sign of 
distress because the intensity of SMI32 signal was decreased, suggesting an ongoing 
damage of their cytoskeleton. It is interesting to note that, shortly after a metabolic insult, 
the SMI32 signal decreased despite unaltered expression of ChAT, whereas a traumatic 
lesion in vivo is associated with loss of ChAT followed by hyperexpression of SMI32 by 
surviving motoneurons, taken as an index to cell repair (Penas et al., 2009). The 
differential expression of ChAT and SMI32 in the present study compared to the in vivo 
experiments could be due to the motoneuronal maturation. However, neonatal 
motoneurons already show somatic size (Carrascal et al., 2005) and there is evidence 
asserting that in the in vitro rat spinal cord the number of SMI32- and ChAT- positive cells 
and their staining pattern remain constant during the first week of life (Cifra et al., 2012). 
Hence, dynamic changes in these biomarkers may indicate distinct processes and 
timecourse of degenerative mechanisms and restoration. AIF-dependent cell death 
mediates neuronal death after hypoxia-ischemia in the neonatal rat brain (Zhu et al., 2003) 
like in the adult rat brain (Wang et al., 2009). In our PM+Mg2+ model too, concomitant with 
the fall in SMI32 signal, was the detection of rising PAR immunoreactivity in the same 
cells. This was likely a sign of an ongoing damage, in fact it was accompanied by strong 
AIF translocation into the nucleus, a known effector of cell death by parthanatos (Yu et al., 
2006). It was interesting that AIF translocation into the nucleus was closely associated with 
loss of NeuN positivity, an intrinsic component of the neuronal nuclear matrix indeed (Dent 
et al., 2010). The degradation of the neuronal nuclear matrix occurs already at 1 h after 
injury (Giordano et al., 2005) so it precedes cytoscheletal changes (observed in our 
studies by a SMI32 staining) in injured motoneurons (Penas et al., 2009). These results 
imply that various motoneuron biomarkers should be tested for assessing damage in 
pathological conditions as their significance for diagnosis of cell death is time-dependent. 
Thus, our view is that the development of parthanatos in motoneurons occurred on a 
slower time base than in the white matter, maybe due to the more complex methabolism of 
large cells such as motoneurons. Nonetheless, these pathological changes have a strong 
negative impact on locomotor network function (Margaryan et al., 2009). 
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TRPM2 and TRPM7 role in the PM+Mg2+ effects. TRPM2 and TRPM7 are membrane 
channels recently investigated for their contribution to ischemic cell death in the brain 
under a variety of experimental conditions (Aarts and Tymianski, 2005a, 2005b; Aarts et 
al., 2003; Sun et al., 2009). These channels show persistent permeability to mono and 
divalent cations, whose influx is believed to trigger neuronal death mechanisms. In normal 
conditions they are minimally activated, as they are gated open by various ions and agents 
including intracellular PAR, reactive oxygen species and Mg2+ (Aarts and Tymianski, 
2005b; Chen et al., 2012; Cook et al., 2009; Kühn et al., 2005; Scharenberg, 2005). 
Because of their ability to respond to PAR and Mg2+, both of them present in our 
experimental model, and because of their involvement in the ischemic damage, we 
decided to investigate how these channels were expressed during our experimental 
protocol. Evidence in the literature reports the ubiquitous occurrence of TRPM7 expression 
(Penner and Fleig, 2007), therefore their immunohistochemical absence in the white 
matter under sham conditions was not anticipated. Analogous lack of signal was found 
when the tissue was immediately put in PFA (for the istological analisis) after dissection, 
so we exclude that this phenomenon could be attributed to loss of protein expression by 
keeping the preparation in vitro. It seems probable that a factor for poor TRPM7 
expression was the immaturity of the neonatal spinal cord; however, already 3 h after 
PM+Mg2+ exposure, a large number of white matter cells, characterized by pyknotic 
nucleus, were positive to TRPM7. Our interpretation is that metabolic distress in the 
presence of Mg2+ triggered rapid trafficking of TRPM7 proteins to the cell membrane where 
their activation might have contributed to the observed damage. This will have to be 
studied with membrane biotynilation experiments. Unlike white matter cells, motoneurons 
and other spinal neurons showed baseline expression of TRPM7 that was decreased 
lately after PM+Mg2+ when pyknosis was not yet manifested. The reason for the differential 
timecourse of TRPM7 expression between white and grey matter remains obscure. 
However, we observed, in the case of TRPM2 expression, a mirror-like situation whereby 
late fall in TRPM7 corresponded to late rise in TRPM2 in grey matter neurons, especially 
strong in central region, whereas large increment of TRPM7 in white matter corresponded 
to lack of detectable TRPM2 expression. It is important to note that the intensity of 
immunoreactivity cannot be related to channel activation, so the present results about 
differential TRPM7 and TRPM2 signal intensities cannot be extrapolated to a specific role 
of these proteins in neuronal survival or death. Despite this limitation, the present results 
indicate a significant dichotomy in TRPM7 and TRPM2 channel expression, whose 
molecular mechanism remains to be clarified through future studies. Unfortunately, 
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investigating the functional activity of TRPM2 or TRPM7 channels under our experimental 
protocols is, however, complex because of the difficulty to isolate, in an intact network 
system, the contribution of these conductances, especially in the absence of selective 
inhibitors, the widespread dysfunction of motoneurons and the lack of knockout rat 
models. As TRPM2 channels are inhibited by intracellular glutathione (Belrose et al., 
2012), TRPM2 overexpression was perhaps related to metabolic dysfunction that 
developed early for superficially located motoneurons. The effects of the toxic solution on 
deep central neurons were likely delayed with morphological preservation of such cells 
that had shown the strongest TRPM2 expression. One hypothesis is that the TRPM2 
activation would eventually lead to central neuron damage occurring at a time point 
beyond the 24 h in vitro survival of the isolated spinal cord, and thus outside our 
experimental range. In analogy with data from brain neurons under in vitro ischemia-like 
conditions, we may propose that persistent activation of TRPM2 channels in spinal 
neurons could determine a long-lasting rise in intracellular free Ca2+ and Mg2+ to activate 
cell death pathways. Since TRPM2 channels are characterized by small conductance 
(Kühn et al., 2005), it would follow that a small scale influx of these cations might 
determine the delayed trigger of parthanatos. 
Role of extracellular Mg2+ during ischemia-anoxia. Various clinical and in vivo animal 
studies have shown that, during brain ischemia, there is an early and reversible fall in the 
extracellular Mg2+ concentration of the cerebrospinal fluid (Lin et al., 2004; Wei et al., 
2007). Longitudinal clinical studies have actually reported that the administration of Mg2+ in 
various injury models including acute stroke, SCI in rabbit and traumatic brain injury might 
has negative effect on the injury outcome (Maas and Murray, 2007; Muir et al., 2004; 
Saeki et al., 2004; Temkin et al., 2007). Analogous observations for the rat spinal cord 
were not available prior, till our investigations (Bianchetti et al., 2013). From the point of 
view of an in vitro model, it is apparent that the standard concentration (1 mM) of Mg2+ led 
to tissue damage, amplified the white matter lesion and extended it to the grey matter. The 
reason for this diversity of damage sensitivity, between white and grey matter, remains 
unclear and might be related to differential expression of TRPM7 and TRPM2 expression 
as well as to the degree of PAR hyperproduction at an early stage. PAR and Mg2+ are in 
fact potent modulators of the activity of these channels (Aarts and Tymianski, 2005b; Xie 
et al., 2010). Recent studies with in vitro brainstem neurons have proposed that changes 
in intracellular Mg2+ concentrations occurring during pathological states can affect the 
conductance of neuronal Cx36 gap junctions48 (Palacios-Prado et al., 2013) and can 
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presumably shape the damage outcome. Although chemical synaptic inputs and Cx36-
dependent electrical synapses contribute to synchronization of spinal motoneuron function 
(Tresch and Kiehn, 2002), the expressions of Cx36 and Cx32 mRNA and proteins are 
sparse and unchanged after rat SCI (Lee et al., 2005). Notwithstanding the resolution of 
this issue, the present study suggests potential risks in administering Mg2+ during early 
ischemia-anoxia of the spinal cord as tissue damage might actually increase (Bianchetti et 
al., 2013), in accordance with reports of the lack of effectiveness of Mg2+ administration on 
rabbit ischemic spinal injury (Saeki et al., 2004). Such clinical results have actually shown 
that many patients receiving Mg2+ infusion fared worse than untreated patients, a result 
unexpectedly found also for stroke patients (Muir et al., 2004). In conclusion, the 
complexity of the processes underlying ischemia-anoxia damage in the spinal cord even 
when studied with an in vitro model, implies diversity of molecular pathways with distinct 
time dependence and cell-specificity, factors that contribute to the difficulty of 
implementing successful neuroprotection in vivo (Faden and Stoica, 2007; Savitz and 
Fisher, 2007; Thuret et al., 2006). The present study suggests that the phisiological 
extracellular level of Mg2+ during an ischemic damage largely affects cell death 
mechanisms in the spinal cord and extends damage to motoneurons by facilitating the 
onset of parthanatos. 
Neuroprotection tested in our in vitro model. Overactivitation of PARP-1 is suggested 
to be a major contributor to neuronal damage following brain or spinal cord injury. Thus, 
we investigated the PARP-1 inhibitor PJ34 (Abdelkarim et al., 2001; Kauppinen et al., 
2009) as a neuroprotective agent. Unexpectedly, preliminary electrophysiological 
experiments showed that, under control conditions, 1-60 μM PJ34 per se strongly 
increased spontaneous network discharges occurring synchronously on ventral roots, 
persisting for 24 h even after PJ34 washout. Another PARP-1 inhibitor named PHE (6-
5(H)-phenathridinone; Nasrabady et al., 2011b; Kuzhandaivel et al., 2010a) had no similar 
effect. These discharges were fully dependent on ionotropic glutamate receptor activation, 
because this action by PJ34 was reversibly suppressed by glutamate receptor blockers 
and remained after applying strychnine and bicuculline. Fictive locomotion evoked by 
neurochemicals or by dorsal root stimulation was present 24 h after PJ34 application. In 
accordance with this observation, lumbar neurons and glia were undamaged. 
Neurochemical experiments showed that PJ34 per se produced up to 33% inhibition of 
synaptosomal glutamate uptake with no effect on GABA uptake. In keeping with this result, 
the glutamate uptake blocker TBOA (5 μM) induced long-lasting synchronous discharges 
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without suppressing the ability to produce fictive locomotion after 24 h. The novel inhibition 
of glutamate uptake by PJ34 suggested that this effect may compound tests for its 
neuroprotective activity which cannot be merely attributed to PARP-1 block. Furthermore, 
the data published by Nasrabadi et al., (2012) indicate that the neonatal rat spinal cord 
could withstand a strong, long-lasting rise in network excitability without compromising 
locomotor pattern generation or circuit structure in contrast with the damage to brain 
circuits known to be readily produced by persistent seizures. As our results after the 
addition of PM+Mg2+ showed the presence of parthanatos even in grey than in white 
matter, PJ34 was added during the washout after PM+Mg2+ insult, in order to neuroprotect 
the SCI immediately after damage. As we expected, it decreased significantly the piknosis 
at 24 h, above all in the white matter elements. The SCI condition seemed to be improved 
especially when PJ34 was administered in association with caspase-3 inhibitor, protecting 
the spinal cord from the induction of apoptosis and parthanatos by the PM+Mg2+ insult. 
Further experiments have to be done, in order to understand if this result is associated 
with an electrophysiological improvement too. Previous results demonstrated that, when 
PJ34 is administered early during the lesion protocol, a degree of neuroprotection is 
observed (Nasrabady et al., 2011a) in accordance with the present data. 
ATF3 as a marker for migrating ependymal stem cells. The manuscript presently under 
review, is the first report of the dynamic expression of the ATF3 by ependymal spinal stem 
cells. In our experimental conditions, this protein was localized to the cytoplasm when 
such cells were quiescent, but was found in their nucleus when cells became activated. 
This property enabled us to follow up activated ependymal cells that migrated from the 
central canal toward the ventral and dorsal white matter, forming the funicular migratory 
stream (FMS) that resembles the rostral migratory stream (RMS) of the brain neural brain 
stem/progenitor cells (SPCs). The fact that ATF3 immunostaining coincided with well-
known SPC markers, such as nestin, vimentin and SOX2, suggests that ATF3 labeling in 
the spinal cord was primarily expressed by intrinsic stem cells, typically found around the 
central canal (Hugnot and Franzen, 2011). Although virtually absent in embryonic and P0 
ependymal cells, ATF3 was mainly expressed in the cytoplasm and processes of these 
cells from P1 onwards, grew during the first postnatal week and remained elevated later 
with a small decrement only. Such ATF3 stained cells in fresh tissue had small diameter, 
large egg-shaped nucleus, and were closely packed together. However, grey matter cells 
remained devoid of ATF3 staining, adding specificity to the role of this protein for stem cell 
labeling. 
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Role of ATF3 in the regulation of SPCs. There is lack of information on ATF3 in the 
regulation of SPCs. Recent evidence (Gao et al., 2013; Gargiulo et al., 2013) shows the 
involvement of ATF3 in the control of genes like SOX2 or BMI1. These genes are critical 
for pluripotency and reprogramming of the human embryonic stem cells or glioblastoma 
stem-like cells, and ATF3 and SOX2 co-staining seen in the present study supports this 
hypotesis. Moreover, the CREB transcription factor family, of which the ATF3 is a member, 
has an established role in the SPC regulation and neurogenesis (Mantamadiotis et al., 
2012; Merz et al., 2011). Our speculation, thus, includes a new role of ATF3 not only in the 
maintenance of the spinal ependymal cells but also in their activation. 
In vitro conditions induce mobilization of stem cells. When spinal cords were kept in 
vitro for 24 h, we observed a novel phenomenon, namely centrifugal mobilization of 
ependymal stem cells which formed a migratory chain analogous to the brain RMS (Lois et 
al., 1996; Tanvig et al., 2009; Wichterle et al., 1997) as they moved away from the central 
canal to the adjacent ventral and dorsal white matter. When this occurred, ATF3 was 
clearly expressed in the cell nucleus. This phenomenon developed gradually after 4 h and 
was clearly observed at 24 h. Interestingly, ependymal cells which did not mobilize, 
retained their SOX2 nuclear staining, yet lost the ATF3 cytoplasmic one. Hence, ATF3 
nuclear labeling could be interpreted as a novel marker of migrating ependymal cells. The 
fact that in vitro conditions induce mobilization of stem cells has been earlier reported with 
organotypic brain slices (Tanvig et al., 2009): in such case RMS toward the olfactory bulb 
is occurring after several days, while the present report shows a much faster process 
developing within hours. The unchanged occurrence of Ki67 or EdU positive cells in FMS 
at 24 h in vitro is consistent with a process of ependymal cell mobilization rather than 
proliferation that occurs at later time. In support of this hypothesis is the recent observation 
that, in rat organotypic slices, significant proliferation of neuroprogenitors was detected 
only after a few days in culture (Mazzone et al., 2013). Spinal networks are fully preserved 
and viable during this timeframe, including electrophysiological activity of locomotor 
networks (Taccola et al., 2008), so we focused our attention on the mechanisms 
responsible for activation and mobilization of ependymal cells in vitro. In vivo ependymal 
cells are in direct contact with the cerebrospinal fluid (CSF) and numerous blood vessels 
(Hugnot and Franzen, 2011). Thus, their delayed activation in vitro might be due to the 
disappearance of yet-unclear signals from the CSF or blood (Menezes et al., 2002), which 
might normally keep the ependymal cells quiescent (Cheung and Rando, 2013). 
Additionally, the activating signal might come from a few cells injured during dissection, 
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even if systematic analysis of in vitro tissue showed minimal pyknosis at 24 h in vitro 
(Taccola et al., 2008). A recent review has highlighted how stem cell quiescence is a state 
maintained by signaling pathways ready to allow rapid activation (Cheung and Rando, 
2013).  
Pathways mediating ATF3 expression. Previous studies have demonstrated that the 
signal transduction pathways mediating ATF3 expression include c-Jun co-expressed with 
ATF3 in the nervous system after injury and stress (Hunt et al., 2012). The selective 
JNK/c-Jun inhibitor SP600125 fully blocks ATF3 induction in adult rat ganglion neurons 
and inhibits outgrowth of their axons (Lindwall et al., 2004). Furthermore, the MAPK/p38 
pathway is also required for ATF3 expression in several non-neuronal cell lines 
undergoing apoptosis, an effect suppressed by the specific MAPK/p38 inhibitor SB203580 
(Lu et al., 2007). In accordance with these results, our current data showed the 
involvement of both molecular pathways (JNK/c-Jun and MAPK/p38) in the control of the 
ATF3 nuclear expression in mobilized spinal ependymal cells. This observation was also 
supported by Western blotting analysis indicating ATF3 expression (of molecular weight in 
full accordance with reports by Chen et al. (1994) and Hashimoto et al. (2002) in nuclear 
fractions at 24 h in vitro. The origin of the variation in the molecular weight between the 
nuclear and cytoplasmic ATF3 protein remains unclear and will need future work. 
ATF3 expression and migration after excitotoxic and ischemic-like conditions. 
Excitotoxic or ischemic-like protocols, that are reported to produce moderate damage to 
the spinal cord (Bianchetti et al., 2013; Mazzone et al., 2010; Taccola et al., 2008), did not 
enhance the number of activated and migrating ATF3 positive cells 24 h later. When the 
excitotoxic stimulus was very strong (1 mM kainate), the number of activated ependymal 
cells actually decreased in line with widespread neurotoxicity (Taccola et al., 2008). Our 
previous investigations have indicated that, in the rat spinal cord, neuronal and glial death 
occurs mainly during the first 24 h (Bianchetti et al., 2013; Mazzone et al., 2013; Taccola 
et al., 2008). Any attempt to repair cell damage might perhaps require an intervention by 
stem cells occurring over several days after the primary injury. This process has been 
examined with long-term organotypic cultures in which stem cell activation two weeks after 
excitotoxic stimulation failed to produce significant neurogenesis (Mazzone et al., 2013). 
Our speculation is that the role of ATF3 might be different in the neuronal (postmitotic) and 
ependymal (mitotic) spinal cells. In neurons ATF3 is viewed as a late marker for injury 
(Francis et al., 2004; Tsujino et al., 2000; Tsuzuki et al., 2001), with a neuroprotective and 
pro-survival influence (Wang et al., 2012; Zhang et al., 2011). The role of ATF3 in 
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proliferation and migration of ependymal cells could be similar to the ATF3 role in cancer 
cells in which ATF3 promotes proliferation, motility and invasiveness of certain cancer cell 
lines (Thompson et al., 2009; Wang et al., 2008). 
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CONCLUSIONS AND FUTURE PROSPECTS 
My project has demonstrated the feasibility of producing an in vitro model that mimics 
ischemia in the spinal cord, thus extending former studies using OGD on brain slices to 
simulate stroke. Our model can reproduce clinical conditions of spinal ischemic damage 
with partial loss of neurons and glia associated with severe functional impairment. In this 
experimental setting, various cell death processes were observed, especially parthanatos. 
Furthermore, PJ34, an inhibitor of PARP-1, produce partial neuroprotection despite its 
ability to induce network persistent activity. Within the field of cell neurorepair, we 
characterized spinal stem/progenitor cells, demonstrating ATF3 as a marker for their 
presence and activation. Future studies concerning pharmacological and cellular 
approaches are thus necessary to test the outcome of our SCI model. 
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